
<html lang="en"     class="pb-page"  data-request-id="74537f47-f8f3-4e67-940c-1c47197ee80e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm901869w;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs" /></meta><meta name="dc.Creator" content="Divita  Garg" /></meta><meta name="dc.Creator" content="Stefan  Henrich" /></meta><meta name="dc.Creator" content="Outi M. H.  Salo-Ahen" /></meta><meta name="dc.Creator" content="Hannu  Myllykallio" /></meta><meta name="dc.Creator" content="Maria P.  Costi" /></meta><meta name="dc.Creator" content="Rebecca C.  Wade" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 8, 2010" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901869w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901869w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901869w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901869w" /></link>
        
    
    

<title>Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901869w" /></meta><meta property="og:title" content="Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901869w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901869w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901869w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901869w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901869w&amp;href=/doi/10.1021/jm901869w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 6539-6549</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901812z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm1008538" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Divita++Garg">Divita Garg</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Henrich">Stefan Henrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Outi+M.+H.++Salo-Ahen">Outi M. H. Salo-Ahen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hannu++Myllykallio">Hannu Myllykallio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+P.++Costi">Maria P. Costi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+C.++Wade">Rebecca C. Wade</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Molecular and Cellular Modeling Group, Heidelberg Institute of Theoretical Studies gGmbH, Heidelberg, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Institute of Structural Biology, Helmholtz Zentrum MÃ¼nchen, Neuherberg, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Department of Biosiences, Biochemistry, Ãbo Akademi University, Turku, Finland</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Laboratoire d'Optique et Biosciences, Ecole Polytechnique, CNRS UMR7645, INSERM U696, Palaiseau, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">Dipartimento di Scienze Farmaceutiche, UniversitÃ  degli Studi di Modena e Reggio Emilia, Modena, Italy</span></div><div class="corresp-info"><strong>*</strong>To whom the correspondence should be addressed. For D.G.: phone, +49-89-28913284; fax, +49-89-28913869; e-mail, <a href="/cdn-cgi/l/email-protection#690d001f001d08470e081b0e290144001d1a47061b0e"><span class="__cf_email__" data-cfemail="23474a554a57420d44425144634b0e4a57500d4c5144">[emailÂ protected]</span></a>. For R.C.W.: phone, +49-6221-533247; fax, +49-6221-533298; e-mail, <a href="/cdn-cgi/l/email-protection#55273037303636347b22343130153d783c21267b3a2732"><span class="__cf_email__" data-cfemail="6e1c0b0c0b0d0d0f40190f0a0b2e0643071a1d40011c09">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901869w&amp;href=/doi/10.1021%2Fjm901869w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 6539â6549</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 8, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 December 2009</li><li><span class="item_label"><b>Published</b> online</span>8 June 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 September 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901869w" title="DOI URL">https://doi.org/10.1021/jm901869w</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6539%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDivita%2BGarg%252C%2BStefan%2BHenrich%252C%2BOuti%2BM.%2BH.%2BSalo-Ahen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D18%26contentID%3Djm901869w%26title%3DNovel%2BApproaches%2Bfor%2BTargeting%2BThymidylate%2BSynthase%2BTo%2BOvercome%2Bthe%2BResistance%2Band%2BToxicity%2Bof%2BAnticancer%2BDrugs%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6549%26publicationDate%3DSeptember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901869w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2832</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901869w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Divita&quot;,&quot;last_name&quot;:&quot;Garg&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Henrich&quot;},{&quot;first_name&quot;:&quot;Outi&quot;,&quot;last_name&quot;:&quot;M. H. Salo-Ahen&quot;},{&quot;first_name&quot;:&quot;Hannu&quot;,&quot;last_name&quot;:&quot;Myllykallio&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;P. Costi&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;C. Wade&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;6539-6549&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901869w&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901869w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901869w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901869w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901869w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901869w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901869w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901869w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901869w&amp;href=/doi/10.1021/jm901869w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901869w" /></input><a href="/doi/pdf/10.1021/jm901869w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901869w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901869w%26sid%3Dliteratum%253Aachs%26pmid%3D20527892%26genre%3Darticle%26aulast%3DGarg%26date%3D2010%26atitle%3DNovel%2BApproaches%2Bfor%2BTargeting%2BThymidylate%2BSynthase%2BTo%2BOvercome%2Bthe%2BResistance%2Band%2BToxicity%2Bof%2BAnticancer%2BDrugs%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D18%26spage%3D6539%26epage%3D6549%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292544" title="Targeting">Targeting</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jmcmar.2010.53.issue-18/production/jmcmar.2010.53.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Thymidylate Synthase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The antifolate drug, methotrexate, was introduced to the clinic as an anticancer agent in the early 1950s.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Subsequently, its mechanism of action was elucidated and it was found to bind in mono- and polyglutamated forms to dihydrofolate reductase (DHFR<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>),<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: Î±FR, Î± folate receptor; CE, carboxylesterase; CDK, cyclin dependent kinase; CD, cytidine deaminase; Cyp 450, cytochrome P450; DHFR, dihydrofolate reductase; DPD, dihydropyrimidine dehydrogenase; ECTA, enzyme catalyzed therapeutic activation; EGFR, epidermal growth factor receptor; FPGS, folylpolyglutamate synthetase; GI, gastrointestinal; GARFT, glycinamide ribonucleotide formyl transferase; HDACi, histone deacetylase inhibitors; ODN, oligodeoxynucleotide; OPRT, orotate phosphoribosyltransferase; PKC, protein kinase C; RFC, reduced folate carrier; siRNA, small inhibitory RNAs; TK, thymidine kinase; TP, thymidine phosphorylase; TS, thymidylate synthase; UK, uridine kinase; UP, uridine phosphorylase.</p></div> thymidylate synthase (TS),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and aminoimidazolecarboxamide ribonucleotide transformylase (AICARTF).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> A fluoropyrimidine, 5-fluorouracil (5FU), was conceived in 1957<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> following the observation that uracil was utilized preferentially in malignant over nonmalignant cells<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and has since been a first line drug in cancer chemotherapy. Subsequently, 5-fluoro-2â²-deoxyuridine 5â²-monophosphate (5FdUMP), an active metabolite of 5FU, was found to inhibit TS by forming a covalent ternary complex with the enzyme and 5,10-methylenetetrahydrofolate (mTHF).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These discoveries marked the dawn of exploiting TS as an anticancer target.</div><div class="NLM_p">TS (EC 2.1.1.45), which is encoded by the TYMS gene in humans, catalyzes the conversion of 2â²-deoxyuridine 5â²-monophosphate (dUMP) to 2â²-deoxythymidine 5â²-monophosphate (dTMP) by using mTHF as a cosubstrate. dTMP is then phosphorylated by thymidylate kinase to 2â²-deoxythymidine diphosphate (dTDP) and then to 2â²-deoxythymidine triphosphate (dTTP) by nucleoside diphosphate kinase for use in the synthesis of new DNA. Thus, in human cells, TS plays a key role in the biosynthetic pathway that provides the sole de novo source of thymidylate, an essential precursor required for DNA replication and repair.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition to its catalytic function, TS acts as a regulator of translation for some mRNAs. One of these is its own mRNA,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and others include p53,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> which is a tumor suppressor, and c-myc,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> which is oncogenic. Binding of the TS protein to its own mRNA leads to the formation of an autoregulatory feedback loop for repression of the translation of TS mRNA (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). A 36 nucleotide sequence (75â110, site I),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> encompassing the start codon, and a 70 nucleotide sequence (480â550, site II)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> within the coding region have been identified as the most essential regions in the TS mRNA for binding to the TS protein. On the p53 mRNA, the nucleotide sequence from 531 to 1020 in the protein coding region,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and for the c-myc mRNA, the C terminal coding region covering nucleotide positions 1625â1790,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> have been identified to be important for binding to the TS protein. On the basis of the observation that overexpression of TS sets the cells into a neoplastic phenotype, oncogenic behavior is a novel role that has been attributed to TS recently.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2">1.1 Resistance and Toxicity: Need for New Approaches</h3><div class="NLM_p">TS has two substrates, dUMP and mTHF, both of which bind in the catalytic site to enable the synthesis of dTMP. Known inhibitors of TS, e.g., fluoropyrimidines or the antifolates such as raltitrexed<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), act as analogues of one of these substrates and compete for the catalytic pocket to inhibit the enzyme. However, soon after exposure, the cells develop resistance to these chemotherapeutic agents. Multiple mechanisms have been proposed to explain this effect.</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanisms of inhibition of hTS by drugs (green) and of drug resistance (red). From left to right: The TYMS gene is transcribed to TS mRNA which is translated to hTS protein which catalyzes the conversion of dUMP and mTHF to dTMP and dihydrofolate (DHF). The TS protein is shown in its monomeric and dimeric forms, as it has been suggested to exist in a monomerâhomodimer equilibrium (black arrows) in nature (<contrib-group>Voeller</contrib-group>et al. <cite>Biochem. Biophys. Res. Commun.</cite> <span class="NLM_year">2002</span>, <em>297</em>, 24â31). The dimeric form is obligatory for its catalytic activity; which of the two forms binds to the TS mRNA is, however, debatable. Drug resistance by gene amplification and by interruption of the proteinâmRNA binding can occur independently of each other.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One proposed mechanism is disruption of the autoregulatory repression of translation (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Only apo-TS can bind the mRNA,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> whereas TS bound to ligands, such as TS inhibitory drugs, cannot interact with the mRNA.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Ligand binding thereby alleviates the translational repression by TS protein, inducing overexpression of TS protein. Increased levels of cellular TS thereby negate the therapeutic effect of TS inhibitory drugs, leading to resistance. In contradiction, though, is the observation that, after treatment of human colon tumor cell lines with 5-fluorodeoxyuridine (5FdUrd), there is no increase of the ribosome/TS mRNA ratio that could be responsible for higher TS expression but instead the half-life of the TS protein is increased.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Gene amplification is another TS-inducing mechanism employed by cells for developing resistance to TS inhibitors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Moreover, some individuals are inherently more resistant to TS targeted therapy than others. In some cases, this can be attributed to the polymorphism of the TS gene. TYMS is a polymorphic gene having two (2R) or three (3R) repeats of a 28 base sequence in the 3â² untranslated region (UTR). Humans can be homozygous for either one of these forms, i.e., 2R/2R or 3R/3R or heterozygous 2R/3R. The individuals with 3R tandem repeats express higher levels of TS and could be intrinsically more resistant to TS inhibitory drugs than those with the 2R type.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a></div><div class="NLM_p">Like other chemotherapeutic drugs, the TS inhibitory anticancer agents also have toxic effects on healthy tissue. Myelotoxicity, thrombocytopenia, neutropenia, mucositis, and diarrhea caused by damage to bone marrow cells, blood cells, or the intestinal lining<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> are a few examples of the various toxicities observed upon administration of TS inhibitors. Most of these toxic effects can be avoided by specific delivery of the drugs to the tumors, thereby sparing the remaining tissues. Advances in this direction have led to the design of drugs such as capecitabine<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) and pemetrexed<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) which show superior toxicity profiles. However, there is still a vast scope for improvement before the severe side effects are completely abrogated.</div><div class="NLM_p last">A PubMed search carried out on March 31, 2010, using âthymidylate synthaseâ and âcancerâ as keywords, retrieved 373 papers published in the past 3 years, illustrating the fact that despite the challenges presented, the status of TS as an anticancer target remains undiminished and it continues to be a focus for cancer therapy research. This Perspective aims to give a brief overview of various strategies that are being employed to overcome the hurdles of resistance and toxicity while targeting TS.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2 New Chemical Strategies for Targeting the Enzyme Thymidylate Synthase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first structure of TS to be solved was that from <i>Lactobacillus casei</i> in 1987.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Since then, many structures for human (hTS) and other TS proteins in free and liganded forms have been determined, giving insights into the structural and dynamic features of the protein. The understanding of the molecular mechanisms involved in the catalytic action of TS and its role in pyrimidine synthesis, and folate and related pathways has also improved immensely over the years since it was recognized as an anticancer target. This improved knowledge is now being applied to identify new compounds that could inhibit the enzyme while bypassing the toxicity and resistance problems. This section will deal with some of the strategies being used, some of which have already shown success in the clinic, while others are still at an early experimental level.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.a 5FU Prodrugs</h3><div class="NLM_p">The concept of a prodrug is widely employed as a means to improve the pharmacology and pharmacokinetics of an active drug molecule. 5FU, which is one of the first choice anticancer drugs, particularly against colorectal cancer, is itself a prodrug (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) (see review by Longley et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>). 5FU is bioactivated to active metabolites, e.g., 5FdUMP (a TS inhibitor), 5-fluorouridine triphosphate (5FUTP, which gets incorporated into the RNA). However, since the enzymes for activating 5FU are not tumor selective, toxicity is a major issue with this drug, e.g., activation in the intestines leads to diarrhea. Moreover, it is rapidly degraded by dihydropyrimidine dehydrogenase (DPD), which is abundantly found in liver, thereby limiting its oral bioavailability. Despite this, 5FU is still being used in a clinical setting in part because of its low therapeutic cost. A prodrug for 5FU, capecitabine (<i>N</i><sup>4</sup>-pentyloxycarbonyl-5â²-deoxy-5-fluorocytidine), was designed by Miwa et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and was approved by the FDA in 1998, with a recommended dose of 2500 (mg/m<sup>2</sup>)/day (<a href="http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/" class="extLink">www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/</a>). Capecitabine is selectively converted to 5FU in tumor cells by a cascade of three enzymes, hepatic carboxylesterase (CE), cytidine deaminase (CD) mainly localized in liver and tumor tissues, and thymidine phosphorylase (TP) which is more highly active in tumorous than in normal tissues (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), thereby making its action tumor-specific. Improved oral bioavailability and reduced incidence of diarrhea are other major advantages of capecitabine over 5FU,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> but incidences of a dose-limiting side effect hand-and-foot syndrome have been reported.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Tegafur (5-fluoro-1-(tetrahydro-2-furanyl)-2,4(1<i>H</i>,3<i>H</i>)-pyrimidinedione)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> is another prodrug of 5FU (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), bioactivated in the liver by cytochromes P-450 (Cyp 450).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> It is administered in combination with modulators such as uracil<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and 5-chloro-2,4-dihydroxypyridine,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> which compete for DPD, consequently improving the bioavailability of the released 5FU. Combination with potassium oxonate, which inhibits orotate phosphoribosyltransferase (OPRT) in the gastrointestinal (GI) tract, helps in reducing the GI toxicities.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a></div><div class="NLM_p">Another experimental approach to designing prodrugs for specific delivery employs the antibody directed prodrug therapy (ADEPT) or gene directed prodrug therapy (GDEPT) methodology. The first step is to specifically deliver enzymes to the surface of tumor tissues. Next the prodrugs that are metabolized by the enzymes are administered, thereby leading to activation of the drug molecule only at the tumor mass.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Application of cephem conjugation and release of the active molecule by Î²-lactamase is a well established strategy in the literature for tumor specific delivery of chemotherapeutic agents such as mitomycin and platinum derived drugs. Recently, an experimental 5FU-cephem conjugate that remains stable until activated by Î²-lactamase has been reported by Phelan et al.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Another type of compound with potential as a prodrug is the FdUMP[N] oligodeoxynucleotide, which can be simply cleaved by enzymes with 3â²-<i>O</i>-exonucleolytic activity such as p53 to release FdUMP.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Mechanism of Activation of Capecitabine and Tegafur to TS Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>CDHP: 5-chloro-2,4-dihydroxypyridine. The enzymes involved are CE, CD, TP, Cyp 450, UP, UK, OPRT, and TK.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.b Enzyme Catalyzed Therapeutic Activation</h3><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Conventional drugs against TS act by inhibiting the enzyme and are ineffective at high concentrations of the protein, as observed in resistant cells. The enzyme catalyzed therapeutic activation (ECTA) approach utilizes the âtargetâ enzyme to activate the ligand, thus turning high concentrations of the enzyme, as observed in resistant cells, to advantage. (<i>E</i>)-5-(2-Bromovinyl)-2â²-deoxyuridine 5â²-monophosphate (BVdUMP), a metabolite of the antiviral agent (<i>E</i>)-5-(2-bromovinyl)-2â²-deoxyuridine (BVdU), is known to be a competitive substrate of TS, which converts it to cytotoxic products intracellularly. Lackey et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> have designed a pronucleotide analogue of BVdU, (<i>E</i>)-5-(2-bromovinyl)-2â²-deoxy-5â²-uridylphenyl <span class="smallcaps smallerCapital">l</span>-methoxylalaninylphosphoramidate <b>1</b> (NB1011, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), which is converted to BVdUMP by intracellular enzymes and subsequently to cytotoxic products by TS. It has been demonstrated that <b>1</b> is at least 10 times more cytotoxic to cells overexpressing TS, including 5FU resistant cells, and its activity is abolished in the presence of TS inhibitors such as raltitrexed.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> Synergistic antitumor effects have been demonstrated with other nucleoside transport inhibitory chemotherapeutic agents, such as dipyridamole and <i>p</i>-nitrobenzylthiosine. The mechanism of synergy is, however, not well understood.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a><b>1</b> has recently completed phase 1 clinical trials on patients with metastatic colorectal cancer with fluoropyrimidine failure<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (e.g., <a href="http://clinicaltrials.gov/ct2/show/NCT00031616" class="extLink">clinicaltrials.gov/ct2/show/NCT00031616</a>). The success of <b>1</b> has stimulated efforts to design new and more potent derivatives of BVdU.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.c Multitarget Inhibitors</h3><div class="NLM_p">Pemetrexed, (<i>N</i>-[4-[2-(2-amino-4,7-dihydro-4-oxo-1<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)ethyl]benzoyl]-<span class="smallcaps smallerCapital">l</span>-glutamic Acid, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) provides one example of successfully targeting more than one enzyme for anticancer activity. Many detailed reviews can be found on its activity (e.g., see Adjei<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a>). In short, the drug enters the cells via a reduced folate carrier and is polyglutamated by folylpolyglutamate synthetase (FPGS) to the pentaglutamate form which is 60 times more potent than the parent compound and has enhanced intracellular retention. It then additively inhibits at least three enzymes in the purine and pyrimidine synthesis pathway, namely, TS (<i>K</i><sub>i</sub> = 1.3 nM), DHFR (<i>K</i><sub>i</sub> = 7.2 nM), and glycinamide ribonucleotide formyl transferase (GARFT) (<i>K</i><sub>i</sub> = 380 nM),<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> all of which have folate derivatives as their natural substrates.</div><div class="NLM_p">The enzymes TS and DHFR are coupled on the folate pathway such that the product of TS is the substrate for DHFR. Folate analogue inhibitors of TS and DHFR have independently found utility in the clinic as anticancer agents. The substitution on the pyrimidine ring seems to determine whether the molecule will be a TS or DHFR inhibitor; TS inhibitors generally contain a 2-amino-4-oxo or 2-methyl-4-oxo substitution on the pyrimidine ring, whereas the inhibitors of DHFR generally carry a 2,4-diamino substitution.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> A common inhibitor for both TS and DHFR could show additive effects while circumventing the pharmaceutical disadvantages of the simultaneous application of two drugs. In view of this idea, Gangjee et al. have been working on the structure-based design and synthesis of potent dual inhibitors of TS and DHFR (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>), such as pyrrolo[2,3-<i>d</i>]pyrimidines <b>2</b>, <b>3</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> thieno[2,3-<i>d</i>]pyrimidines <b>4</b>,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and pyrrolo[3,2-<i>d</i>]pyrimidines <b>5</b>,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> some of which do not require polyglutamylation for activity, e.g., the 2-[(benzoylamino)-4â²-yl]-<span class="smallcaps smallerCapital">l</span>-glutamic acid derivative of <b>5</b> (<b>5i</b>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> This latter aspect is important for avoiding one route to developing resistance, that via reduced FPGS activity.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Some of these molecules, e.g., <i>N</i>-{4-[(2-amino-6-methyl-4-oxo-3,4-dihydrothieno[2,3-<i>d</i>]pyrimidin-5-yl)sulfanyl]benzoyl}-<span class="smallcaps smallerCapital">l</span>-glutamic acid (<b>4bi</b>)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> have shown potent dual inhibitory activity, not only against human enzymes (IC<sub>50</sub> of 40 and 20 nM, respectively, for hTS and DHFR) but also against <i>Escherichia coli</i> and <i>Toxoplasma gondii</i> enzymes, with IC<sub>50</sub> values nearly in the same range, and they could thus be possible leads for antiparasitic and anticancer agents. A further step could be to design molecules that would additionally inhibit other folate enzymes but not be dependent upon polyglutamation by FPGS for activity.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Mechanism of Activation and Targeting Pathway of Multitarget Folate Analogue Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>The known inhibitor pemetrexed is pentaglutamated by FPGS for potent inhibitory activity, whereas some of the experimental dual TS-DHFR inhibitors do not need glutamation. THF: tetrahydrofolate. fTHF: formyltetrahydrofolate.</p></p></figure><figure id="cht2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Examples of Dual TS-DHFR Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.d Stabilizing the Inactive Conformer and Allosteric Inhibitors</h3><div class="NLM_p">When Schiffer and co-workers<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> first crystallized the unliganded form of hTS, they found that the active site loop (residues 181â197) containing the catalytic cysteine (Cys195) was twisted about 180Â° compared to the corresponding loop conformation in the liganded hTS. Since in unliganded hTS, Cys195 is outside the active site, the enzyme must be inactive (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The authors suggested that the inactive conformation might serve to protect the catalytic cysteine from cellular modification. Three phosphate/sulfate ions were observed to be bound near the active site, suggesting that inactive hTS could bind to TS mRNA, thereby repressing TS protein synthesis. In addition, the disordered small domain (residues 107â128) of the inactive hTS likely increases its proneness to cellular degradation, further reducing the cellular TS levels. They demonstrated through fluorescence studies that there is an equilibrium between the active and inactive states; phosphate ions were shown to shift the equilibrium toward the inactive state and binding of dUMP toward the active state.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The R163K mutant which stabilizes the active conformer is at least 33% more active than WT hTS, suggesting that at least <sup>1</sup>/<sub>3</sub> of hTS populates the inactive state.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In another crystal of the inactive conformer obtained under low salt conditions,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> a clear density was observed in a hydrophobic pocket unique to the inactive conformation (formed by residues Phe137, Gln138, Phe142, Gly143, Trp182, and Leu187). It was interpreted as a valine or leucine residue, either from the flexible N-terminus or from the neighboring molecule in the crystal. As this allosteric pocket is located about 16â18 Ã from the phosphate/sulfate ions binding site, ligands binding to it could possibly stabilize the inactive conformation.</div><div class="NLM_p">On the basis of structural considerations, Lovelace et al.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> designed an anionic inhibitor of hTS, 1,3-propanediphosphonic acid (PDPA), which binds partially to the previously detected phosphate/sulfate sites (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Since this position is distinct from the dUMP or folate binding sites, PDPA is an allosteric inhibitor. It shows a complex inhibition profile for the WT hTS, uncompetitive inhibition at low concentrations (<i>K</i><sub>i</sub> = 0.26 Î¼M), and mixed (noncompetitive) inhibition at higher concentrations (<i>K</i><sub>i</sub> = 2.7 Î¼M). On the other hand, the R163K mutant and mouse TS are only weakly but competitively inhibited by PDPA (most likely by binding to the site of the dUMP phosphate moiety). Since these proteins probably do not populate the inactive state, the complex inhibition profile of PDPA for the WT hTS is proposed to be related to the presence of the inactive conformer. Further, PDPA also demonstrated positive cooperativity with an antifolate inhibitor, (<i>S</i>)-2-[4-[<i>N</i>-[(3,4-dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl]-<i>N</i>-prop-2-ynylamino]-2-fluorobenzamido]-4-(1<i>H</i>-1,2,3,4-tetrazol-5-yl)butyric acid (ZD9331).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Unfortunately, this small ligand is very polar in nature and is not an ideal lead structure for drug development.</div><div class="NLM_p">The structural and kinetic features involved in the activeâinactive transition and stabilization of either state are still not well understood. Experimental studies, such as design of the fully active R163K variant and the recently reported fully inactive M190K variant,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> can aid in designing inhibitors to stabilize the inactive state. Thus, ligands designed to prevent the conformational change from the catalytically inactive to the active form might provide a novel approach to inhibiting the enzyme and may also help to avoid the development of cellular resistance associated with higher TS protein levels. The allosteric sites mentioned above may be too small to be targeted by druglike molecules. However, it might be possible to usefully exploit them by additionally targeting neighboring pockets. There may also be other, as yet undiscovered binding sites in hTS that can be targeted to affect the amount of active enzyme.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Cartoon representation of the superimposed monomeric subunits (from the crystallized dimers) of human thymidylate synthase in active (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HVY">1HVY</a>) (yellow) and inactive (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ONB">2ONB</a>) (gray) conformations. The active conformation of the active site loop is shown in green and the inactive conformation in red. The catalytic cysteine, C195, is highlighted with stick representation on the loops. The small domain visible in the active crystal structure is shown in brown. dUMP (cyan sticks) and a folate analogue raltitrexed (dark-blue sticks) are present in the active site, whereas PDPA (ball-and-stick representation) is located in an allosteric position. (b) Interactions of dUMP with the protein. Dashed lines represent direct hydrogen bonds between amino acid residues and the ligand. Solid line between Cys195 and dUMP represents a covalent bond. (c) Interactions of folate analogue raltitrexed with the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.e Exploiting the Overexpressed Transporters</h3><div class="NLM_p last">The reduced folate carrier (RFC) is ubiquitously expressed in cells for the transport of folate into the cells and is also used by a large number of antifolate drugs. These drugs also show high affinity for the Î± folate receptor (Î±FR), which is a low capacity folate transporter, highly overexpressed in some cancerous tissues. The Î² isoform of the folate receptor is instead overexpressed in activated macrophages and some tumors. The high overexpression of the specific isoform of the FR can be utilized for specific delivery of antifolate drugs into the cancerous cells, thereby sparing the remaining tissue. For detailed accounts of folate receptor based targeting, see reviews from Low et al.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and Salazar and Ratnam.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> This approach has been realized for TS inhibition with cyclopenta[<i>g</i>]quinazoline derivatives such as 2(<i>R</i>)-(4(<i>S</i>)-carboxy-4-{4-[<i>N</i>-(2-methyl-4-oxo-4,6,7,8-tetrahydro-3<i>H</i>-cyclopenta[<i>g</i>]quinazolin-6-yl)-<i>N</i>-(2-propynyl)amino]benzamido}butyramido)pentanedioic acid (BGC 638) and 2(<i>R</i>)-[4(<i>S</i>)-carboxy-4-[4-[<i>N</i>-(2-hydroxymethyl-4-oxo-4,6,7,8-tetrahydro-3<i>H</i>-cyclopenta[<i>g</i>]quinazolin-6-yl)-<i>N</i>-(2-propynyl)amino]benzamido]butyramido]pentanedioic acid <b>6</b> (BGC 945, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) which have unexpectedly high affinity for Î±FR and low affinity for RFC.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The <i>K</i><sub>i</sub> value of <b>6</b> for isolated TS is 1.2 nM, and the IC<sub>50</sub> for Î±FR overexpressing human tumor cells is â¼1â300 nM; in contrast, the IC<sub>50</sub> for Î± FR negative mouse L1210 or human A431 cells is 7 Î¼M. Following its success in mice models, <b>6</b> has been taken up for clinical development.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Since the underlying mechanism for the selective uptake by Î±FR is not understood, this approach can as yet not be rationally exploited for drug development.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.f Peptidic Inhibitors of the TS Protein</h3><div class="NLM_p last">On the basis of an analysis of a <i>L. casei</i> TS crystal structure and counting the number of contacts between residues of both subunits, three peptides, N22, M17 and C20, were selected corresponding to the <i>L. casei</i> TS sequences 17â38, 174â190, and 201â220, respectively.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> After incubation of <i>L. casei</i> TS with the C20 peptide, inhibition of enzyme activity and aggregation were observed. This effect was not detected for the N22 and M17 peptides, or after incubating the ternary complex of TS, FdUMP, and mTHF, with C20. The ability to use peptides to inhibit TS may be a good starting point for developing peptide-like or peptidomimetic inhibitors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">3 Targeting the Step before: mRNA</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Various techniques using antisense oligodeoxynucleotides (ODNs), oligoribonucleotides, small inhibitory RNAs (siRNA), and microRNAs are known to be useful for modulating gene expression at the post-transcriptional level. In 1998, the first antisense ODN drug, fomivirsen was approved for treatment of cytomegalovirus retinitis;<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> many others are now in clinical trials for an array of diseases<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> including cancer (e.g., <a href="http://clinicaltrials.gov/ct2/show/NCT00689065" class="extLink">clinicaltrials.gov/ct2/show/NCT00689065</a>). Since interruption of the autoregulatory mechanism for inhibiting the translation of mRNA is proposed to play a role in development of resistance against TS targeting drugs, therapies targeted at silencing the TS mRNA could be of importance in tackling this resistance problem. Even though the delivery and specificity of RNA inhibitory molecules to the tumor cells remain an issue, targeting the TS mRNA is a possible strategy for development as standalone or, more likely, as adjuvant therapy together with conventional TS inhibitory chemotherapeutic agents.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">3.a Antisense Oligodeoxynucleotides (ODNs)</h3><div class="NLM_p">ODNs are designed to anneal against the target mRNA, forming an RNAâDNA duplex leading to abolition of protein synthesis either by direct inhibition of translation or by stimulation of the degradation of mRNA. From the TS proteinâmRNA binding studies, it would be expected that since regions of the mRNA important for protein binding, sites I and II, should be important for regulating the translation of TS mRNA in cells, these would be effective antisense targets as well. Surprisingly, this does not seem to be the case.</div><div class="NLM_p">Several regions throughout the length of the TS mRNA have been investigated for targeting by the antisense technology, both in vitro and in vivo. Application of ODNs to target TS has been extensively reviewed by Berg et al.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Interestingly, the ODN found to be most effective in cell proliferation assays is the one targeting nucleotides 1184â1203 in the 3â² UTR of hTS mRNA.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> Contrary to expectations, the ODNs targeting the translational start site encompassed in site I led to up-regulation of the TS gene transcription and were ineffective in decreasing the TS protein levels.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Whether the ODNs bound specifically to the intended target or made any additional interactions affecting this discrepancy remains to be investigated.</div><div class="NLM_p last">It is commonly accepted that use of an ODN leads to insufficient decrease in cellular protein levels to present any significant translation repression effect on cell proliferation. Thus, ODNs are generally considered as an option for adjuvant therapy. However, the effectiveness of using a standalone combination of ODNs targeting different mRNAs was first demonstrated by Normanno et al.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> for the epidermal growth factor family. Subsequently, the effectiveness of combinations of ODNs targeting the same mRNA has been demonstrated by Berg et al., by using the example of TS mRNA. Combining the ODN targeting nucleotides 1184â1203 with ODNs targeting either 1081â1100 or 1436â1455 showed an additive antiproliferative action, whereas the combination of the latter two failed to show any additivity.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Whether ODNs can eventually be developed into an independent treatment for cancer is still questionable. However, they are surely candidates to be considered for combination chemotherapy.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">3.b Small Interfering RNA (siRNA)</h3><div class="NLM_p">Small double stranded RNA sequences called siRNA are widely used for selective post-transcriptional silencing of gene expression in functional genomics experiments.<a onclick="showRef(event, 'ref63 ref68'); return false;" href="javascript:void(0);" class="ref ref63 ref68">(63, 68)</a> The siRNAs are about 21 nucleotides long and are reported to be 100- to 1000-fold more efficient than the corresponding ODNs. The specificity of gene silencing by siRNA depends on the length and the concentration of the RNA. Longer siRNAs tend to induce interferon response, and the probability of off-target effects is high at higher concentrations.</div><div class="NLM_p">Not much literature on identification of effective siRNA targets for TS is available, but as for the ODNs, the general trend seems to be that targeting the sequences toward the 3â² end, i.e., beyond the putative protein binding sites, is more effective. Transfection of cells with siRNA targeting nucleotides 978â996 (R1), 991â1109 (R2), or 1058â1077 (R3) has been reported to cause 90â95% decrease in TS levels,<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69-71)</a> whereas targeting the sequences 95â122 and 208â226 had negligible effects on TS expression.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Although the observed reduction in TS levels is insufficient to have any significant effect on cell proliferation of HeLa and RKO cell lines, it is enough to resensitize the resistant cells to TS inhibitors.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> In another study carried out on ACC3 cells from salivary adenoid carcinoma, targeting nucleotides 978â996 effectively inhibited the cell growth and also induced apoptosis in a xenograft model in nude mice.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p">Direct transfection of cells with siRNA leads to a temporary reduction in gene expression, which resumes after the degradation of the inserted siRNA. A retroviral infection that encodes for the siRNA can lead to stable introduction of the gene and a âpermanentâ or longer lived effect, but the choice of the plasmid could be a crucial determinant of the effectiveness of the cloned siRNA.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p last">Site 1 is not only implicated in the proteinâmRNA binding for translational repression, it also contains the start codon, which is responsible for initiation of translation, so the ineffectiveness of the ODN and siRNA sequences targeting site 1 comes as a surprise. This observation brings into question the significance of site 1 in translational repression and, additionally, the role it plays in translation initiation and mRNA stability.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">3.c Peptides</h3><div class="NLM_p">Though sites I and II sequences of the TS mRNA have been found to be important for the proteinâmRNA binding, the mRNA binding regions of the TS protein are still unknown. Identification of these sites would be useful for developing new inhibitors of TS translation, for example, by mimicking the structural features of the RNA binding moieties of the protein. Chu et al. showed that enzymatically active exogenous human recombinant TS protein, but not that synthesized directly in vitro in a rabbit reticulocyte lysate system, is sufficient for binding to the full-length TS mRNA.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The presence of oxidizing agents blocked mRNA binding, whereas reducing agents increased the binding.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Mutating each cysteine residue in TS to alanine led to partial and drastic reduction in mRNA binding, respectively, for the C199A and C180A mutants, suggesting the impact of residue C180 on translation control.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">By screening a series of overlapping 17-mer peptides spanning the complete sequence of hTS, Voeller and co-workers identified five peptides capable of binding the full-length as well as the site I sequence from hTS mRNA.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> All of the five peptides correspond to sequences located in the interface region between the two monomers of the homodimeric protein, and four of them contain at least one arginine that is conserved in several TS species. One of the peptides corresponds to the sequence of the C20 peptide (see section <a class="ref internalNav" href="#sec2_6" aria-label=""></a> above) whose binding resulted in TS protein aggregation. From the location of the peptides at the interface region, Voeller et al. concluded that a monomeric form of TS must exist to make those regions accessible to mRNA. They confirmed the existence of the monomeric form by equilibrium dialysis in which only the monomeric form was able to pass the membrane because of its smaller size. Afterward, it still showed enzymatic activity, presumably in the reformed dimeric form.</div><div class="NLM_p">In a more recent paper, peptides binding to the site I sequence from TS mRNA were selected from a large peptide library using mRNA display.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> After 12 rounds of amplification, an analysis of the amino acid composition of 18 totally random sequence positions within the yielded peptides suggested that mainly basic side chains took part in mRNA binding. Specific sequences were not found, and it was suggested that nonspecific interactions were involved in mRNAâpeptide binding.</div><div class="NLM_p last">So far, no clearly defined sequence and structural characterization of the TS mRNAâprotein/peptide binding complex has been achieved; therefore, further investigations are important for the rational design of peptides or peptidomimetics to specifically inhibit TS translation.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">4 Indirect Thymidylate Synthase Expression Regulators</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The techniques discussed so far deal with direct targeting of the TS protein or mRNA. However, targeting other proteins that act as TS expression regulators could also affect the in vivo levels of the TS protein or mRNA and consequently synergize with the TS inhibitors. We shall here discuss histone deacetylase inhibitors and E2F-1 inhibitors as examples from this category.</div><figure id="cht3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.a Histone Deacetylase Inhibitors (HDACi)</h3><div class="NLM_p">HDACi have recently emerged as potent and selective anticancer agents and are undergoing clinical trials. These agents inhibit histone deacetylases, leading to altered acetylation of histone and non-histone proteins. Through microarrays, HDACi have been shown to modulate transcription of about 5% of the genome.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a> Potent transcriptional repression of the TYMS gene encoding TS has been demonstrated making TYMS one of the most prominently down-regulated genes following HDACi treatment.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Mechanisms of TS mRNA down-regulation by the HDACi, trichostatin A (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>), have been elucidated by Lee et al.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> They observed that trichostatin A induced TS mRNA down-regulation was abrogated by cycloheximide, which inhibits the synthesis of new proteins, suggesting that trichostatin A induced the expression of a transcriptional repressor of TS mRNA. Additionally, proteasomal degradation of the TS protein, mediated by acetylation of chaperonic Hsp90, was also induced by trichostatin A. HDACi have been shown to synergize the antiproliferative effects of TS inhibitors in in vitro and in vivo mice models and to aid in resensitizing the resistant cells.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a></div><div class="NLM_p last">The synergism of HDACi to TS inhibitors, however, is not universal, as there is at least one report in which the HDACi, valproic acid<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> and <i>N</i>-(2-aminophenyl)-4-[<i>N</i>-(pyridin-3-ylmethoxycarbonyl) aminomethyl]benzamide (MS275,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>) antagonize the antiproliferative effects of the folate analogue methotrexate, at least in part by up-regulating TS expression.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> It should, however, be noted that this study was carried out on choroid plexus cells, which, in order to maintain the folate levels in cerebrospinal fluid, have a highly differentiated folate metabolism and transport system, unlike in other cells where the folate pathway is involved in proliferation and dedifferentiation. Further studies to detail the mechanism in play and to study the cell line specificity of the observed effect need to be carried out.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.b E2F-1 Modulators</h3><div class="NLM_p">By regulating the transcription of genes that encode for proteins required for DNA synthesis, the E2F family, consisting of six transcription factors, plays a key role in progression of cells from late G1 into S phase of the cell cycle.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> However, only the E2F1 factor has been noted for its role in apoptosis. It has also been suggested to be one of the regulators of TS levels in the cell. Though this regulation has not been demonstrated directly, TS expression has been found to be inversely correlated with E2F1 expression in various cell lines.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> Thus, the importance of E2F1 for TS gene expression has been generally accepted. To our knowledge, no specific inhibitors of E2F1 are known; however, many known and potential antitumor compounds have been shown to induce E2F1 mediated down-regulation of TS; protein kinase C/cyclin dependent kinase (PKC/CDK) inhibitors and epidermal growth factor receptor (EGFR) inhibitors are two such classes of molecules.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">4.b.1 Protein Kinase C/Cyclin Dependent Kinase Inhibitors</h4><div class="NLM_p last">7-Hydroxystaurosporine <b>7</b> (UCN-01, Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>)<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> is a selective PKC/CDK inhibitor undergoing clinical trials as a standalone drug or in various combination chemotherapies (<a href="http://clinicaltrials.gov" class="extLink">clinicaltrials.gov</a>). Significant synergism with 5FU has been reported, and attempts at deciphering the mechanism of its action have been made. Though the activity of TS remains unaffected, a decrease in normal and 5FU-induced TS mRNA and consequent protein levels has been observed on administration of <b>7</b>.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> This decrease is preceded by a decrease in E2F1 protein level, while the E2F1 mRNA level remains unaltered.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> This phenomenon can be explained by a cascade of events triggered by the CDK inhibition caused by <b>7</b>. Members of the CDK family are responsible for the phosphorylation of the retinoblastoma protein (pRb); pRb inhibits E2F1 by forming a pRBâE2F1 complex. Phosphorylation of pRb dissociates the E2F1âpRb complex, releasing functional E2F1.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> CDK inhibitors such as <b>7</b>, prevent the release of E2F1 by preventing phosphorylation of pRb. The decrease in the free and functional transcription factor E2F1 results in a decrease in TS gene expression and thus the down-regulation of TS mRNA and protein levels.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">4.b.2 Epidermal Growth Factor Receptor Inhibitors</h4><div class="NLM_p last">The EGFR inhibitors, gefitinib and lapatinib (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>), have also been reported to cause down-regulation of TS. EGFR belongs to a family of receptor tyrosine kinases and is being established as an anticancer target.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a> Since EGFR signal transduction is involved in the activity of E2F1, inhibitors of EGFR could mediate interference of TS expression. Okabe et al.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> have shown that gefitinib synergizes with 5FU by specifically down-regulating TS and does not affect the expression of other 5FU modulators like DPD or OPRT.</div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">5 Conclusions and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Even 37 years after the discovery of TS as an anticancer target, resistance and toxicity continue to pose a challenge to the development of a foolproof TS inhibitory drug. The various approaches being employed to address these problems from the three levels, the protein, the mRNA, and the gene, have been summarized in this Perspective. While approaches aimed at tumor-specific concentration or activation of TS protein active-site inhibitors have considerably reduced toxicity to normal tissues, these do not overcome the development of resistance. Effective inhibition of the TS mRNA or the TYMS gene could play a crucial role in tackling the problem of resistance. Allosteric inhibitors of the TS protein might also be useful in preventing the development of resistance, but this hypothesis remains to be validated. The ECTA approach, on the other hand, requires TS overexpression, as observed in resistant cells, for activating a cytotoxic agent. Improved understanding of cancer biology has highlighted the involvement of TS in a complicated network of different pathways. Identification of TS expression regulators produced by such TS-interconnected pathways opens new possibilities for TS function repression. The strategies for targeting TS for treating cancer should not focus exclusively on protein inhibition but also consider the concept of protein down-regulation to have a more effective and forceful impact in the clinical setting. Consequently, TS continues to present ample opportunities for drug discovery scientists.</div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08850" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08850" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Divita Garg</span> - <span class="hlFld-Affiliation affiliation">Molecular and Cellular Modeling Group, Heidelberg Institute of Theoretical Studies gGmbH, Heidelberg, Germany</span>;Â 
    <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, Helmholtz Zentrum MÃ¼nchen, Neuherberg, Germany</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c3a7aab5aab7a2eda4a2b1a483abeeaab7b0edacb1a4e3b1a6a1a6a0a0a2edb4a2a7a683abeeaab7b0edacb1a4"><span class="__cf_email__" data-cfemail="d3b7baa5baa7b2fdb4b2a1b493bbfebaa7a0fdbca1b4">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="4d3f282f282e2e2c633a2c29280d256024393e63223f2a">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca C. Wade</span> - <span class="hlFld-Affiliation affiliation">Molecular and Cellular Modeling Group, Heidelberg Institute of Theoretical Studies gGmbH, Heidelberg, Germany</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#65010c130c11044b02041702250d480c11164b0a170245170007000606044b12040100250d480c11164b0a1702"><span class="__cf_email__" data-cfemail="5e3a3728372a3f70393f2c391e3673372a2d70312c39">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="196b7c7b7c7a7a78376e787d7c597134706d6a37766b7e">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Henrich</span> - <span class="hlFld-Affiliation affiliation">Molecular and Cellular Modeling Group, Heidelberg Institute of Theoretical Studies gGmbH, Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Outi M. H. Salo-Ahen</span> - <span class="hlFld-Affiliation affiliation">Molecular and Cellular Modeling Group, Heidelberg Institute of Theoretical Studies gGmbH, Heidelberg, Germany</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biosiences, Biochemistry, Ãbo Akademi University, Turku, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannu Myllykallio</span> - <span class="hlFld-Affiliation affiliation">Laboratoire d'Optique et Biosciences, Ecole Polytechnique, CNRS UMR7645, INSERM U696, Palaiseau, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria P. Costi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Scienze Farmaceutiche, UniversitÃ  degli Studi di Modena e Reggio Emilia, Modena, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901869w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Divita Garg</b> is a Ph.D. student with Dr. Rebecca Wade at Heidelberg Institute for Theoretical Studies (Germany). After completing her Bachelor of Pharmacy degree from Guru Nanak Dev University (India) and Masterâs degree in Pharmacoinformatics from National Institute of Pharmaceutical Education and Research (India), she moved to Germany to pursue doctoral studies. She is currently working at the Institute of Structural Biology, Helmholtz Zentrum and Munich Center for Integrated Protein Science at the Department of Chemistry, Technical University of Munich, Germany.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Stefan Henrich</b> studied biology at the University of Karlsruhe, Germany. After finishing his Diploma thesis in 1999, he worked for 1 year at the University of MÃ¼nster, Germany. He did his doctoral research under the supervision of Prof. Robert Huber and Prof. Wolfram Bode, at the Department for Structure Research, Max Planck Institute of Biochemistry, Martinsried, Germany, and was awarded a Ph.D. in 2004 from the Technical University of Munich, Germany. He then joined the research group of Dr. Rebecca Wade at Heidelberg Institute for Theoretical Studies, Germany, where he has worked on techniques for docking and scoring proteinâligand and proteinâpeptide interactions, with one of the applications being to thymidylate synthase.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Outi M. H. Salo-Ahen</b> is a postdoctoral researcher currently at Ãbo Akademi University, Turku (Finland), and Heidelberg Institute for Theoretical Studies (Germany). She obtained her Ph.D. (Pharm.) degree at the University of Kuopio in 2006. Her doctoral thesis was about molecular modeling of the endogenous cannabinoid system and the usability of the modeling results in drug design. She spent the following 3 years as a postdoctoral fellow in Dr. Rebecca Wadeâs group at Heidelberg Institute of Theoretical Studies, where she has applied biomolecular simulation techniques to studying the structure and function of human thymidylate synthase.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hannu Myllykallio</b> is Research Director (Centre National de la Recherche Scientifique) and Professor of Biology in the leading French engineering school, Ecole Polytechnique, located in Palaiseau, close to Paris. He performed his doctoral studies at the University of Pennsylvania (Philadelphia, PA). His research focuses on understanding how thymidylate metabolism influences DNA replication and repair in bacterial and human cells. He is a recipient of the Coups dâÃ©lan pour la Recherche FranÃ§aise (Fondation Bettencourt-Schueller) and the CNRS bronze medal.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Maria P. Costi</b> is Professor of Medicinal Chemistry at the Faculty of Bioscience and Biotechnology and leads the âlaboratory of drug discovery of enzyme inhibitorsâ at the Department of Pharmaceutical Science at the University of Modena and Reggio Emilia, Italy. She performed her doctoral research at the same university and was a visiting scientist at the University of California, San Francisco. She works in the areas of anticancer agents and antiinfectives, focusing on the discovery of new drug candidates capable of modulating the folate pathways in different organisms in order to overcome drug resistance. She has expertise in folate pathway modulation and biomolecular studies. She is the coordinator of the 6FP European Union Project LIGHTS (<a href="http://www.lights-eu.org" class="extLink">www.lights-eu.org</a>) aimed at discovering anticancer drugs targeting thymidylate synthase.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rebecca C. Wade</b> leads the Molecular and Cellular Modeling Group at Heidelberg Institute for Theoretical Studies, a private nonprofit research institute in Heidelberg, Germany. The group works on the development and application of computer-aided methods to model and simulate biomolecular interactions. She did her doctoral research in structure-based drug design at Oxford University, U.K., and postdoctoral research in biomolecular simulation at the University of Houston and University of Illinois. She was a group leader at the European Molecular Biology Laboratory (EMBL) in Heidelberg before taking up her present position. She is an Associate Editor of the <i>Journal of Molecular Recognition</i> and a member of the editorial boards of several journals, including the <i>Journal of Medicinal Chemistry</i>. She is the recipient of the 2004 Hansch Award of the QSAR and Modelling Society.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge the support of the Klaus Tschira Foundation and the European Union (FP6 STREP Project LIGHTS LSH-2005-2.2.0-8).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 91 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">McGuire, J. J.</span><span> </span><span class="NLM_article-title">Anticancer antifolates: current status and future directions</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">â</span> <span class="NLM_lpage">2613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.2174%2F1381612033453712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=14529544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=2593-2613&author=J.+J.+McGuire&title=Anticancer+antifolates%3A+current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer antifolates: Current status and future directions</span></div><div class="casAuthors">McGuire, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">2593-2613</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Antifolates are the oldest of the antimetabolite class of anticancer agents and were one of the first modern anticancer drugs.  The first clin. useful antifolate, described in 1947, was 2,4-diamino-pteroylglutamate (4-amino-folic acid; aminopterin; AMT) which yielded the first-ever remissions in childhood leukemia.  AMT was soon superseded by its 10-Me congener, methotrexate (MTX), based on toxicity considerations; MTX remains, with one limited exception, the only antifolate anticancer agent in clin. use to this date.  Because of the safety and utility of MTX, considerable effort has been invested in attempting to design more therapeutically selective antifolates or antifolates with a wider tumor spectrum.  Initially, the design was based on the burgeoning knowledge of folate-dependent pathways and the determinants of the mechanism of action of MTX.  These determinants include transport, the tight-binding inhibition of its target (the folate-dependent enzyme dihydrofolate reductase (DHFR)), and metab. of MTX to poly-Î³-glutamate (Glun) metabolites.  These early studies led to the development of other antifolate DHFR inhibitors of two types: (1) "classical" analogs that use the same cellular transport systems as MTX and are also metabolized to Glun; and (2) "nonclassical" (i.e., lipophilic) analogs that do not require transport systems and that are not metabolized to Glun.  Although several of these analogs have undergone clin. trial, none is proved superior to MTX.  Detailed examn. of the mechanisms of cytotoxicity and selectivity of MTX showed that inhibition of both dTMP synthesis and de novo purine synthesis, secondary to DHFR inhibition, led to DNA synthesis inhibition and subsequent cell death; inhibition of other folate-dependent pathways did not appear necessary for cell death.  Further studies showed that the contribution of inhibition of dTMP or purine synthesis to cell death varied in different cell types.  These data suggested that inhibition of one of these pathways individually might (at least in some cases) be therapeutically superior to the dual inhibition induced by MTX.  Thus in rational design and in structure-based design studies, two new classes of antifolate enzyme inhibitors were elaborated-direct inhibitors of thymidylate synthase (TMPS) and direct inhibitors of one or both of the two folate-dependent enzymes of de novo purine synthesis.  Members of each class included both classical and nonclassical types.  After preclin. evaluation, several of these have moved into clin. trials.  To date only one new TMPS inhibitor has successfully completed clin. trials and been approved for routine use; this drug, Tomudex (D1694, raltitrexed) is currently approved only in Europe and only for the treatment of colon cancer.  This still represents a step forward for antifolates, however, since MTX is well-known to be ineffective in colon cancer; thus Tomudex extends the tumor range of antifolates.  Antifolate development continues.  Based on the immense body of knowledge now extant on antifolates, specific aspects of the mechanism of action have been the focus.  Newer antifolates have been described that inhibit more than one pathway in folate metab., that have improved delivery, or that inhibit other targets in folate metab.  These new analogs are in various stages of preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGwUdwGzF0rVg90H21EOLACvtfcHk0liKRZP5LeEkzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D&md5=3e9aef8e71a32144ad5bcb661df3fa47</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1381612033453712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033453712%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26atitle%3DAnticancer%2520antifolates%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D2593%26epage%3D2613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Werkheiser, W. C.</span><span> </span><span class="NLM_article-title">Specific binding of 4-amino folic acid analogues by folic acid reductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">â</span> <span class="NLM_lpage">893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1961&pages=888-893&author=W.+C.+Werkheiser&title=Specific+binding+of+4-amino+folic+acid+analogues+by+folic+acid+reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWerkheiser%26aufirst%3DW.%2BC.%26atitle%3DSpecific%2520binding%2520of%25204-amino%2520folic%2520acid%2520analogues%2520by%2520folic%2520acid%2520reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1961%26volume%3D236%26spage%3D888%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaumont, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baugh, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, B. T.</span><span> </span><span class="NLM_article-title">Interaction of polyglutamyl derivatives of methotrexate, 10-deazaaminopterin, and dihydrofolate with dihydrofolate reductase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5020</span><span class="NLM_x">â</span> <span class="NLM_lpage">5023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=5020-5023&author=P.+Kumarauthor=R.+L.+Kisliukauthor=Y.+Gaumontauthor=M.+G.+Nairauthor=C.+M.+Baughauthor=B.+T.+Kaufman&title=Interaction+of+polyglutamyl+derivatives+of+methotrexate%2C+10-deazaaminopterin%2C+and+dihydrofolate+with+dihydrofolate+reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26aulast%3DGaumont%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DM.%2BG.%26aulast%3DBaugh%26aufirst%3DC.%2BM.%26aulast%3DKaufman%26aufirst%3DB.%2BT.%26atitle%3DInteraction%2520of%2520polyglutamyl%2520derivatives%2520of%2520methotrexate%252C%252010-deazaaminopterin%252C%2520and%2520dihydrofolate%2520with%2520dihydrofolate%2520reductase%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D5020%26epage%3D5023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Allegra, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodbard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivet, J.</span><span> </span><span class="NLM_article-title">Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">9720</span><span class="NLM_x">â</span> <span class="NLM_lpage">9726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=2410416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaL2MXltlCltL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=9720-9726&author=C.+J.+Allegraauthor=B.+A.+Chabnerauthor=J.+C.+Drakeauthor=R.+Lutzauthor=D.+Rodbardauthor=J.+Jolivet&title=Enhanced+inhibition+of+thymidylate+synthase+by+methotrexate+polyglutamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates</span></div><div class="casAuthors">Allegra, Carmen J.; Chabner, Bruce A.; Drake, James C.; Lutz, Rudolf; Rodbard, David; Jolivet, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9720-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The effects of methotrexate (MTX-Glu1)  [59-05-2] and the polyglutamate derivs. of methotrexate (MTXPGs) on the catalytic activity of thymidylate synthase  [9031-61-2] purified from MCF-7 human breast cancer cells and on the kinetics of the ternary complex formation by 5-fluoro-2'-deoxyuridine 5'-monophosphate  [134-46-3], folate cofactor, and thymidylate synthase were studied.  MTX-Glu1 exhibited uncompetitive inhibition of thymidylate synthase when reaction kinetics were analyzed by either double reciprocal plots or a computerized math. model based on nonlinear least-squares curve fitting.  The Ki for MTX-Glu1 inhibition was 13 Î¼M and the I50 was 22 Î¼M, irresp. of the degree of polyglutamation of the folate.  In contrast, the polyglutamated derivs. of MTX all acted as noncompetitive inhibitors.  The MTXPGs had 75-300-fold greater potency than MTX-Glu1 as inhibitors of thymidylate synthase catalytic activity, with K1 values from 0.17 to 0.047 Î¼M for MTX-Glu2 to MTX-Glu5  [80801-53-2], resp.  Neither MTX-Glu1 nor MTXPGs promoted the formation of a charcoal-stable ternary complex with thymidylate synthase and 5-fluoro-2'-deoxyuridine 5'-monophosphate CH2-H4PteGlu5  [98258-47-0] (where PteGlu represents pteroylglutamic acid) was 40-fold more potent than CH2-H4PteGlu1  [5786-82-3] in participating in the formation of a ternary complex, and 10 Î¼M MTX-Glu5 inhibited the formation of a ternary complex contg. this folate as cofactor.  The inhibition was detd. to be due to a redn. in the kon.  The potency of this inhibition was markedly greater in the presence of CH2-H4PteGlu1 as compared to CH2-H4PteGlu5.  This finding suggests that the degree of interference with complex formation in intact cells would depend on the state of polyglutamation of available folate cofactor.  Ternary complex formation with H2PteGlu5 as the folate cofactor was also investigated, and a 50% redn. in complex formation was found in the presence of a 2 Î¼M concn. of MTX-Glu5.  These findings have significant implications regarding the mechanism of action of MTX-Glu1 and contribute to an understanding of the complex interactions of MTX-Glu1 and 5-fluorouracil  [51-21-8].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzNfRBATHwE7Vg90H21EOLACvtfcHk0liKRZP5LeEkzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltlCltL8%253D&md5=fa585e8ce3144af2a0f8032bb99ac9a2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DLutz%26aufirst%3DR.%26aulast%3DRodbard%26aufirst%3DD.%26aulast%3DJolivet%26aufirst%3DJ.%26atitle%3DEnhanced%2520inhibition%2520of%2520thymidylate%2520synthase%2520by%2520methotrexate%2520polyglutamates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D9720%26epage%3D9726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Allegra, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B. A.</span><span> </span><span class="NLM_article-title">Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">4881</span><span class="NLM_x">â</span> <span class="NLM_lpage">4885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1073%2Fpnas.82.15.4881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=3860829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaL2MXltFGrt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=4881-4885&author=C.+J.+Allegraauthor=J.+C.+Drakeauthor=J.+Jolivetauthor=B.+A.+Chabner&title=Inhibition+of+phosphoribosylaminoimidazolecarboxamide+transformylase+by+methotrexate+and+dihydrofolic+acid+polyglutamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates</span></div><div class="casAuthors">Allegra, Carmen J.; Drake, James C.; Jolivet, Jacques; Chabner, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4881-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The enhanced inhibitory potency of methotrexate polyglutamate (MTX polyglutamate)  [82334-40-5] and dihydrofolate pentaglutamate  [98204-33-2] on the catalytic activity of phosphoribosylaminoimidazolecarboxamide transformylase (AICAR transformylase)  [9032-03-5] purified from MCF-7 human breast cancer cells was detd.  MTX  [59-05-2] and dihydrofolate  [4033-27-6] both monoglutamates, were weak competitive inhibitors of AICAR transformylase with Ki of 143 and 63 Î¼M, resp., and their inhibitory capacity was largely unaffected by the glutamated state of the folate cosubstrate.  In contrast, MTX polyglutamates were potent competitive inhibitors, with an â10-fold increase in inhibitory potency with the addn. of each glutamate group up to 4 (i.e., the pentaglutamate deriv.  [80801-53-2]).  MTX tetraglutamate  [80801-54-3] and MTX pentaglutamates were the most potent, with equiv. Kis of 5.6 Ã 10-8 M; they were 2500-fold more potent than MTX.  Dihydrofolate pentaglutamate was as potent an inhibitor as MTX pentaglutamate, with a Ki of 4.3 Ã 10-8 M.  The potent inhibitory effects demonstrated by the polyglutamate compds., when tested against the folate monoglutamate substrate were sharply curtailed when folate pentaglutamate was used as the substrate.  MTX and dehydrofolate pentaglutamates were only 7- and 25-fold more potent than their monoglutamate counterparts under these conditions.  A model depicting these complex interactions is postulated.  These findings have significant implications regarding the antitumor mechanism of action of MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdj6Jb-DzFrVg90H21EOLACvtfcHk0liKRZP5LeEkzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltFGrt7k%253D&md5=2e89e65beda64b5972a7dd689b928311</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.15.4881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.15.4881%26sid%3Dliteratum%253Aachs%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DJolivet%26aufirst%3DJ.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520phosphoribosylaminoimidazolecarboxamide%2520transformylase%2520by%2520methotrexate%2520and%2520dihydrofolic%2520acid%2520polyglutamates%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1985%26volume%3D82%26spage%3D4881%26epage%3D4885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Heidelberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danneberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesbach, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duschinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitzer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleven, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiner, J.</span><span> </span><span class="NLM_article-title">Fluorinated pyrimidines, a new class of tumour-inhibitory compounds</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2F179663a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=13418758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaG1cXislyn" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1957&pages=663-666&author=C.+Heidelbergerauthor=N.+K.+Chaudhuriauthor=P.+Dannebergauthor=D.+Moorenauthor=L.+Griesbachauthor=R.+Duschinskyauthor=R.+J.+Schnitzerauthor=E.+Plevenauthor=J.+Scheiner&title=Fluorinated+pyrimidines%2C+a+new+class+of+tumour-inhibitory+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated pyrimidines, a new class of tumor-inhibitory compounds</span></div><div class="casAuthors">Heidelberger, Charles; Chaudhuri, N. K.; Danneberg, Peter; Mooren, Dorothy; Griesbach, Lois; Duschinsky, Robert; Schnitzer, R. J.; Pleven, E.; Scheiner, J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">663-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">5-Fluorouracil (I) and 5-fluoro.ovrddot.orotic acid (II) have demonstrated growth-inhibitory activity against the following transplanted tumors in rats and mice: Flexner-Jobling carcinoma, Walker 256 carcinosarcoma, Yoshida ascites tumor, Shay's chloroleukemia, sarcoma 180, Ehrlich ascites carcinoma, L-1210 leukemia, EO771, mammary adenocarcinoma 755, and sarcoma A-1.  Where compared in solid tumors, I was more effective than II and a more pronounced effect was observed with repeated rather than single doses.  With the L-1210 leukemia II gave a consistently greater prolongation of life than I.  A combination of equal quantities of I and 6-mercaptopurine showed a synergistic effect against transplanted tumors.  I also exhibited marked in vitro antimicrobial activity.  Against Proteus vulgaris activity was half that of streptomycin.  Radioactive tracer studies with mice indicated that I was incorporated into the nucleic acids as such.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn21WsyVXk3rVg90H21EOLACvtfcHk0lhKNG6XzZtqPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXislyn&md5=f6f48dd10339e9ec06dbcb2fb7834d99</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F179663a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F179663a0%26sid%3Dliteratum%253Aachs%26aulast%3DHeidelberger%26aufirst%3DC.%26aulast%3DChaudhuri%26aufirst%3DN.%2BK.%26aulast%3DDanneberg%26aufirst%3DP.%26aulast%3DMooren%26aufirst%3DD.%26aulast%3DGriesbach%26aufirst%3DL.%26aulast%3DDuschinsky%26aufirst%3DR.%26aulast%3DSchnitzer%26aufirst%3DR.%2BJ.%26aulast%3DPleven%26aufirst%3DE.%26aulast%3DScheiner%26aufirst%3DJ.%26atitle%3DFluorinated%2520pyrimidines%252C%2520a%2520new%2520class%2520of%2520tumour-inhibitory%2520compounds%26jtitle%3DNature%26date%3D1957%26volume%3D179%26spage%3D663%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Rutman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantarow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschkis, K. E.</span><span> </span><span class="NLM_article-title">Studies in 2-acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=13126946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaG2cXmvV2gtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1954&pages=119-123&author=R.+J.+Rutmanauthor=A.+Cantarowauthor=K.+E.+Paschkis&title=Studies+in+2-acetylaminofluorene+carcinogenesis.+III.+The+utilization+of+uracil-2-C14+by+preneoplastic+rat+liver+and+rat+hepatoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">2-Acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma</span></div><div class="casAuthors">Rutman, Robert J.; Cantarow, Abraham; Paschkis, Karl E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1954</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-23</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">During the process of liver carcinogenesis by I (preneoplastic liver and hepatoma), exogenous uracil-2-C14 (IV) was utilized for nucleic acid formation, although no such utilization occurred in normal rats.  IV was an effective precursor of uridylic acid, but not of the purine nucleotides.  IV did not serve as a precursor of the deoxypentose pyrimidine nucleotides in either preneoplastic liver or hepatoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp468flHH4m47Vg90H21EOLACvtfcHk0lhKNG6XzZtqPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXmvV2gtQ%253D%253D&md5=61db9fcd3cb74bdc2eca4e7859b54cc4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRutman%26aufirst%3DR.%2BJ.%26aulast%3DCantarow%26aufirst%3DA.%26aulast%3DPaschkis%26aufirst%3DK.%2BE.%26atitle%3DStudies%2520in%25202-acetylaminofluorene%2520carcinogenesis.%2520III.%2520The%2520utilization%2520of%2520uracil-2-C14%2520by%2520preneoplastic%2520rat%2520liver%2520and%2520rat%2520hepatoma%26jtitle%3DCancer%2520Res.%26date%3D1954%26volume%3D14%26spage%3D119%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHenry, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, H.</span><span> </span><span class="NLM_article-title">Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00700a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1974&pages=471-481&author=D.+V.+Santiauthor=C.+S.+McHenryauthor=H.+Sommer&title=Mechanism+of+interaction+of+thymidylate+synthetase+with+5-fluorodeoxyuridylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi00700a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00700a012%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DMcHenry%26aufirst%3DC.%2BS.%26aulast%3DSommer%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520interaction%2520of%2520thymidylate%2520synthetase%2520with%25205-fluorodeoxyuridylate%26jtitle%3DBiochemistry%26date%3D1974%26volume%3D13%26spage%3D471%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">The role of thymidylate synthase in cellular regulation</span> <span class="citation_source-journal">Adv Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1996&pages=143-163&author=E.+Chuauthor=C.+J.+Allegra&title=The+role+of+thymidylate+synthase+in+cellular+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520role%2520of%2520thymidylate%2520synthase%2520in%2520cellular%2520regulation%26jtitle%3DAdv%2520Enzyme%2520Regul.%26date%3D1996%26volume%3D36%26spage%3D143%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elwood, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">8977</span><span class="NLM_x">â</span> <span class="NLM_lpage">8981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=8977-8981&author=E.+Chuauthor=D.+M.+Koellerauthor=J.+L.+Caseyauthor=J.+C.+Drakeauthor=B.+A.+Chabnerauthor=P.+C.+Elwoodauthor=S.+Zinnauthor=C.+J.+Allegra&title=Autoregulation+of+human+thymidylate+synthase+messenger+RNA+translation+by+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DKoeller%26aufirst%3DD.%2BM.%26aulast%3DCasey%26aufirst%3DJ.%2BL.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DElwood%26aufirst%3DP.%2BC.%26aulast%3DZinn%26aufirst%3DS.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DAutoregulation%2520of%2520human%2520thymidylate%2520synthase%2520messenger%2520RNA%2520translation%2520by%2520thymidylate%2520synthase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D8977%26epage%3D8981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen-Lane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Regulation of p53 expression by thymidylate synthase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">â</span> <span class="NLM_lpage">3774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=3769-3774&author=J.+Juauthor=J.+Pedersen-Laneauthor=F.+Maleyauthor=E.+Chu&title=Regulation+of+p53+expression+by+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DPedersen-Lane%26aufirst%3DJ.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DRegulation%2520of%2520p53%2520expression%2520by%2520thymidylate%2520synthase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D3769%26epage%3D3774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takechi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">â</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1128%2FMCB.15.1.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=7799924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK2MXislamsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=179-185&author=E.+Chuauthor=T.+Takechiauthor=K.+L.+Jonesauthor=D.+M.+Voellerauthor=S.+M.+Copurauthor=G.+F.+Maleyauthor=F.+Maleyauthor=S.+Segalauthor=C.+J.+Allegra&title=Thymidylate+synthase+binds+to+c-myc+RNA+in+human+colon+cancer+cells+and+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro</span></div><div class="casAuthors">Chu, Edward; Takechi, Teiji; Jones, Kristen L.; Voeller, Donna M.; Copur, Sitki M.; Maley, Gladys F.; Maley, Frank; Segal, Shoshana; Allegra, Carmen J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-85</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Using an immunopptn.-reverse transcription-PCR technique, the authors characterized a thymidylate synthase (TS) ribonucleoprotein complex in cultured human colon cancer cells that consists of TS protein and the mRNA of the nuclear oncogene c-myc.  TS protein is complexed in intact cells with the C-terminal coding region of c-myc mRNA that includes nucleotide positions 1625 to 1790.  RNA electrophoretic gel mobility shift assays confirm a specific interaction between TS protein and c-myc mRNA and provide addnl. evidence that the C-terminal coding region represents an important cis-acting regulatory element.  Further evidence demonstrates that the in vitro translational efficiency of c-myc mRNA is inhibited as a result of its direct interaction with TS protein.  In addn., the presence of exogenous c-myc mRNA specifically relieves the inhibitory effects of TS protein on TS mRNA translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVjwYx4fwcbVg90H21EOLACvtfcHk0lgQ2DqcvOrxBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislamsbc%253D&md5=100a67320c658ed4519e13198b26d1e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.15.1.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.15.1.179%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DTakechi%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DCopur%26aufirst%3DS.%2BM.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DSegal%26aufirst%3DS.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThymidylate%2520synthase%2520binds%2520to%2520c-myc%2520RNA%2520in%2520human%2520colon%2520cancer%2520cells%2520and%2520in%2520vitro%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1995%26volume%3D15%26spage%3D179%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Identification of an RNA binding site for human thymidylate synthase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">â</span> <span class="NLM_lpage">521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=517-521&author=E.+Chuauthor=D.+Voellerauthor=D.+M.+Koellerauthor=J.+C.+Drakeauthor=C.+H.+Takimotoauthor=G.+F.+Maleyauthor=F.+Maleyauthor=C.+J.+Allegra&title=Identification+of+an+RNA+binding+site+for+human+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DVoeller%26aufirst%3DD.%26aulast%3DKoeller%26aufirst%3DD.%2BM.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DTakimoto%26aufirst%3DC.%2BH.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520RNA%2520binding%2520site%2520for%2520human%2520thymidylate%2520synthase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D517%26epage%3D521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsels, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">â</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1381-1389&author=X.+Linauthor=L.+A.+Parselsauthor=D.+M.+Voellerauthor=C.+J.+Allegraauthor=G.+F.+Maleyauthor=F.+Maleyauthor=E.+Chu&title=Characterization+of+a+cis-acting+regulatory+element+in+the+protein+coding+region+of+thymidylate+synthase+mRNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DParsels%26aufirst%3DL.%2BA.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DCharacterization%2520of%2520a%2520cis-acting%2520regulatory%2520element%2520in%2520the%2520protein%2520coding%2520region%2520of%2520thymidylate%2520synthase%2520mRNA%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D1381%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khleif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizunuma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1582</span><span class="NLM_x">â</span> <span class="NLM_lpage">1594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1128%2FMCB.19.2.1582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9891091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVKgs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=1582-1594&author=E.+Chuauthor=S.+M.+Copurauthor=J.+Juauthor=T.+M.+Chenauthor=S.+Khleifauthor=D.+M.+Voellerauthor=N.+Mizunumaauthor=M.+Patelauthor=G.+F.+Maleyauthor=F.+Maleyauthor=C.+J.+Allegra&title=Thymidylate+synthase+protein+and+p53+mRNA+form+an+in+vivo+ribonucleoprotein+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex</span></div><div class="casAuthors">Chu, Edward; Copur, Sitki M.; Ju, Jingfang; Chen, Tian-Men; Khleif, Samir; Voeller, Donna M.; Mizunuma, Nobuyuki; Patel, Mahendra; Maley, Gladys F.; Maley, Frank; Allegra, Carmen J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1582-1594</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A thymidylate synthase (TS)-ribonucleoprotein (RNP) complex composed of TS protein and the mRNA of the tumor suppressor gene p53 was isolated from cultured human colon cancer cells.  RNA gel shift assays confirmed a specific interaction between TS protein and the protein-coding region of p53 mRNA, and in vitro translation studies demonstrated that this interaction resulted in the specific repression of p53 mRNA translation.  To demonstrate the potential biol. role of the TS protein-p53 mRNA interaction, Western immunoblot anal. revealed nearly undetectable levels of p53 protein in TS-overexpressing human colon cancer H630-R10 and rat hepatoma H35(F/F) cell lines compared to the levels in their resp. parent H630 and H35 cell lines.  Polysome anal. revealed that the p53 mRNA was assocd. with higher-mol.-wt. polysomes in H35 cells compared to H35(F/F) cells.  While the level of p53 mRNA expression was identical in parent and TS-overexpressing cell lines, the level of p53 RNA bound to TS in the form of RNP complexes was significantly higher in TS-overexpressing cells.  The effect of TS on p53 expression was also investigated with human colon cancer RKO cells by use of a tetracycline-inducible system.  Treatment of RKO cells with a tetracycline deriv., doxycycline, resulted in 15-fold-induced expression of TS protein and nearly complete suppression of p53 protein expression.  However, p53 mRNA levels were identical in transfected RKO cells in the absence and presence of doxycycline.  Taken together, these findings suggest that TS regulates the expression of p53 at the translational level.  This study identifies a novel pathway for regulating p53 gene expression and expands current understanding of the potential role of TS as a regulator of cellular gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrosb2vurSeF7Vg90H21EOLACvtfcHk0li4NOBLGlhL7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVKgs7c%253D&md5=68eaf9eae69db31512211c7e9420acd1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.2.1582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.2.1582%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DCopur%26aufirst%3DS.%2BM.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%2BM.%26aulast%3DKhleif%26aufirst%3DS.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DMizunuma%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThymidylate%2520synthase%2520protein%2520and%2520p53%2520mRNA%2520form%2520an%2520in%2520vivo%2520ribonucleoprotein%2520complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D1582%26epage%3D1594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rahman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac-Kaye, M.</span><span> </span><span class="NLM_article-title">Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=341-351&author=L.+Rahmanauthor=D.+Voellerauthor=M.+Rahmanauthor=S.+Lipkowitzauthor=C.+Allegraauthor=J.+C.+Barrettauthor=F.+J.+Kayeauthor=M.+Zajac-Kaye&title=Thymidylate+synthase+as+an+oncogene%3A+a+novel+role+for+an+essential+DNA+synthesis+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DL.%26aulast%3DVoeller%26aufirst%3DD.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DLipkowitz%26aufirst%3DS.%26aulast%3DAllegra%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DZajac-Kaye%26aufirst%3DM.%26atitle%3DThymidylate%2520synthase%2520as%2520an%2520oncogene%253A%2520a%2520novel%2520role%2520for%2520an%2520essential%2520DNA%2520synthesis%2520enzyme%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D341%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hasnat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichenkova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J.</span><span> </span><span class="NLM_article-title">Fluorescence spectroscopic and (19)F NMR studies of human thymidylate synthase with its cognate RNA</span> <span class="citation_source-journal">J. Biomol. Struct. Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">â</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1080%2F07391102.2007.10507174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17937487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7nO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=253-270&author=A.+Hasnatauthor=E.+Bichenkovaauthor=X.+Yuauthor=J.+R.+Arnoldauthor=J.+Fisherauthor=O.+Fedorovaauthor=J.+Andrews&title=Fluorescence+spectroscopic+and+%2819%29F+NMR+studies+of+human+thymidylate+synthase+with+its+cognate+RNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence spectroscopic and 19F NMR studies of human thymidylate synthase with its cognate RNA</span></div><div class="casAuthors">Hasnat, Abul; Bichenkova, Elena; Yu, Xuan; Arnold, J. R. P.; Fisher, Julie; Fedorova, Olga; Andrews, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-269</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Adenine Press</span>)
        </div><div class="casAbstract">In order to investigate the interaction between hTS protein and its cognate mRNA, a 29nt fragment of TS mRNA was synthesized.  This region has been suggested as a putative stem-loop involved in translational autoregulation.  The melting temp. of the 29ntRNA was 65 Â°C, suggesting that this region does indeed form a stem-loop.  Fluorescence spectroscopy was used to monitor the RNA: hTS protein interaction [dissocn. const. (Kd) 3.9 Â± 0.8 nM; stoichiometry of binding 1dimeric hTS: 1RNA].  When hTS was titrated against FdUMP, this gave the expected stoichiometry of 1dimeric hTS: 1.7 FdUMP but in the presence of the 29ntRNA, the stoichiometry of binding changed to 1dimeric hTS: 1RNA: 1FdUMP.  Expts. using methotrexate (MTX) gave a stoichiometry of 1dimeric hTS: 1MTX and in the presence of 29ntRNA, the stoichiometry was unchanged.  19F-NMR spectra of human TS: FdUMP complexes were found to be strikingly similar to analogous NMR spectra of complexes formed by L.casei TS and mouse TS.  In the presence of FdUMP, spectra exhibited two addnl. resonances (-1.50ppm and -34.4ppm).  The resonance at -1.50ppm represents non-covalently bound FdUMP, the peak at -34.4ppm represents covalently bound FdUMP.  The addn. of methotrexate to the binary TS-FdUMP complex caused a displacement of the internal equil., with only the covalently-bound form seen, and with a slightly disturbed 19F chem. shift (-36.5ppm).  Similar results were found when MTX was replaced by folinic or folic acid.  The addn. of 29ntRNA caused no changes to the 19F spectra of either the binary or ternary complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhsNo9DyATZ7Vg90H21EOLACvtfcHk0li4NOBLGlhL7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7nO&md5=0fe6bd0c0a231ae0a92c35b2b2a46a1b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F07391102.2007.10507174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2007.10507174%26sid%3Dliteratum%253Aachs%26aulast%3DHasnat%26aufirst%3DA.%26aulast%3DBichenkova%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DArnold%26aufirst%3DJ.%2BR.%26aulast%3DFisher%26aufirst%3DJ.%26aulast%3DFedorova%26aufirst%3DO.%26aulast%3DAndrews%26aufirst%3DJ.%26atitle%3DFluorescence%2520spectroscopic%2520and%2520%252819%2529F%2520NMR%2520studies%2520of%2520human%2520thymidylate%2520synthase%2520with%2520its%2520cognate%2520RNA%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2007%26volume%3D25%26spage%3D253%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kitchens, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsthoefel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafique, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. G.</span><span> </span><span class="NLM_article-title">Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization. Implications for autoregulation of translation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">12544</span><span class="NLM_x">â</span> <span class="NLM_lpage">12547</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=12544-12547&author=M.+E.+Kitchensauthor=A.+M.+Forsthoefelauthor=Z.+Rafiqueauthor=H.+T.+Spencerauthor=F.+G.+Berger&title=Ligand-mediated+induction+of+thymidylate+synthase+occurs+by+enzyme+stabilization.+Implications+for+autoregulation+of+translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitchens%26aufirst%3DM.%2BE.%26aulast%3DForsthoefel%26aufirst%3DA.%2BM.%26aulast%3DRafique%26aufirst%3DZ.%26aulast%3DSpencer%26aufirst%3DH.%2BT.%26aulast%3DBerger%26aufirst%3DF.%2BG.%26atitle%3DLigand-mediated%2520induction%2520of%2520thymidylate%2520synthase%2520occurs%2520by%2520enzyme%2520stabilization.%2520Implications%2520for%2520autoregulation%2520of%2520translation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D12544%26epage%3D12547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Berger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. G.</span><span> </span><span class="NLM_article-title">Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=461-467&author=S.+H.+Bergerauthor=C.+H.+Jenhauthor=L.+F.+Johnsonauthor=F.+G.+Berger&title=Thymidylate+synthase+overproduction+and+gene+amplification+in+fluorodeoxyuridine-resistant+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DS.%2BH.%26aulast%3DJenh%26aufirst%3DC.%2BH.%26aulast%3DJohnson%26aufirst%3DL.%2BF.%26aulast%3DBerger%26aufirst%3DF.%2BG.%26atitle%3DThymidylate%2520synthase%2520overproduction%2520and%2520gene%2520amplification%2520in%2520fluorodeoxyuridine-resistant%2520human%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D1985%26volume%3D28%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Iacopetta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsaleh, H.</span><span> </span><span class="NLM_article-title">A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">â</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1054%2Fbjoc.2001.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11556832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1KisLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2001&pages=827-830&author=B.+Iacopettaauthor=F.+Grieuauthor=D.+Josephauthor=H.+Elsaleh&title=A+polymorphism+in+the+enhancer+region+of+the+thymidylate+synthase+promoter+influences+the+survival+of+colorectal+cancer+patients+treated+with+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil</span></div><div class="casAuthors">Iacopetta, B.; Grieu, F.; Joseph, D.; Elsaleh, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">High levels of thymidylate synthase (TS) expression have been assocd. with poor survival of colorectal cancer (CRC) patients to 5-fluorouracil (5-FU)-based chemotherapy.  Recent evidence suggests that a polymorphism within the enhancer region of the TS gene promoter can influence TS expression, with the triple repeat homozygote (3R/3R) being assocd. with significantly higher tumor TS levels than either the double repeat homozygote (2R/2R) or heterozygotes (2R/3R).  In the present study we investigated whether TS genotype was assocd. with the degree of survival benefit from chemotherapy in 221 Dukes' C stage CRC patients.  Patients with the 3R/3R polymorphism (n = 58, 26%) showed no significant long-term survival benefit from chemotherapy (RR = 0.62, 95% CI: 0.30-1.25, P = 0.18), whereas those with the 2R/2R or 2R/3R genotype (n = 163, 74%) showed significant gains in survival from this treatment (RR = 0.52, 95% CI: 0.52-0.82, P = 0.005).  These results demonstrate that a polymorphism within the TS gene, probably through its effect on TS expression levels, can influence the survival benefit obtained by CRC patients from 5-FU-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMYfvjISbY_LVg90H21EOLACvtfcHk0libSm8dqp5A9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1KisLY%253D&md5=ef22f00e4eff28aee5116d3e9a990dc4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.2001.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.2001.2007%26sid%3Dliteratum%253Aachs%26aulast%3DIacopetta%26aufirst%3DB.%26aulast%3DGrieu%26aufirst%3DF.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DElsaleh%26aufirst%3DH.%26atitle%3DA%2520polymorphism%2520in%2520the%2520enhancer%2520region%2520of%2520the%2520thymidylate%2520synthase%2520promoter%2520influences%2520the%2520survival%2520of%2520colorectal%2520cancer%2520patients%2520treated%2520with%25205-fluorouracil%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2001%26volume%3D85%26spage%3D827%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kawakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salonga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danenberg, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brabender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danenberg, P. V.</span><span> </span><span class="NLM_article-title">Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">4096</span><span class="NLM_x">â</span> <span class="NLM_lpage">4101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11751507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFShsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=4096-4101&author=K.+Kawakamiauthor=D.+Salongaauthor=J.+M.+Parkauthor=K.+D.+Danenbergauthor=H.+Uetakeauthor=J.+Brabenderauthor=K.+Omuraauthor=G.+Watanabeauthor=P.+V.+Danenberg&title=Different+lengths+of+a+polymorphic+repeat+sequence+in+the+thymidylate+synthase+gene+affect+translational+efficiency+but+not+its+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression</span></div><div class="casAuthors">Kawakami, Kazuyuki; Salonga, Dennis; Park, Ji Min; Danenberg, Kathleen D.; Uetake, Hiroyuki; Brabender, Jan; Omura, Kenji; Watanabe, Go; Danenberg, Peter V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4096-4101</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is a target enzyme of 5-fluorouracil.  Recently, the TS gene has been shown to contain a polymorphic tandem repeat sequence.  The aim of this study was to det. whether differences in the no. of tandem repeats could affect gene expression or mRNA translation.  We quantified TS mRNA isolated from 130 colorectal cancer tissues by real-time reverse transcription-PCR and TS protein in 92 available samples by the fluoro-dUMP binding assay.  These values were compared with TS genotypes of the samples detd. by a PCR assay.  There was no relation between TS genotype and mRNA expression level.  On the other hand, cancer tissues with the 3R/3R genotype had a significantly higher TS protein expression level than did those with the 2R/3R genotype.  These results suggest that the efficiency of TS mRNA translation is responsible for the genotype-dependent difference in TS protein expression.  Further anal. using TS 5'-untranslated region-luciferase reporter constructs showed that the RNA with the three-repeat sequence was translated three to four times more efficiently than that with two-repeat sequence.  From the results of both in vitro and in vivo study, we conclude that TS mRNA with a three-repeat sequence has greater translation efficiency than that with the two-repeat sequence.  The results provide the rationale for comprehensive usage of TS genotyping with quantitation of TS mRNA or TS protein to predict the patient's response to 5-fluorouracil-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8L7CZyv23dLVg90H21EOLACvtfcHk0libSm8dqp5A9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFShsg%253D%253D&md5=c836f16aac25d4fd186db62de9183c43</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DSalonga%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DDanenberg%26aufirst%3DK.%2BD.%26aulast%3DUetake%26aufirst%3DH.%26aulast%3DBrabender%26aufirst%3DJ.%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DG.%26aulast%3DDanenberg%26aufirst%3DP.%2BV.%26atitle%3DDifferent%2520lengths%2520of%2520a%2520polymorphic%2520repeat%2520sequence%2520in%2520the%2520thymidylate%2520synthase%2520gene%2520affect%2520translational%2520efficiency%2520but%2520not%2520its%2520gene%2520expression%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D4096%26epage%3D4101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Marsh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, H. L.</span><span> </span><span class="NLM_article-title">Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">â</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11445856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslSmtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=383-386&author=S.+Marshauthor=J.+A.+McKayauthor=J.+Cassidyauthor=H.+L.+McLeod&title=Polymorphism+in+the+thymidylate+synthase+promoter+enhancer+region+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer</span></div><div class="casAuthors">Marsh, Sharon; McKay, Judith A.; Cassidy, James; McLeod, Howard L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-386</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is an important target for chemotherapy drugs such as 5-fluorouracil and raltitrexed.  Over-expression of TS has been linked to chemotherapy resistance.  A polymorphic tandem repeat sequence in the 5' untranslated region (5'UTR) of the human TS gene (TSER) has been shown to influence TS expression.  The presence of a triple tandem repeat (TSER*3) increases in vitro TS expression compared to a double tandem repeat (TSER*2) and is assocd. with higher in vivo tumor TS activity.  The polymorphism of this promoter enhancer region has not been extensively studied in patients with cancer and may represent a possible mechanism of intrinsic resistance to TS inhibitors.  In this study, PCR anal. of genomic DNA from 121 patients with colorectal cancer demonstrated 29% of patients were homozygous for TSER*3, 16% were homozygous for TSER*2 and 55% were heterozygous.  In 44/45 microdissected tumors the TS enhancer genotype was identical between paired samples of colorectal tumor and normal tissue.  In 24 patients receiving a bolus/infusion 5-fluorouracil (5FU) regimen for metastatic colorectal cancer, 22% of non-responders to chemotherapy were homozygous for TSER*2 compared with 40% of responders.  Median survival dropped from 16 mo for homozygous TSER*2 to 12 mo for homozygous TSER*3.  This is consistent with previous studies where higher TS expression was assocd. with poor response to TS inhibitors.  Prospective anal. of the influence of the TS polymorphism on patient outcome is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogYmDCgryQmrVg90H21EOLACvtfcHk0libSm8dqp5A9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslSmtLw%253D&md5=78ef25df7e88f511aa19ceb78676b5e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsh%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DJ.%2BA.%26aulast%3DCassidy%26aufirst%3DJ.%26aulast%3DMcLeod%26aufirst%3DH.%2BL.%26atitle%3DPolymorphism%2520in%2520the%2520thymidylate%2520synthase%2520promoter%2520enhancer%2520region%2520in%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2001%26volume%3D19%26spage%3D383%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lorenz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wescott, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnyder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinchuk, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Car, B. D.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1494</span><span class="NLM_x">â</span> <span class="NLM_lpage">1502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1016%2FS0301-472X%2899%2900087-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=10517490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1MXmslWmtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1494-1502&author=M.+Lorenzauthor=H.+S.+Slaughterauthor=D.+M.+Wescottauthor=S.+I.+Carterauthor=B.+Schnyderauthor=J.+E.+Dinchukauthor=B.+D.+Car&title=Cyclooxygenase-2+is+essential+for+normal+recovery+from+5-fluorouracil-induced+myelotoxicity+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice</span></div><div class="casAuthors">Lorenz, Meike; Slaughter, Helen S.; Wescott, Debra M.; Carter, Sherryann I.; Schnyder, Bruno; Dinchuk, Joseph E.; Car, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1494-1502</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Cyclooxygenase (COX) plays a key regulatory role in prostaglandin synthesis.  COX-2 is inducible and is the major isoform of inflammatory cells.  COX-2-deficient mice were shown to have normal basal hematopoiesis and hematol.  We hypothesized that COX-2 induction plays a role in the recovery phase of 5-fluorouracil (5-FU) induced bone marrow injury, because significant macrophage-driven phagocytic removal of necrotic debris and stromal cell reorganization of repopulating marrow occur after 5-FU induction of bone marrow necrosis.  Hematol. recovery was markedly delayed with moderately severe leukopenia, thrombocytopenia and reticulocytopenia compared to heterozygotes on day 8 or 12 in Cox-2-/- mice.  Mild anemia was present in 5-FU-treated Cox-2-/- and Cox-2+/- mice on days 8 and 12, which was more severe in Cox-2-/- mice.  Cox-2-/- mice had markedly decreased bone marrow cell counts per femur and reduced nos. of erythroid and myeloid colony-forming cells compared to heterozygote mice on days 8 and 12 post 5-FU.  Histol. examn. of 5-FU-treated Cox-2-/- mice revealed a failure to repopulate the intact marrow stroma with hematopoietic cells.  Accelerated erythropoiesis following phenylhydrazine-induced hemolytic anemia, however, was comparable between Cox-2-/- and Cox+/- mice, as were induced levels of renal erythropoietin mRNA.  COX-2 induction is likely a central event in the accelerated hematopoiesis following myelotoxic injury, because recovery from 5-FU-induced myeloablation is markedly impaired in Cox-2-/- mice but is normal after phenylhydrazine induction of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriiypcLAh867Vg90H21EOLACvtfcHk0libSm8dqp5A9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslWmtbo%253D&md5=dc92a30f1e0a66a6b8091061fd339c11</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0301-472X%2899%2900087-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-472X%252899%252900087-9%26sid%3Dliteratum%253Aachs%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DSlaughter%26aufirst%3DH.%2BS.%26aulast%3DWescott%26aufirst%3DD.%2BM.%26aulast%3DCarter%26aufirst%3DS.%2BI.%26aulast%3DSchnyder%26aufirst%3DB.%26aulast%3DDinchuk%26aufirst%3DJ.%2BE.%26aulast%3DCar%26aufirst%3DB.%2BD.%26atitle%3DCyclooxygenase-2%2520is%2520essential%2520for%2520normal%2520recovery%2520from%25205-fluorouracil-induced%2520myelotoxicity%2520in%2520mice%26jtitle%3DExp.%2520Hematol.%26date%3D1999%26volume%3D27%26spage%3D1494%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Jackman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrap, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span> </span><span class="NLM_article-title">ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">31A</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">â</span> <span class="NLM_lpage">1282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31A&publication_year=1995&pages=1277-1282&author=A.+L.+Jackmanauthor=D.+C.+Farrugiaauthor=W.+Gibsonauthor=R.+Kimbellauthor=K.+R.+Harrapauthor=T.+C.+Stephensauthor=M.+Azabauthor=F.+T.+Boyle&title=ZD1694+%28Tomudex%29%3A+a+new+thymidylate+synthase+inhibitor+with+activity+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackman%26aufirst%3DA.%2BL.%26aulast%3DFarrugia%26aufirst%3DD.%2BC.%26aulast%3DGibson%26aufirst%3DW.%26aulast%3DKimbell%26aufirst%3DR.%26aulast%3DHarrap%26aufirst%3DK.%2BR.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26aulast%3DAzab%26aufirst%3DM.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26atitle%3DZD1694%2520%2528Tomudex%2529%253A%2520a%2520new%2520thymidylate%2520synthase%2520inhibitor%2520with%2520activity%2520in%2520colorectal%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1995%26volume%3D31A%26spage%3D1277%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rafi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvete, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clendeninn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span> </span><span class="NLM_article-title">Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">â</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9508200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1cXitVKit7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=1131-1141&author=I.+Rafiauthor=A.+V.+Boddyauthor=J.+A.+Calveteauthor=G.+A.+Taylorauthor=D.+R.+Newellauthor=N.+P.+Baileyauthor=M.+J.+Lindauthor=M.+Greenauthor=J.+Hinesauthor=A.+Johnstoneauthor=N.+Clendeninnauthor=A.+H.+Calvert&title=Preclinical+and+phase+I+clinical+studies+with+the+nonclassical+antifolate+thymidylate+synthase+inhibitor+nolatrexed+dihydrochloride+given+by+prolonged+administration+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors</span></div><div class="casAuthors">Rafi, Imran; Boddy, Alan V.; Calvete, Joanne A.; Taylor, Gordon A.; Newell, David R.; Bailey, Nigel P.; Lind, Michael J.; Green, Mark; Hines, John; Johnstone, Amanda; Clendeninn, Neil; Calvert, A. Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1131-1141</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A phase I, multicenter trial of the thymidylate synthase (TS) inhibitor THYMITAQ (nolatrexed dihydrochloride; Agouron Pharmaceuticals, Inc, San Diego, CA) given by 5-day continuous infusion was performed to establish the max.-tolerated dose (MTD) and to investigate pharmacokinetics, pharmaco-dynamics, and antitumor effects.  In vitro and in vivo preclin. studies demonstrated increased activity with prolonged nolatrexed exposure.  In 32 patients, nolatrexed was given as a 5-day infusion at 96 to 1,040 mg/m2/d for 5 days.  Pharmacokinetics were detd. from high-performance liq. chromatog. (HPLC) analyses of plasma and urine.  In addn. to studying toxicity, plasma deoxyuridine (UdR) elevations were measured as a marker of TS inhibition.  The MTD was 904 mg/m2/d for 5 days and the recommended phase II dose is 800 mg/m2/d for 5 days.  The dose-limiting toxicity was neutropenia with clin. significant thrombocytopenia and mucositis.  These antiproliferative toxicities of nolatrexed were predictable and reversible.  A partial response that lasted 3 mo occurred in a patient with metastatic colorectal cancer.  Pharmacokinetics were nonlinear, with the median plasma clearance (Cl) decreasing from 151 mL/min/m2 (range, 124 to 211) at 96 mg/m2/d for 5 days to 49 mL/min/m2 (range, 30 to 84) at 768 mg/m2/d for 5 days.  The half-life (t1/2) was 173 min (range, 43 to 784) and 18% (range, 9% to 35%) of the dose was excreted unchanged in the urine.  Plasma UdR increased, but returned to pretreatment levels after the end of infusion.  Hematol. toxicity was significantly related to nolatrexed plasma concns. and dose.  Nolatrexed can be safely administered to patients at a dose of 800 mg/m2/d over 5 days by continuous i.v. infusion and this schedule is assocd. with antitumor effects.  The phase II evaluation of nolatrexed is ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9u49TpGLuorVg90H21EOLACvtfcHk0lhz6DSBgjISoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitVKit7s%253D&md5=ef6a7787d20b95e4b17585de5e8f2fff</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRafi%26aufirst%3DI.%26aulast%3DBoddy%26aufirst%3DA.%2BV.%26aulast%3DCalvete%26aufirst%3DJ.%2BA.%26aulast%3DTaylor%26aufirst%3DG.%2BA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DBailey%26aufirst%3DN.%2BP.%26aulast%3DLind%26aufirst%3DM.%2BJ.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DJohnstone%26aufirst%3DA.%26aulast%3DClendeninn%26aufirst%3DN.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26atitle%3DPreclinical%2520and%2520phase%2520I%2520clinical%2520studies%2520with%2520the%2520nonclassical%2520antifolate%2520thymidylate%2520synthase%2520inhibitor%2520nolatrexed%2520dihydrochloride%2520given%2520by%2520prolonged%2520administration%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1998%26volume%3D16%26spage%3D1131%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Miwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umeda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitsuka, H.</span><span> </span><span class="NLM_article-title">Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">â</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=1274-1281&author=M.+Miwaauthor=M.+Uraauthor=M.+Nishidaauthor=N.+Sawadaauthor=T.+Ishikawaauthor=K.+Moriauthor=N.+Shimmaauthor=I.+Umedaauthor=H.+Ishitsuka&title=Design+of+a+novel+oral+fluoropyrimidine+carbamate%2C+capecitabine%2C+which+generates+5-fluorouracil+selectively+in+tumours+by+enzymes+concentrated+in+human+liver+and+cancer+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiwa%26aufirst%3DM.%26aulast%3DUra%26aufirst%3DM.%26aulast%3DNishida%26aufirst%3DM.%26aulast%3DSawada%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DUmeda%26aufirst%3DI.%26aulast%3DIshitsuka%26aufirst%3DH.%26atitle%3DDesign%2520of%2520a%2520novel%2520oral%2520fluoropyrimidine%2520carbamate%252C%2520capecitabine%252C%2520which%2520generates%25205-fluorouracil%2520selectively%2520in%2520tumours%2520by%2520enzymes%2520concentrated%2520in%2520human%2520liver%2520and%2520cancer%2520tissue%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1998%26volume%3D34%26spage%3D1274%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hardy, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer-Moore, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montfort, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span> </span><span class="NLM_article-title">Atomic structure of thymidylate synthase: target for rational drug design</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">â</span> <span class="NLM_lpage">455</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=448-455&author=L.+W.+Hardyauthor=J.+S.+Finer-Mooreauthor=W.+R.+Montfortauthor=M.+O.+Jonesauthor=D.+V.+Santiauthor=R.+M.+Stroud&title=Atomic+structure+of+thymidylate+synthase%3A+target+for+rational+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DL.%2BW.%26aulast%3DFiner-Moore%26aufirst%3DJ.%2BS.%26aulast%3DMontfort%26aufirst%3DW.%2BR.%26aulast%3DJones%26aufirst%3DM.%2BO.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DAtomic%2520structure%2520of%2520thymidylate%2520synthase%253A%2520target%2520for%2520rational%2520drug%2520design%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D448%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Longley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span> </span><span class="NLM_article-title">5-Fluorouracil: mechanisms of action and clinical strategies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">â</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2Fnrc1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12724731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlals70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=330-338&author=D.+B.+Longleyauthor=D.+P.+Harkinauthor=P.+G.+Johnston&title=5-Fluorouracil%3A+mechanisms+of+action+and+clinical+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">5-Fluorouracil: mechanisms of action and clinical strategies</span></div><div class="casAuthors">Longley, Daniel B.; Harkin, D. Paul; Johnston, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">330-338</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  5-Fluorouracil (5-FU) is widely used in the treatment of cancer.  Over the past 20 yr, increased understanding of the mechanism of action of 5-FU has led to the development of strategies that increase its anticancer activity.  Despite these advances, drug resistance remains a significant limitation to the clin. use of 5-FU.  Emerging technologies, such as DNA microarray profiling, have the potential to identify novel genes that are involved in mediating resistance to 5-FU.  Such target genes might prove to be therapeutically valuable as new targets for chemotherapy, or as predictive biomarkers of response to 5-FU-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnuu833TFVrVg90H21EOLACvtfcHk0lgodzZoKRW9Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlals70%253D&md5=79095f6753c79f281bc9548c9c1c8bd5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrc1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1074%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DHarkin%26aufirst%3DD.%2BP.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3D5-Fluorouracil%253A%2520mechanisms%2520of%2520action%2520and%2520clinical%2520strategies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D330%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Reigner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidekamm, E.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics of capecitabine</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">â</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.2165%2F00003088-200140020-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11286326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislansrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=85-104&author=B.+Reignerauthor=K.+Bleschauthor=E.+Weidekamm&title=Clinical+pharmacokinetics+of+capecitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of capecitabine</span></div><div class="casAuthors">Reigner, Bruno; Blesch, Karen; Weidekamm, Erhard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-104</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 58 refs.  Capecitabine is a novel oral fluoropyrimidine carbamate that is preferentially converted to the cytotoxic moiety fluorouracil (5-fluorouracil; 5-FU) in target tumor tissue through a series of 3 metabolic steps.  After oral administration of 1250 mg/m2, capecitabine is rapidly and extensively absorbed from the gastrointestinal tract [with a time to reach peak concn. (tmax) of 2 h and peak plasma drug concn. (Cmax) of 3 to 4 mg/L] and has a relatively short elimination half-life (t1/2) [0.55 to 0.89h].  Recovery of drug-related material in urine and feces is nearly 100%.  Plasma concns. of the cytotoxic moiety fluorouracil are very low [with a Cmax of 0.22 to 0.31 mg/L and area under the concn.-time curve (AUC) of 0.461 to 0.698 mg â¢ h/L].  The apparent t1/2 of fluorouracil after capecitabine administration is similar to that of the parent compd.  Comparison of fluorouracil concns. in primary colorectal tumor and adjacent healthy tissues after capecitabine administration demonstrates that capecitabine is preferentially activated to fluorouracil in colorectal tumor, with the av. concn. of fluorouracil being 3.2-fold higher than in adjacent healthy tissue (p = 0.002).  This tissue concn. differential does not hold for liver metastasis, although concns. of fluorouracil in liver metastases are sufficient for antitumor activity to occur.  The tumor-preferential activation of capecitabine to fluorouracil is explained by tissue differences in the activity of cytidine deaminase and thymidine phosphorylase, key enzymes in the conversion process.  As with other cytotoxic drugs, the interpatient variability of the pharmacokinetic parameters of capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine and fluorouracil, is high (27 to 89%) and is likely to be primarily due to variability in the activity of the enzymes involved in capecitabine metab.  Capecitabine and the fluorouracil precursors 5'-deoxy-5-fluorocytidine and 5'-deoxy-5-fluorouridine do not accumulate significantly in plasma after repeated administration.  Plasma concns. of fluorouracil increase by 10 to 60% during long term administration, but this time-dependency is assumed to be not clin. relevant.  A potential drug interaction of capecitabine with warfarin has been obsd.  There is no evidence of pharmacokinetic interactions between capecitabine and leucovorin, docetaxel or paclitaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6-xy5Lm9HrVg90H21EOLACvtfcHk0lgodzZoKRW9Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislansrs%253D&md5=80bda92090968db47a7f67a42abc1c92</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2165%2F00003088-200140020-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200140020-00002%26sid%3Dliteratum%253Aachs%26aulast%3DReigner%26aufirst%3DB.%26aulast%3DBlesch%26aufirst%3DK.%26aulast%3DWeidekamm%26aufirst%3DE.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520capecitabine%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2001%26volume%3D40%26spage%3D85%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Gressett, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanford, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwicke, F.</span><span> </span><span class="NLM_article-title">Management of handâfoot syndrome induced by capecitabine</span> <span class="citation_source-journal">J. Oncol. Pharm. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1177%2F1078155206069242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17022868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSksrfL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=131-141&author=S.+M.+Gressettauthor=B.+L.+Stanfordauthor=F.+Hardwicke&title=Management+of+hand%E2%88%92foot+syndrome+induced+by+capecitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Management of hand-foot syndrome induced by capecitabine</span></div><div class="casAuthors">Gressett, Sarah M.; Stanford, Brad L.; Hardwicke, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Oncology Pharmacy Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-141</span>CODEN:
                <span class="NLM_cas:coden">JOPPFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-1552</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Capecitabine (Xeloda) is a systemic prodrug of 5-fluorouracil (5-FU), which is administered in an oral formulation.  Hand-foot syndrome (HFS) has proven to be a chronic dose-limiting toxicity of capecitabine, leading to significant morbidity in patients receiving this agent.  The purpose of this review is to define the pathophysiol., risk factors, incidence and management of capecitabine-induced HFS.  Literature for this review article was collected from the following databases: PubMed, CINAHL, and the proceedings of the American Society of Clin. Oncol. (ASCO) confined to the years 1995-2006.  The following key terms were used in the search: hand-foot syndrome, palmar-plantar erythrodysesthesia, capecitabine, Xeloda, colorectal cancer, and metastatic breast cancer.  HFS assocd. with capecitabine is a serious dose-limiting toxicity.  Incidence of grade 3/4 toxicity is of extreme significance, and introduces the need for dose redns. and/or interruptions in capecitabine therapy.  Drug-related therapies studied include topical emollients and creams, systemic and topical corticosteroids, nicotine patch, vitamin E, pyridoxine, and COX-2 inhibitors.  However, due to the lack of randomized, controlled trials with these therapies, the current mainstay of treatment for the management of this toxicity is interruption of therapy and, if necessary, dose redn.  Treatment interruption or dose redn. remain the only methods shown to effectively manage HFS, but supportive measures to reduce pain and discomfort and prevent secondary infection are very important.  Many other prophylactic and treatment strategies have been investigated, with pyridoxine and COX-2 inhibitors being the most promising in case reports and retrospective studies; therefore, prospective, randomized, controlled trials are needed to prove their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAkpNbAgrQdLVg90H21EOLACvtfcHk0lgodzZoKRW9Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSksrfL&md5=1fe11c88f027b20b1af1a4680488ac52</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1078155206069242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1078155206069242%26sid%3Dliteratum%253Aachs%26aulast%3DGressett%26aufirst%3DS.%2BM.%26aulast%3DStanford%26aufirst%3DB.%2BL.%26aulast%3DHardwicke%26aufirst%3DF.%26atitle%3DManagement%2520of%2520hand%25E2%2588%2592foot%2520syndrome%2520induced%2520by%2520capecitabine%26jtitle%3DJ.%2520Oncol.%2520Pharm.%2520Pract.%26date%3D2006%26volume%3D12%26spage%3D131%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hiller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuk, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lidak, M. Y.</span><span> </span><span class="NLM_article-title">Analogs of pyrimidine nucleosides. I. <i>N</i>1-(Î±-furanidyl) derivatives of natural pyrimidine bases and their antimetabolites</span> <span class="citation_source-journal">Dokl. Akad. Nauk Uzb. USSR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">â</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=1967&pages=332-335&author=S.+A.+Hillerauthor=R.+A.+Zhukauthor=M.+Y.+Lidak&title=Analogs+of+pyrimidine+nucleosides.+I.+N1-%28%CE%B1-furanidyl%29+derivatives+of+natural+pyrimidine+bases+and+their+antimetabolites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DS.%2BA.%26aulast%3DZhuk%26aufirst%3DR.%2BA.%26aulast%3DLidak%26aufirst%3DM.%2BY.%26atitle%3DAnalogs%2520of%2520pyrimidine%2520nucleosides.%2520I.%2520N1-%2528%25CE%25B1-furanidyl%2529%2520derivatives%2520of%2520natural%2520pyrimidine%2520bases%2520and%2520their%2520antimetabolites%26jtitle%3DDokl.%2520Akad.%2520Nauk%2520Uzb.%2520USSR%26date%3D1967%26volume%3D176%26spage%3D332%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshisue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, Y.</span><span> </span><span class="NLM_article-title">Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4409</span><span class="NLM_x">â</span> <span class="NLM_lpage">4415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11106261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVSgu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=4409-4415&author=K.+Ikedaauthor=K.+Yoshisueauthor=E.+Matsushimaauthor=S.+Nagayamaauthor=K.+Kobayashiauthor=C.+A.+Tysonauthor=K.+Chibaauthor=Y.+Kawaguchi&title=Bioactivation+of+tegafur+to+5-fluorouracil+is+catalyzed+by+cytochrome+P-450+2A6+in+human+liver+microsomes+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of Tegafur to 5-fluorouracil is catalyzed by cytochrome P 450 2A6 in human liver microsomes in vitro</span></div><div class="casAuthors">Ikeda, Kazumasa; Yoshisue, Kunihiro; Matsushima, Eiji; Nagayama, Sekio; Kobayashi, Kaoru; Tyson, Charles A.; Chiba, Kan; Kawaguchi, Yasuro</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4409-4415</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tegafur is a prodrug of 5-fluorouracil (5-FU) consisting of a new class of oral chemotherapeutic agents, Tegafur/uracil and S-1, which are classified as dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines.  It is bioactivated to 5-FU via 5'-hydroxylation mediated by cytochrome P 450 (CYP).  However, which isoform(s) of CYP is responsible for the bioactivation process of Tegafur remains unclear.  The purpose of the present study was to identify the human CYP isoform(s) involved in the metabolic activation of Tegafur using human liver microsomes and cDNA-expressed human CYPs.  The formation of 5-FU from Tegafur in human liver microsomes showed bi-phase kinetics with Km and Vmax values for the high-affinity component of 0.43 Â± 0.05 mM and 4.02 Â± 1.70 nmol/mg/min (mean Â± SD, n = 4), resp.  In the correlation study using a panel of 10 human liver microsomes, the formation of 5-FU from Tegafur showed a significant correlation (r = 0.98; P < 0.001) with coumarin 7-hydroxylation, a marker activity of CYP2A6.  In addn., a specific substrate of CYP2A6 and anti-CYP2A6 antibody inhibited the formation of 5-FU by 90% in human liver microsomes.  Moreover, cDNA-expressed CYP2A6 showed the highest activity for the formation of 5-FU among 10 cDNA-expressed CYPs, with a Km value similar to that found for the high-affinity component in human liver microsomes.  These findings clearly suggest that CYP2A6 is a principal enzyme responsible for the bioactivation process of Tegafur in human liver microsomes.  However, to what extent the bioactivation of Tegafur by CYP2A6 accounts for the formation of 5-FU in vivo remains unclear, because the formation of 5-FU from Tegafur is also catalyzed by the sol. fraction of a 100,000 Ã g supernatant and also derived from spontaneous degrdn. of Tegafur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrixYHiy9fSb7Vg90H21EOLACvtfcHk0lgodzZoKRW9Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVSgu7k%253D&md5=b58a79ca070032ac1aa709285ca744f0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DYoshisue%26aufirst%3DK.%26aulast%3DMatsushima%26aufirst%3DE.%26aulast%3DNagayama%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DTyson%26aufirst%3DC.%2BA.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DKawaguchi%26aufirst%3DY.%26atitle%3DBioactivation%2520of%2520tegafur%2520to%25205-fluorouracil%2520is%2520catalyzed%2520by%2520cytochrome%2520P-450%25202A6%2520in%2520human%2520liver%2520microsomes%2520in%2520vitro%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D4409%26epage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikenaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirasaka, T.</span><span> </span><span class="NLM_article-title">Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents</span> <span class="citation_source-journal">Gann</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1979&pages=209-214&author=S.+Fujiiauthor=S.+Kitanoauthor=K.+Ikenakaauthor=T.+Shirasaka&title=Effect+of+coadministration+of+uracil+or+cytosine+on+the+anti-tumor+activity+of+clinical+doses+of+1-%282-tetrahydrofuryl%29-5-fluorouracil+and+level+of+5-fluorouracil+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DS.%26aulast%3DIkenaka%26aufirst%3DK.%26aulast%3DShirasaka%26aufirst%3DT.%26atitle%3DEffect%2520of%2520coadministration%2520of%2520uracil%2520or%2520cytosine%2520on%2520the%2520anti-tumor%2520activity%2520of%2520clinical%2520doses%2520of%25201-%25282-tetrahydrofuryl%2529-5-fluorouracil%2520and%2520level%2520of%25205-fluorouracil%2520in%2520rodents%26jtitle%3DGann%26date%3D1979%26volume%3D70%26spage%3D209%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Shirasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshimo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, M.</span><span> </span><span class="NLM_article-title">Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas</span> <span class="citation_source-journal">Jpn. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1093%2Fjjco%2Fhyn127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=19052037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FgsFehtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=2-15&author=T.+Shirasakaauthor=Y.+Shimamatoauthor=H.+Ohshimoauthor=M.+Yamaguchiauthor=T.+Katoauthor=K.+Yonekuraauthor=M.+Fukushima&title=Development+history+and+concept+of+an+oral+anticancer+agent+S-1+%28TS-1%29%3A+its+clinical+usefulness+and+future+vistas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas</span></div><div class="casAuthors">Shirasaka Tetsuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Japanese journal of clinical oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dushinsky et al. left a great gift to human beings with the discovery of 5-fluorouracil (5-FU).  Approximately 50 years have elapsed from that discovery to the development of S-1 (TS-1).  The concept of developing an anticancer agent that simultaneously possesses both efficacy-enhancing and adverse reaction-reducing effects could be achieved only with a three-component combination drug.  S-1 is an oral anticancer agent containing two biochemical modulators for 5-FU and tegafur (FT), a metabolically activated prodrug of 5-FU.  The first modulator, 5-chloro-2,4-dihydroxypyridine (CDHP), enhances the pharmacological actions of 5-FU by potently inhibiting its degradation.  The second modulator, potassium oxonate (Oxo), localizing in mucosal cells of the gastrointestinal (GI) tract after oral administration, reduces the incidence of GI toxicities by suppressing the activation of 5-FU in the GI tract.  Thus, S-1 combines FT, CDHP and Oxo at a molar ratio of 1:0.4:1.  In 1999-2007, S-1 was approved for the treatment of the following seven cancers: gastric, head and neck, colorectal, non-small cell lung, breast, pancreatic and biliary tract cancers. 'S-1 and low-dose cisplatin therapy' without provoking Grade 3 non-hematologic toxicities was proposed to enhance its clinical usefulness.  Furthermore, 'alternate-day S-1 regimen' may improve the dosing schedule for 5-FU by utilizing its strongly time-dependent mode of action; the former is characterized by the low incidences of myelotoxicity and non-hematologic toxicities (e.g. < or =Grade 1 anorexia, fatigue, stomatitis, nausea, vomiting and taste alteration).  These two approaches are considered to allow long-lasting therapy with S-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTD8YPu8Cz4JkNoizSOkG_FfW6udTcc2ebI7rZnztnFQbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FgsFehtg%253D%253D&md5=013a729ca0f7009b295eb630c9d977e2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fjjco%2Fhyn127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjjco%252Fhyn127%26sid%3Dliteratum%253Aachs%26aulast%3DShirasaka%26aufirst%3DT.%26aulast%3DShimamato%26aufirst%3DY.%26aulast%3DOhshimo%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYonekura%26aufirst%3DK.%26aulast%3DFukushima%26aufirst%3DM.%26atitle%3DDevelopment%2520history%2520and%2520concept%2520of%2520an%2520oral%2520anticancer%2520agent%2520S-1%2520%2528TS-1%2529%253A%2520its%2520clinical%2520usefulness%2520and%2520future%2520vistas%26jtitle%3DJpn.%2520J.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D39%26spage%3D2%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Shirasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshimo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, M.</span><span> </span><span class="NLM_article-title">Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators</span> <span class="citation_source-journal">Anti-Cancer drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">â</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=548-557&author=T.+Shirasakaauthor=Y.+Shimamatoauthor=H.+Ohshimoauthor=M.+Yamaguchiauthor=T.+Katoauthor=K.+Yonekuraauthor=M.+Fukushima&title=Development+of+a+novel+form+of+an+oral+5-fluorouracil+derivative+%28S-1%29+directed+to+the+potentiation+of+the+tumor+selective+cytotoxicity+of+5-fluorouracil+by+two+biochemical+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShirasaka%26aufirst%3DT.%26aulast%3DShimamato%26aufirst%3DY.%26aulast%3DOhshimo%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYonekura%26aufirst%3DK.%26aulast%3DFukushima%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520form%2520of%2520an%2520oral%25205-fluorouracil%2520derivative%2520%2528S-1%2529%2520directed%2520to%2520the%2520potentiation%2520of%2520the%2520tumor%2520selective%2520cytotoxicity%2520of%25205-fluorouracil%2520by%2520two%2520biochemical%2520modulators%26jtitle%3DAnti-Cancer%2520drugs%26date%3D1996%26volume%3D7%26spage%3D548%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Senter, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C. J.</span><span> </span><span class="NLM_article-title">Selective activation of anticancer prodrugs by monoclonal antibodyâenzyme conjugates</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=247-264&author=P.+D.+Senterauthor=C.+J.+Springer&title=Selective+activation+of+anticancer+prodrugs+by+monoclonal+antibody%E2%88%92enzyme+conjugates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSenter%26aufirst%3DP.%2BD.%26aulast%3DSpringer%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520anticancer%2520prodrugs%2520by%2520monoclonal%2520antibody%25E2%2588%2592enzyme%2520conjugates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D53%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Phelan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermeier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, C. A.</span><span> </span><span class="NLM_article-title">Design and synthesis of a beta-lactamase activated 5-fluorouracil prodrug</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">â</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1261-1263&author=R.+M.+Phelanauthor=M.+Ostermeierauthor=C.+A.+Townsend&title=Design+and+synthesis+of+a+beta-lactamase+activated+5-fluorouracil+prodrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhelan%26aufirst%3DR.%2BM.%26aulast%3DOstermeier%26aufirst%3DM.%26aulast%3DTownsend%26aufirst%3DC.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520beta-lactamase%2520activated%25205-fluorouracil%2520prodrug%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1261%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Gmeiner, W. H.</span><span> </span><span class="NLM_article-title">Novel chemical strategies for thymidylate synthase inhibition</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=15638735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=191-202&author=W.+H.+Gmeiner&title=Novel+chemical+strategies+for+thymidylate+synthase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Novel chemical strategies for thymidylate synthase inhibition</span></div><div class="casAuthors">Gmeiner, W. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Thymidylate synthase (TS) is a well-validated target for cancer chemotherapy.  TS was established as the principal target of the widely used anticancer drug 5-fluorouracil (5FU).  The 5FU metabolite FdUMP forms a covalent complex with TS that is stabilized by 5-formyl tetrahydrofolate (leucovorin; LV).  Numerous chem. strategies were employed to develop novel TS inhibitors that are superior to 5FU/LV.  5FU is non-ideal as a TS-inhibitory drug because it is only inefficiently converted to FdUMP, while the remainder of the administered dose is converted to toxic metabolites.  My lab. has explored the utility of FdUMP[N] compds. (oligodeoxynucleotides comprised of FdUMP nucleotides) as FdUMP pro-drugs.  FdUMP[N] compds. result in potent TS-inhibition, and display many advantages relative to 5FU/LV.  A no. of other chem. strategies were also employed to develop pro-drugs, or metabolic precursors of FdUMP, and several of these strategies will be reviewed.  In addn. to chem. strategies to develop FdUMP pro-drugs, a no. of chem. strategies were devised to develop mols. that resemble the reduced folate co-factor required for TS catalysis.  The synthesis of antifolates that have TS-inhibitory activity, such as Raltitrexed, has resulted in compds. that are effective and specific TS-inhibitors and, in some cases, have clin. potential.  Chem. strategies that target TS mRNA for destruction are also being explored as potential chemotherapeutics.  These diverse chem. approaches to control TS activity in tumor cells for the treatment of cancer will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaxbcmUD33u7Vg90H21EOLACvtfcHk0liAhf_tw7RCDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOqtA%253D%253D&md5=6901ee803f118d4500b2f5a96e322c9d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGmeiner%26aufirst%3DW.%2BH.%26atitle%3DNovel%2520chemical%2520strategies%2520for%2520thymidylate%2520synthase%2520inhibition%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lackey, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groziak, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beryt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegram, M.</span><span> </span><span class="NLM_article-title">Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">â</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=179-189&author=D.+B.+Lackeyauthor=M.+P.+Groziakauthor=M.+Sergeevaauthor=M.+Berytauthor=C.+Boyerauthor=R.+M.+Stroudauthor=P.+Sayreauthor=J.+W.+Parkauthor=P.+Johnstonauthor=D.+Slamonauthor=H.+M.+Shepardauthor=M.+Pegram&title=Enzyme-catalyzed+therapeutic+agent+%28ECTA%29+design%3A+activation+of+the+antitumor+ECTA+compound+NB1011+by+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DD.%2BB.%26aulast%3DGroziak%26aufirst%3DM.%2BP.%26aulast%3DSergeeva%26aufirst%3DM.%26aulast%3DBeryt%26aufirst%3DM.%26aulast%3DBoyer%26aufirst%3DC.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DSayre%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DJohnston%26aufirst%3DP.%26aulast%3DSlamon%26aufirst%3DD.%26aulast%3DShepard%26aufirst%3DH.%2BM.%26aulast%3DPegram%26aufirst%3DM.%26atitle%3DEnzyme-catalyzed%2520therapeutic%2520agent%2520%2528ECTA%2529%2520design%253A%2520activation%2520of%2520the%2520antitumor%2520ECTA%2520compound%2520NB1011%2520by%2520thymidylate%2520synthase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D179%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, H. M.</span><span> </span><span class="NLM_article-title">A novel approach to thymidylate synthase as a target for cancer chemotherapy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">â</span> <span class="NLM_lpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=446-452&author=Q.+Liauthor=C.+Boyerauthor=J.+Y.+Leeauthor=H.+M.+Shepard&title=A+novel+approach+to+thymidylate+synthase+as+a+target+for+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DBoyer%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DShepard%26aufirst%3DH.%2BM.%26atitle%3DA%2520novel%2520approach%2520to%2520thymidylate%2520synthase%2520as%2520a%2520target%2520for%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D446%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Neuteboom, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beryt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, H. M.</span><span> </span><span class="NLM_article-title">Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">â</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12477050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=377-384&author=S.+T.+Neuteboomauthor=P.+L.+Karjianauthor=C.+R.+Boyerauthor=M.+Berytauthor=M.+Pegramauthor=G.+M.+Wahlauthor=H.+M.+Shepard&title=Inhibition+of+cell+growth+by+NB1011+requires+high+thymidylate+synthase+levels+and+correlates+with+p53%2C+p21%2C+bax%2C+and+GADD45+induction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, Bax, and GADD45 induction</span></div><div class="casAuthors">Neuteboom, Saskia T. C.; Karjian, Patricia L.; Boyer, Christopher R.; Beryt, Malgorzhata; Pegram, Mark; Wahl, Geoffrey M.; Shepard, H. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">377-384</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">NB1011, a phosphoramidate deriv. of (E)-5-(2-bromovinyl)-2'-deoxyuridine, is a novel small mol. anticancer agent.  NB1011 is selectively active against tumor cells expressing high levels of thymidylate synthase (TS), a crit. enzyme in DNA biosynthesis.  NB1011 is different from the current TS-targeted drugs, which require inhibition of TS to be effective, because NB1011 cytotoxicity depends upon activation by TS.  Here we report a dose-dependent, antitumor activity of NB1011 against established Tomudex-resistant breast cancer (MCF7TDX) xenografts in athymic mice.  Against 5-fluorouracil-resistant colon carcinoma (H630R10) xenografts, NB1011 was as efficacious as irinotecan, a drug recently approved for the treatment of 5-fluorouracil-resistant colon cancer.  To gain insight into the mechanisms NB1011 uses to suppress cellular growth, we analyzed the downstream mol. events in the high TS-expressing MCF7TDX and RKOTDX cell lines upon NB1011 treatment.  NB1011 treatment increased the mRNA levels of p21, Bax, and GADD45.  Furthermore, NB1011 induced p53, p21, and Bax proteins specifically in high TS-expressing tumor cells, whereas no induction was obsd. in low TS-expressing tumor cells (MCF7) or normal cells (WI38).  Cell cycle anal. demonstrated that NB1011 treatment of MCF7TDX and RKOTDX cells resulted in an accumulation of cells in the G2-M phase of the cell cycle.  Altogether, our data indicate that the induction of the p53 target genes p21, bax, and GADD45, with a concomitant deregulation of the cell cycle, may represent one of the mechanisms by which NB1011 exerts its growth-suppressive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu8wvk2rEnyLVg90H21EOLACvtfcHk0liAhf_tw7RCDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7w%253D&md5=7a940b42399757200361320490841f62</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DBoyer%26aufirst%3DC.%2BR.%26aulast%3DBeryt%26aufirst%3DM.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26aulast%3DShepard%26aufirst%3DH.%2BM.%26atitle%3DInhibition%2520of%2520cell%2520growth%2520by%2520NB1011%2520requires%2520high%2520thymidylate%2520synthase%2520levels%2520and%2520correlates%2520with%2520p53%252C%2520p21%252C%2520bax%252C%2520and%2520GADD45%2520induction%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D377%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Boyer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuteboom, S. T.</span><span> </span><span class="NLM_article-title">Nucleoside transport inhibitors, dipyridamole and <i>p</i>-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=29-36&author=C.+R.+Boyerauthor=P.+L.+Karjianauthor=G.+M.+Wahlauthor=M.+Pegramauthor=S.+T.+Neuteboom&title=Nucleoside+transport+inhibitors%2C+dipyridamole+and+p-nitrobenzylthioinosine%2C+selectively+potentiate+the+antitumor+activity+of+NB1011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DC.%2BR.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%26atitle%3DNucleoside%2520transport%2520inhibitors%252C%2520dipyridamole%2520and%2520p-nitrobenzylthioinosine%252C%2520selectively%2520potentiate%2520the%2520antitumor%2520activity%2520of%2520NB1011%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2002%26volume%3D13%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Pegram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeon, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottlieb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cossum, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, H. J.</span><span> </span><span class="NLM_article-title">Enzyme catalyzed therapeutic activation of NB1011 (N) selectively targets thymidylate synthase (TS)-overexpressing tumor cells: phase I results</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=3144&author=M.+Pegramauthor=C.+H.+Yeonauthor=N.+Kuauthor=C.+Gottliebauthor=M.+Shepardauthor=P.+Cossumauthor=E.+Johnauthor=S.+Iqbalauthor=A.+Garciaauthor=H.+J.+Lenz&title=Enzyme+catalyzed+therapeutic+activation+of+NB1011+%28N%29+selectively+targets+thymidylate+synthase+%28TS%29-overexpressing+tumor+cells%3A+phase+I+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DYeon%26aufirst%3DC.%2BH.%26aulast%3DKu%26aufirst%3DN.%26aulast%3DGottlieb%26aufirst%3DC.%26aulast%3DShepard%26aufirst%3DM.%26aulast%3DCossum%26aufirst%3DP.%26aulast%3DJohn%26aufirst%3DE.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26atitle%3DEnzyme%2520catalyzed%2520therapeutic%2520activation%2520of%2520NB1011%2520%2528N%2529%2520selectively%2520targets%2520thymidylate%2520synthase%2520%2528TS%2529-overexpressing%2520tumor%2520cells%253A%2520phase%2520I%2520results%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Congiatu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M. D.</span><span> </span><span class="NLM_article-title">Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: design, synthesis and biological evaluation</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">â</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1081%2FNCN-200061774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=16247976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGisb3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=485-489&author=C.+Congiatuauthor=C.+McGuiganauthor=W.+G.+Jiangauthor=G.+Daviesauthor=M.+D.+Mason&title=Naphthyl+phosphoramidate+derivatives+of+BVdU+as+potential+anticancer+agents%3A+design%2C+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: Design, synthesis and biological evaluation</span></div><div class="casAuthors">Congiatu, C.; McGuigan, C.; Jiang, W. G.; Davies, G.; Mason, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">485-489</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The phosphoramidate technol. has been recently applied to BVdU, leading to NB1011 (NewBiotics Inc., California), a novel potential anticancer compd. recently entered into phase 2 of the clin. trials for colon cancer.  A new series of derivs. contg. naphthol and amino acid moieties as aryl masking group on the phosphate moiety, e.g. I, which has shown a significant increase in anticancer activity in preliminary biol. evaluations, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon_axc3D-7hLVg90H21EOLACvtfcHk0lgpV9it_dKtMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGisb3O&md5=8a994c7a7114d116b0a830a0d5caaccf</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1081%2FNCN-200061774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-200061774%26sid%3Dliteratum%253Aachs%26aulast%3DCongiatu%26aufirst%3DC.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26aulast%3DDavies%26aufirst%3DG.%26aulast%3DMason%26aufirst%3DM.%2BD.%26atitle%3DNaphthyl%2520phosphoramidate%2520derivatives%2520of%2520BVdU%2520as%2520potential%2520anticancer%2520agents%253A%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2005%26volume%3D24%26spage%3D485%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Adjei, A. A.</span><span> </span><span class="NLM_article-title">Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4276s</span><span class="NLM_x">â</span> <span class="NLM_lpage">4280s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4276s-4280s&author=A.+A.+Adjei&title=Pemetrexed+%28ALIMTA%29%2C+a+novel+multitargeted+antineoplastic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DPemetrexed%2520%2528ALIMTA%2529%252C%2520a%2520novel%2520multitargeted%2520antineoplastic%2520agent%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D4276s%26epage%3D4280s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habeck, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. M.</span><span> </span><span class="NLM_article-title">Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA)</span> <span class="citation_source-journal">Adv. Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1998&pages=135-152&author=C.+Shihauthor=L.+L.+Habeckauthor=L.+G.+Mendelsohnauthor=V.+J.+Chenauthor=R.+M.+Schultz&title=Multiple+folate+enzyme+inhibition%3A+mechanism+of+a+novel+pyrrolopyrimidine-based+antifolate+LY231514+%28MTA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DC.%26aulast%3DHabeck%26aufirst%3DL.%2BL.%26aulast%3DMendelsohn%26aufirst%3DL.%2BG.%26aulast%3DChen%26aufirst%3DV.%2BJ.%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26atitle%3DMultiple%2520folate%2520enzyme%2520inhibition%253A%2520mechanism%2520of%2520a%2520novel%2520pyrrolopyrimidine-based%2520antifolate%2520LY231514%2520%2528MTA%2529%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D1998%26volume%3D38%26spage%3D135%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3-<i>d</i>]pyrimidine antifolates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5789</span><span class="NLM_x">â</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006933" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5789-5797&author=A.+Gangjeeauthor=Y.+Qiuauthor=W.+Liauthor=R.+L.+Kisliuk&title=Potent+dual+thymidylate+synthase+and+dihydrofolate+reductase+inhibitors%3A+classical+and+nonclassical+2-amino-4-oxo-5-arylthio-substituted-6-methylthieno%5B2%2C3-d%5Dpyrimidine+antifolates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm8006933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006933%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DPotent%2520dual%2520thymidylate%2520synthase%2520and%2520dihydrofolate%2520reductase%2520inhibitors%253A%2520classical%2520and%2520nonclassical%25202-amino-4-oxo-5-arylthio-substituted-6-methylthieno%255B2%252C3-d%255Dpyrimidine%2520antifolates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5789%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J. J.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-yl)thio]benz oyl}-<span class="smallcaps smallerCapital">l</span>-glutamic acid and <i>N</i>-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-yl)thio]benzoyl}-<span class="smallcaps smallerCapital">l</span>-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">â</span> <span class="NLM_lpage">7222</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058234m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7215-7222&author=A.+Gangjeeauthor=X.+Linauthor=R.+L.+Kisliukauthor=J.+J.+McGuire&title=Synthesis+of+N-%7B4-%5B%282%2C4-diamino-5-methyl-4%2C7-dihydro-3H-pyrrolo%5B2%2C3-d%5Dpyrimidin-6-yl%29thio%5Dbenz+oyl%7D-l-glutamic+acid+and+N-%7B4-%5B%282-amino-4-oxo-5-methyl-4%2C7-dihydro-3H-pyrrolo%5B2%2C3-d%5Dpyrimidin-6-yl%29thio%5Dbenzoyl%7D-l-glutamic+acid+as+dual+inhibitors+of+dihydrofolate+reductase+and+thymidylate+synthase+and+as+potential+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm058234m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058234m%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520N-%257B4-%255B%25282%252C4-diamino-5-methyl-4%252C7-dihydro-3H-pyrrolo%255B2%252C3-d%255Dpyrimidin-6-yl%2529thio%255Dbenz%2520oyl%257D-l-glutamic%2520acid%2520and%2520N-%257B4-%255B%25282-amino-4-oxo-5-methyl-4%252C7-dihydro-3H-pyrrolo%255B2%252C3-d%255Dpyrimidin-6-yl%2529thio%255Dbenzoyl%257D-l-glutamic%2520acid%2520as%2520dual%2520inhibitors%2520of%2520dihydrofolate%2520reductase%2520and%2520thymidylate%2520synthase%2520and%2520as%2520potential%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7215%26epage%3D7222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-<i>d</i>]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">â</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701052u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=68-76&author=A.+Gangjeeauthor=W.+Liauthor=J.+Yangauthor=R.+L.+Kisliuk&title=Design%2C+synthesis%2C+and+biological+evaluation+of+classical+and+nonclassical+2-amino-4-oxo-5-substituted-6-methylpyrrolo%5B3%2C2-d%5Dpyrimidines+as+dual+thymidylate+synthase+and+dihydrofolate+reductase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm701052u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701052u%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520classical%2520and%2520nonclassical%25202-amino-4-oxo-5-substituted-6-methylpyrrolo%255B3%252C2-d%255Dpyrimidines%2520as%2520dual%2520thymidylate%2520synthase%2520and%2520dihydrofolate%2520reductase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D68%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Liani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothem, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assaraf, Y. G.</span><span> </span><span class="NLM_article-title">Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">â</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fijc.10829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12494465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFKgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=587-599&author=E.+Lianiauthor=L.+Rothemauthor=M.+A.+Bunniauthor=C.+A.+Smithauthor=G.+Jansenauthor=Y.+G.+Assaraf&title=Loss+of+folylpoly-gamma-glutamate+synthetase+activity+is+a+dominant+mechanism+of+resistance+to+polyglutamylation-dependent+novel+antifolates+in+multiple+human+leukemia+sublines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of folylpoly-Î³-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines</span></div><div class="casAuthors">Liani, Esti; Rothem, Lilah; Bunni, Marlene A.; Smith, Clyde A.; Jansen, Gerrit; Assaraf, Yehuda G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-599</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We have studied the mol. basis of drug resistance in human CCRF-CEM leukemia cells exposed to high dose intermittent pulses of novel polyglutamatable antifolates that target various folate-dependent enzymes.  These include the dihydrofolate reductase (DHFR) inhibitors edatrexate, methotrexate and aminopterin, the thymidylate synthase (TS) inhibitors ZD1694 and GW1843, the glycinamide ribonucleotide formyltransferase (GARTF) inhibitor DDATHF as well as the multitargeted antifolate LY231514 inhibiting both TS, DHFR and GARTF.  Fourteen antifolate-resistant sublines were isolated, 11 of which displayed a drug resistance phenotype that was based on impaired folylpoly-Î³-glutamate synthetase (FPGS) activity as these cell lines: (1) typically lost 90-99% of parental FPGS activity; (2) expressed 1.4-3.3-fold less FPGS mRNA (only 4 cell lines); (3) displayed up to 105-fold resistance to polyglutamylation-dependent antifolates including ZD1694 and MTA; (4) retained sensitivity to polyglutamylation-independent antifolates including ZD9331 and PT523; (5) were up to 19-fold hypersensitive to the lipid-sol. antifolates trimetrexate and AG377; (6) had a normal or a small decrease in [3H]MTX transport; and (7) had a 2.1-8.3-fold decreased cellular folate pools and a consequently increased folate growth requirement.  The remaining 3 antifolate-resistant sublines lost 94-97% of parental [3H]MTX transport and thus displayed a high level resistance to all hydrophilic antifolates.  To screen for mutations in the hFPGS gene, we devised an RT-PCR single strand conformational polymorphism (SSCP) assay.  RT-PCR-SSCP anal. and DNA sequencing showed that only a single FPGS-deficient subline harbored an FPGS mutation (Cys346Phe).  Three-dimensional modeling of the human FPGS based on the crystal structure of Lactobacillus casei FPGS suggested that this mutation maps to the active site and interferes with the catalytic activity of the enzyme due to a putative bulky clash between the mutant Phe346 and a native Phe350 within Î±-helix A10 in a highly conserved C-terminal hydrophobic core.  This was consistent with a 23-fold decreased affinity of the mutant Cys346Phe FPGS for L-glutamate.  We conclude that decreased FPGS activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates upon a high-dose intermittent exposure schedule.  The finding that cells may exhibit 5 orders of magnitude of resistance to polyglutamylation-dependent antifolates but in the same time retain parental sensitivity or hypersensitivity to polyglutamylation-independent antifolates or lipophilic antifolates offers a potentially promising treatment strategy in the overcoming of FPGS-based anticancer drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwGTrWc0hDLbVg90H21EOLACvtfcHk0lh6-Joi6xyeKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFKgtg%253D%253D&md5=afd837df1d51f37f5ab7f37593da931e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fijc.10829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10829%26sid%3Dliteratum%253Aachs%26aulast%3DLiani%26aufirst%3DE.%26aulast%3DRothem%26aufirst%3DL.%26aulast%3DBunni%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BA.%26aulast%3DJansen%26aufirst%3DG.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26atitle%3DLoss%2520of%2520folylpoly-gamma-glutamate%2520synthetase%2520activity%2520is%2520a%2520dominant%2520mechanism%2520of%2520resistance%2520to%2520polyglutamylation-dependent%2520novel%2520antifolates%2520in%2520multiple%2520human%2520leukemia%2520sublines%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2003%26volume%3D103%26spage%3D587%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifton, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davisson, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span> </span><span class="NLM_article-title">Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">16279</span><span class="NLM_x">â</span> <span class="NLM_lpage">16287</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00050a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=16279-16287&author=C.+A.+Schifferauthor=I.+J.+Cliftonauthor=V.+J.+Davissonauthor=D.+V.+Santiauthor=R.+M.+Stroud&title=Crystal+structure+of+human+thymidylate+synthase%3A+a+structural+mechanism+for+guiding+substrates+into+the+active+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi00050a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00050a007%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DDavisson%26aufirst%3DV.%2BJ.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520thymidylate%2520synthase%253A%2520a%2520structural%2520mechanism%2520for%2520guiding%2520substrates%2520into%2520the%2520active%2520site%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D16279%26epage%3D16287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Phan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlap, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">14170</span><span class="NLM_x">â</span> <span class="NLM_lpage">14177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14170-14177&author=J.+Phanauthor=D.+J.+Steadmanauthor=S.+Koliauthor=W.+C.+Dingauthor=W.+Minorauthor=R.+B.+Dunlapauthor=S.+H.+Bergerauthor=L.+Lebioda&title=Structure+of+human+thymidylate+synthase+suggests+advantages+of+chemotherapy+with+noncompetitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DSteadman%26aufirst%3DD.%2BJ.%26aulast%3DKoli%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DW.%2BC.%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DDunlap%26aufirst%3DR.%2BB.%26aulast%3DBerger%26aufirst%3DS.%2BH.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DStructure%2520of%2520human%2520thymidylate%2520synthase%2520suggests%2520advantages%2520of%2520chemotherapy%2520with%2520noncompetitive%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14170%26epage%3D14177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Gibson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">The R163K mutant of human thymidylate synthase is stabilized in an active conformation: structural asymmetry and reactivity of cysteine 195</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4636</span><span class="NLM_x">â</span> <span class="NLM_lpage">4643</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7019386" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=4636-4643&author=L.+M.+Gibsonauthor=L.+L.+Lovelaceauthor=L.+Lebioda&title=The+R163K+mutant+of+human+thymidylate+synthase+is+stabilized+in+an+active+conformation%3A+structural+asymmetry+and+reactivity+of+cysteine+195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fbi7019386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7019386%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DL.%2BM.%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DThe%2520R163K%2520mutant%2520of%2520human%2520thymidylate%2520synthase%2520is%2520stabilized%2520in%2520an%2520active%2520conformation%253A%2520structural%2520asymmetry%2520and%2520reactivity%2520of%2520cysteine%2520195%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D4636%26epage%3D4643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Structure of human thymidylate synthase under low-salt conditions</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">â</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=622-627&author=L.+L.+Lovelaceauthor=W.+Minorauthor=L.+Lebioda&title=Structure+of+human+thymidylate+synthase+under+low-salt+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DStructure%2520of%2520human%2520thymidylate%2520synthase%2520under%2520low-salt%2520conditions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D61%26spage%3D622%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2823</span><span class="NLM_x">â</span> <span class="NLM_lpage">2830</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi061309j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFOlur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=2823-2830&author=L.+L.+Lovelaceauthor=L.+M.+Gibsonauthor=L.+Lebioda&title=Cooperative+inhibition+of+human+thymidylate+synthase+by+mixtures+of+active+site+binding+and+allosteric+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cooperative Inhibition of Human Thymidylate Synthase by Mixtures of Active Site Binding and Allosteric Inhibitors</span></div><div class="casAuthors">Lovelace, Leslie L.; Gibson, Lydia M.; Lebioda, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2823-2830</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is a target in the chemotherapy of colorectal cancer and some other neoplasms.  It catalyzes the transfer of a Me group from methylenetetrahydrofolate to dUMP to form dTMP.  On the basis of structural considerations, we have introduced 1,3-propanediphosphonic acid (PDPA) as an allosteric inhibitor of human TS (hTS); it is proposed that PDPA acts by stabilizing an inactive conformer of loop 181-197.  Kinetic studies showed that PDPA is a mixed (noncompetitive) inhibitor vs. dUMP.  In contrast, vs. methylenetrahydrofolate at concns. lower than 0.25 Î¼M, PDPA is an uncompetitive inhibitor, while at PDPA concns. higher than 1 Î¼M the inhibition is noncompetitive , as expected.  At the concns. corresponding to uncompetitive inhibition, PDPA shows pos. cooperativity with an antifolate inhibitor, ZD9331, which binds to the active conformer.  PDPA binding leads to the formation of hTS tetramers, but not higher oligomers.  These data are consistent with a model in which hTS exists preferably as an asym. dimer with one subunit in the active conformation of loop 181-197 and the other in the inactive conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptxszjn8zrlbVg90H21EOLACvtfcHk0lhkGnYsAJJ4Qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFOlur8%253D&md5=41716ed87998f22bd2f0a93d0fc43e02</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi061309j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061309j%26sid%3Dliteratum%253Aachs%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DGibson%26aufirst%3DL.%2BM.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DCooperative%2520inhibition%2520of%2520human%2520thymidylate%2520synthase%2520by%2520mixtures%2520of%2520active%2520site%2520binding%2520and%2520allosteric%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D2823%26epage%3D2830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Variants of human thymidylate synthase with loop 181â197 stabilized in the inactive conformation</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1628</span><span class="NLM_x">â</span> <span class="NLM_lpage">1636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fpro.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=19569192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Cmu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1628-1636&author=L.+L.+Lovelaceauthor=S.+R.+Johnsonauthor=L.+M.+Gibsonauthor=B.+J.+Bellauthor=S.+H.+Bergerauthor=L.+Lebioda&title=Variants+of+human+thymidylate+synthase+with+loop+181%E2%88%92197+stabilized+in+the+inactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation</span></div><div class="casAuthors">Lovelace, Leslie L.; Johnson, Saphronia R.; Gibson, Lydia M.; Bell, Brittnaie J.; Berger, Sondra H.; Lebioda, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1628-1636</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Loop 181-197 of human thymidylate synthase (hTS) populates two major conformations, essentially corresponding to the loop flipped by 180Â°.  In one of the conformations, the catalytic Cys195 residue lies distant from the active site making the enzyme inactive.  Ligands stabilizing this inactive conformation may function as allosteric inhibitors.  To facilitate the search for such inhibitors, we have expressed and characterized several mutants designed to shift the equil. toward the inactive conformer.  In most cases, the catalytic efficiency of the mutants was only somewhat impaired with values of kcat/Km reduced by factors in a 2-12 range.  One of the mutants, M190K, is however unique in having the value of kcat/Km smaller by a factor of â¼7500 than the wild type.  The crystal structure of this mutant is similar to that of the wt. hTS with loop 181-197 in the inactive conformation.  However, the direct vicinity of the mutation, residues 188-194 of this loop, assumes a different conformation with the positions of CÎ± shifted up to 7.2 Ã.  This affects region 116-128, which became ordered in M190K while it is disordered in wt.  The conformation of 116-128 is however different than that obsd. in hTS in the active conformation.  The side chain of Lys190 does not form contacts and is in solvent region.  The very low activity of M190K as compared to another mutant with a charged residue in this position, M190E, suggests that the protein is trapped in an inactive state that does not equilibrate easily with the active conformer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0ApTtd59BrVg90H21EOLACvtfcHk0lhkGnYsAJJ4Qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Cmu74%253D&md5=725b3648f21947a674ad0bef18dc534d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fpro.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.171%26sid%3Dliteratum%253Aachs%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DGibson%26aufirst%3DL.%2BM.%26aulast%3DBell%26aufirst%3DB.%2BJ.%26aulast%3DBerger%26aufirst%3DS.%2BH.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DVariants%2520of%2520human%2520thymidylate%2520synthase%2520with%2520loop%2520181%25E2%2588%2592197%2520stabilized%2520in%2520the%2520inactive%2520conformation%26jtitle%3DProtein%2520Sci.%26date%3D2009%26volume%3D18%26spage%3D1628%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doorneweerd, D. D.</span><span> </span><span class="NLM_article-title">Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">â</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar7000815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=120-129&author=P.+S.+Lowauthor=W.+A.+Henneauthor=D.+D.+Doorneweerd&title=Discovery+and+development+of+folic-acid-based+receptor+targeting+for+imaging+and+therapy+of+cancer+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases</span></div><div class="casAuthors">Low, Philip S.; Henne, Walter A.; Doorneweerd, Derek D.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-129</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of folic-acid-targeted drug delivery has grown rapidly over the past decade, with several applications currently in human clin. trials.  Owing to the small size of the vitamin, its high affinity for the folate receptor (Kd = 10-10 M), the limited distribution of its receptor in normal tissues (primarily in kidney proximal tubules), the overexpression of its receptor in pathol. cells (upregulated in cancer cells and activated macrophages/monocytes), and its ease of conjugation to imaging and therapeutic agents, the use of folate as a targeting ligand for selective delivery of attached mols. to tumor tissues and sites of inflammation has attracted considerable interest.  This account reviews the discovery of folic acid as a targeting ligand and its current use in the selective targeting of drugs to malignant masses and sites of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM5t9sRmCOBbVg90H21EOLACvtfcHk0lhkGnYsAJJ4Qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D&md5=20620eb124d19634b10c27a48ed46849</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Far7000815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far7000815%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHenne%26aufirst%3DW.%2BA.%26aulast%3DDoorneweerd%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520folic-acid-based%2520receptor%2520targeting%2520for%2520imaging%2520and%2520therapy%2520of%2520cancer%2520and%2520inflammatory%2520diseases%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D120%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Salazar, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span> </span><span class="NLM_article-title">The folate receptor: What does it promise in tissue-targeted therapeutics?</span> <span class="citation_source-journal">Cancer Metastasis Rev</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs10555-007-9048-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17333345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1KqtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=141-152&author=M.+D.+Salazarauthor=M.+Ratnam&title=The+folate+receptor%3A+What+does+it+promise+in+tissue-targeted+therapeutics%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The folate receptor: What does it promise in tissue-targeted therapeutics?</span></div><div class="casAuthors">Salazar, Marcela D'Alincourt; Ratnam, Manohar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-152</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  For over a decade the folate receptor has been intensively investigated as a means for tumor-specific delivery of a broad range of exptl. therapies including several conceptually new treatments.  Despite a few set backs in clin. trials, the literature is replete with encouraging in vitro and pre-clin. studies of gynecol. and other tumors and more therapeutic approaches are ready for clin. testing.  Recent studies have added myelogenous leukemias to the list of candidate cancers for FR-targeted therapies.  Each approach faces unique challenges in translation that could be addressed through a mechanistic understanding of the function and expression of the receptor in the appropriate exptl. systems and by improvements in the technol.  This review discusses FR in the context of pos. recent developments in broad areas of FR-targeted therapy and attempts to highlight its potential and the anticipated challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFSZ_TRHfku7Vg90H21EOLACvtfcHk0lg9yZEfV_rVag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1KqtLY%253D&md5=3511e865e6f19fb1680364758b558465</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9048-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9048-0%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DM.%2BD.%26aulast%3DRatnam%26aufirst%3DM.%26atitle%3DThe%2520folate%2520receptor%253A%2520What%2520does%2520it%2520promise%2520in%2520tissue-targeted%2520therapeutics%253F%26jtitle%3DCancer%2520Metastasis%2520Rev%26date%3D2007%26volume%3D26%26spage%3D141%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Bavetsias, V.; Jackman, A. L.</span><span> </span><span class="NLM_article-title">Use of Cyclopenta[<i>g</i>]quinazoline Derivatives for Treating Cancer</span>. WO Patent 03/020300 A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=V.+Bavetsias&author=A.+L.+Jackman&title=Use+of+Cyclopenta%5Bg%5Dquinazoline+Derivatives+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBavetsias%26aufirst%3DV.%26atitle%3DUse%2520of%2520Cyclopenta%255Bg%255Dquinazoline%2520Derivatives%2520for%2520Treating%2520Cancer%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Gibbs, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theti, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span> </span><span class="NLM_article-title">BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">11721</span><span class="NLM_x">â</span> <span class="NLM_lpage">11728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=11721-11728&author=D.+D.+Gibbsauthor=D.+S.+Thetiauthor=N.+Woodauthor=M.+Greenauthor=F.+Raynaudauthor=M.+Valentiauthor=M.+D.+Forsterauthor=F.+Mitchellauthor=V.+Bavetsiasauthor=E.+Hendersonauthor=A.+L.+Jackman&title=BGC+945%2C+a+novel+tumor-selective+thymidylate+synthase+inhibitor+targeted+to+alpha-folate+receptor-overexpressing+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DD.%2BD.%26aulast%3DTheti%26aufirst%3DD.%2BS.%26aulast%3DWood%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DForster%26aufirst%3DM.%2BD.%26aulast%3DMitchell%26aufirst%3DF.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DHenderson%26aufirst%3DE.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26atitle%3DBGC%2520945%252C%2520a%2520novel%2520tumor-selective%2520thymidylate%2520synthase%2520inhibitor%2520targeted%2520to%2520alpha-folate%2520receptor-overexpressing%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D11721%26epage%3D11728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Prasanna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharjya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaram, P.</span><span> </span><span class="NLM_article-title">Synthetic interface peptides as inactivators of multimeric enzymes: inhibitory and conformational properties of three fragments from <i>Lactobacillus casei</i> thymidylate synthase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">6883</span><span class="NLM_x">â</span> <span class="NLM_lpage">6893</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9720989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=6883-6893&author=V.+Prasannaauthor=S.+Bhattacharjyaauthor=P.+Balaram&title=Synthetic+interface+peptides+as+inactivators+of+multimeric+enzymes%3A+inhibitory+and+conformational+properties+of+three+fragments+from+Lactobacillus+casei+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fbi9720989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9720989%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanna%26aufirst%3DV.%26aulast%3DBhattacharjya%26aufirst%3DS.%26aulast%3DBalaram%26aufirst%3DP.%26atitle%3DSynthetic%2520interface%2520peptides%2520as%2520inactivators%2520of%2520multimeric%2520enzymes%253A%2520inhibitory%2520and%2520conformational%2520properties%2520of%2520three%2520fragments%2520from%2520Lactobacillus%2520casei%2520thymidylate%2520synthase%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D6883%26epage%3D6893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Roehr, B.</span><span> </span><span class="NLM_article-title">Fomivirsen approved for CMV retinitis</span> <span class="citation_source-journal">J. Int. Assoc. Physicians AIDS Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11365956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A280%3ADC%252BD3M3ot1Gltg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=14-16&author=B.+Roehr&title=Fomivirsen+approved+for+CMV+retinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Fomivirsen approved for CMV retinitis</span></div><div class="casAuthors">Roehr B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the International Association of Physicians in AIDS Care</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">14-6</span>
        ISSN:<span class="NLM_cas:issn">1081-454X</span>.
    </div><div class="casAbstract">Fomivirsen (Vitravene) is the first antisense drug to be approved by the Food and Drug Administration (FDA), and it will be used for the treatment of cytomegalovirus (CMV) retinitis.  Fomivirsen is administered by intravitreal injection, and it can be used to help patients who are resistant to other treatments for CMV.  Isis Pharmaceuticals, Inc., manufacturer of fomivirsen, had a difficult time recruiting people for its clinical trials, due to the decline in the incidence of opportunistic infections.  However, Isis still made a presentation to the FDA, providing clinical data about patients, treatment methods, and outcomes.  A detailed explanation of antisense drugs is included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyD7emN5KWMjUE-swuRqsHfW6udTcc2eYubf-8xivX77ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3ot1Gltg%253D%253D&md5=03982d8d684e448ac425bf7b5b14a77e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoehr%26aufirst%3DB.%26atitle%3DFomivirsen%2520approved%2520for%2520CMV%2520retinitis%26jtitle%3DJ.%2520Int.%2520Assoc.%2520Physicians%2520AIDS%2520Care%26date%3D1998%26volume%3D4%26spage%3D14%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Kurreck, J.</span><span> </span><span class="NLM_article-title">RNA interference: from basic research to therapeutic applications</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1378</span><span class="NLM_x">â</span> <span class="NLM_lpage">1398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fanie.200802092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFOrsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1378-1398&author=J.+Kurreck&title=RNA+interference%3A+from+basic+research+to+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">RNA interference: from basic research to therapeutic applications</span></div><div class="casAuthors">Kurreck, Jens</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1378-1398</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Only ten years ago Andrew Fire and Craig Mello were able to show that double-stranded RNA mols. could inhibit the expression of homologous genes in eukaryotes.  This process, termed RNA interference, has developed into a std. method of mol. biol.  This review provides an overview of the mol. processes involved, with a particular focus on the posttranscriptional inhibition of gene expression in mammalian cells, the possible applications in research, and the results of the first clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkLDyjy36ynbVg90H21EOLACvtfcHk0lg9yZEfV_rVag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFOrsLY%253D&md5=20270346c637e5665350c2472a42b4f1</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fanie.200802092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200802092%26sid%3Dliteratum%253Aachs%26aulast%3DKurreck%26aufirst%3DJ.%26atitle%3DRNA%2520interference%253A%2520from%2520basic%2520research%2520to%2520therapeutic%2520applications%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D1378%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Berg, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguso, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMoor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincen, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koropatnick, J.</span><span> </span><span class="NLM_article-title">The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger</span> <span class="citation_source-journal">Curr Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.2174%2F1389450023347605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12102601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFyjtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=297-309&author=R.+W.+Bergauthor=P.+J.+Fergusoauthor=J.+M.+DeMoorauthor=M.+D.+Vincenauthor=J.+Koropatnick&title=The+means+to+an+end+of+tumor+cell+resistance+to+chemotherapeutic+drugs+targeting+thymidylate+synthase%3A+shoot+the+messenger"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger</span></div><div class="casAuthors">Berg, Randal W.; Ferguson, Peter J.; DeMoor, Janice M.; Vincent, Mark D.; Koropatnick, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-309</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review. Thymidylate synthase (TS) is an essential enzyme in the de novo synthesis of thymidylate and is required for DNA synthesis and cell proliferation in the absence of exogenous thymidine.  As a consequence, TS is a target for anticancer chemotherapy by several drugs, including 5-fluorouracil (5-FU) and raltitrexed (Tomudex), in the treatment of colorectal and other tumors.  TS overexpression due to increased gene transcription and mRNA translation can mediate drug resistance.  Decreased cellular uptake and polyglutamylation of TS-targeting drugs (raltitrexed, for example), increased drug efflux, altered metab. of cytotoxic drugs (for example, 5-FU), and other events can decrease the effectiveness of TS-targeting drugs.  Recent preclin. and clin. studies have addressed the resistance problem by using combinations of different drugs that target TS, or by combining TS-targeting and non-TS-targeting drugs.  One approach has been to circumvent and/or prevent TS-overexpression-mediated drug resistance by employing antisense oligodeoxynucleotides (ODNs) to downregulate TS mRNA and protein.  These studies have revealed that targeting the 3'-end of human TS mRNA downregulates TS mRNA and protein, inhibits cell proliferation, and sensitizes HeLa cells to raltitrexed, 5-FU, and 5-fluorodeoxyuridine (5-FUdR) in vitro.  In addn., growth of human HT29 colon carcinoma cell explants in immunocompromised mice is inhibited by antisense downregulation of TS.  TS-overexpressing, 5-FUdR-resistant HeLa cells have been established in order to examine resistance mechanisms and cross-resistance to 5-FU and raltitrexed.  Treatment of 5-FUdR-resistant HeLa cells with TS antisense ODN effectively reduces TS mRNA and protein and decreases the IC50 of 5-FUdR by â¤80%.  These results indicate that antisense ODN treatment improves the efficacy of anti-TS chemotherapeutic drugs in vitro and in vivo and is effective in overcoming tumor cell resistance to these drugs.  However, cellular responses to antisense targeting of different TS mRNA domains are complex.  In fact, targeting the translation start site (but not other TS mRNA regions) stimulates TS gene transcription.  Distinctive cellular responses to targeting of specific TS mRNA regions provide exciting therapeutic opportunities.  Antisense ODN treatment to modulate TS activity, in combination with TS-targeting chemotherapeutic drugs, has the potential to be an effective antitumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvtx_-z0oQFrVg90H21EOLACvtfcHk0ljrq8lSgGx9-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFyjtbw%253D&md5=0f1f4718be9dc4777a7e2c3d3563f26e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2174%2F1389450023347605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450023347605%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DR.%2BW.%26aulast%3DFerguso%26aufirst%3DP.%2BJ.%26aulast%3DDeMoor%26aufirst%3DJ.%2BM.%26aulast%3DVincen%26aufirst%3DM.%2BD.%26aulast%3DKoropatnick%26aufirst%3DJ.%26atitle%3DThe%2520means%2520to%2520an%2520end%2520of%2520tumor%2520cell%2520resistance%2520to%2520chemotherapeutic%2520drugs%2520targeting%2520thymidylate%2520synthase%253A%2520shoot%2520the%2520messenger%26jtitle%3DCurr%2520Drug%2520Targets%26date%3D2002%26volume%3D3%26spage%3D297%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Berg, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koropatnick, D. J.</span><span> </span><span class="NLM_article-title">A âcombination oligonucleotideâ antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">â</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2Fsj.cgt.7700566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12679800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1CitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=278-286&author=R.+W.+Bergauthor=P.+J.+Fergusonauthor=M.+D.+Vincentauthor=D.+J.+Koropatnick&title=A+%E2%80%9Ccombination+oligonucleotide%E2%80%9D+antisense+strategy+to+downregulate+thymidylate+synthase+and+decrease+tumor+cell+growth+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance</span></div><div class="casAuthors">Berg, Randal W.; Ferguson, Peter J.; Vincent, Mark D.; Koropatnick, D. James</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) catalyzes de novo prodn. of thymidylate for DNA synthesis and cell proliferation.  As such, TS has been a target of antitumor chemotherapy for many years.  Our lab. has identified several antisense oligodeoxynucleotides (ODNs) that downregulate TS mRNA and protein, inhibit cell proliferation, and sensitize cells to TS-directed chemotherapeutic drugs.  Based on our observation that targeting distinct regions of the TS mRNA with a variety of antisense mols. resulted in differential effects on TS mRNA levels, it was hypothesized that use of multiple ODNs targeting distinct noncontiguous regions would result in synergistic or antagonistic interactions.  In this study, we report that some combinations of TS antisense ODNs were more effective at reducing TS mRNA abundance and inhibiting cell proliferation than the individual ODNs used alone.  However, in contrast to the effects on cell proliferation, the enhanced sensitivity to anti-TS chemotherapeutic drugs (i.e., raltitrexed and 5-fluorodeoxyuridine) that is achieved by treatment with individual ODNs was not further augmented by combined ODN treatment.  This suggests that ODNs targeting TS mRNA inhibit an alternative function of TS mRNA or protein, distinct from thymidylate prodn.  The results are evidence that the novel use of multiple antisense ODNs that target different regions of the same mRNA represents a general strategy to improve antisense effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr466IvcfF2gbVg90H21EOLACvtfcHk0ljrq8lSgGx9-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1CitL8%253D&md5=a3cf97b8d5cb12a9297ef3b5fc462968</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700566%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DR.%2BW.%26aulast%3DFerguson%26aufirst%3DP.%2BJ.%26aulast%3DVincent%26aufirst%3DM.%2BD.%26aulast%3DKoropatnick%26aufirst%3DD.%2BJ.%26atitle%3DA%2520%25E2%2580%259Ccombination%2520oligonucleotide%25E2%2580%259D%2520antisense%2520strategy%2520to%2520downregulate%2520thymidylate%2520synthase%2520and%2520decrease%2520tumor%2520cell%2520growth%2520and%2520drug%2520resistance%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D278%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">DeMoor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koropatnick, J.</span><span> </span><span class="NLM_article-title">Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1006%2Fexcr.1998.4059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9716444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Shsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1998&pages=11-21&author=J.+M.+DeMoorauthor=M.+D.+Vincentauthor=O.+M.+Collinsauthor=J.+Koropatnick&title=Antisense+nucleic+acids+targeted+to+the+thymidylate+synthase+%28TS%29+mRNA+translation+start+site+stimulate+TS+gene+transcription"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription</span></div><div class="casAuthors">DeMoor, Janice M.; Vincent, Mark D.; Collins, Olga M.; Koropatnick, James</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is a key enzyme in the synthesis of DNA and a target for cancer chemotherapeutic agents.  Antisense TS nucleic acids may be useful in enhancing anticancer drug effectiveness.  MCF-7 and HeLa cells were transfected with vectors expressing antisense TS RNA or with antisense oligodeoxynucleotides (AS-ODNs) to different TS mRNA regions.  Antisense RNAs were targeted to 30 bases of the TS mRNA including part of the stem loop at the translation start site and to 30 bases spanning the exon1/exon2 boundary.  AS-ODNs were targeted to the translation start site and the translation stop site.  Antisense nucleic acids complementary to the translation start site (and not the exon1/exon2 boundary or translation stop site) significantly enhanced constitutive TS gene transcription.  Therefore, TS mRNA sequences appear to be involved in a novel pathway controlling TS gene transcription.  Induced transcription could hinder antisense-based attempts to inhibit TS and must be considered when designing such strategies.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR4HWJnb0H17Vg90H21EOLACvtfcHk0ljrq8lSgGx9-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Shsbo%253D&md5=6e782938382b3ce5d18bab615e66b1a1</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1998.4059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1998.4059%26sid%3Dliteratum%253Aachs%26aulast%3DDeMoor%26aufirst%3DJ.%2BM.%26aulast%3DVincent%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DO.%2BM.%26aulast%3DKoropatnick%26aufirst%3DJ.%26atitle%3DAntisense%2520nucleic%2520acids%2520targeted%2520to%2520the%2520thymidylate%2520synthase%2520%2528TS%2529%2520mRNA%2520translation%2520start%2520site%2520stimulate%2520TS%2520gene%2520transcription%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1998%26volume%3D243%26spage%3D11%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Normanno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvam, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliulo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span> </span><span class="NLM_article-title">Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">â</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9816209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK28XitVylsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=601-609&author=N.+Normannoauthor=C.+Biancoauthor=V.+Damianoauthor=E.+de+Angelisauthor=M.+P.+Selvamauthor=M.+Grassiauthor=G.+Magliuloauthor=G.+Tortoraauthor=A.+R.+Biancoauthor=J.+Mendelsohnauthor=D.+S.+Salomonauthor=F.+Ciardiello&title=Growth+inhibition+of+human+colon+carcinoma+cells+by+combinations+of+anti-epidermal+growth+factor-related+growth+factor+antisense+oligonucleotides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides</span></div><div class="casAuthors">Normanno, Nicola; Bianco, Caterina; Damiano, Vincenzo; De Angelis, Ernesto; Selvam, Mouna P.; Grassi, Michele; Magliulo, Gabriella; Tortora, Giampaolo; Bianco, Angelo R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-9</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GEO is a well-differentiated colon cancer cell line that coexpresses the epidermal growth factor-like growth factors CRIPTO (CR), amphiregulin (AR), and transforming growth factor Î± (TGF-Î±).  Antisense 20-mer phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against CR, AR, and TGF-Î± mRNAs were equipotent in their ability to inhibit both the anchorage-dependent growth and the anchorage-independent growth (AIG) of GEO cells, with a 50% inhibitory concn. of about 5 Î¼M in the AIG assay.  A supraadditive effect was obsd. when a combination of S-oligos was used.  For example, a combination of two different AS S-oligos (either AR + CR, or TGF-Î± + CR, or TGF-Î± + AR) at a concn. of 1 Î¼M each (total concn., 2 Î¼M) resulted in 50% inhibition of GEO cells AIG, whereas the use of each AS S-Oligo at a 1 or 2 Î¼M concn. resulted resp. in about 10 and 20% growth inhibition.  A combination of the three AS S-oligos was even more effective, resulting in about 60% inhibition of GEO cells AIG at a concn. of 1 Î¼M each (3 Î¼M total concn.).  The AS S-oligos were also able to inhibit specifically the expression of either AR, CR, or TGF-Î± proteins in GEO cells, as assessed using immunocytochem. or Western blot anal.  Finally, a supraadditive growth inhibitory effect of the AS S-oligos and an epidermal growth factor receptor-blocking antibody (monoclonal antibody 528) was obsd.  These data suggest that the use of a combination of AS S-oligos directed against different growth factors and antibodies directed against their receptors might result in an efficient inhibition of colon carcinoma cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO7y5iXyoXs7Vg90H21EOLACvtfcHk0ljmLjpmNGqDpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitVylsro%253D&md5=da42502ca8e2e5c9c31c553f7f8e6807</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNormanno%26aufirst%3DN.%26aulast%3DBianco%26aufirst%3DC.%26aulast%3DDamiano%26aufirst%3DV.%26aulast%3Dde%2BAngelis%26aufirst%3DE.%26aulast%3DSelvam%26aufirst%3DM.%2BP.%26aulast%3DGrassi%26aufirst%3DM.%26aulast%3DMagliulo%26aufirst%3DG.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DBianco%26aufirst%3DA.%2BR.%26aulast%3DMendelsohn%26aufirst%3DJ.%26aulast%3DSalomon%26aufirst%3DD.%2BS.%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DGrowth%2520inhibition%2520of%2520human%2520colon%2520carcinoma%2520cells%2520by%2520combinations%2520of%2520anti-epidermal%2520growth%2520factor-related%2520growth%2520factor%2520antisense%2520oligonucleotides%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1996%26volume%3D2%26spage%3D601%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Dorsett, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuschl, T.</span><span> </span><span class="NLM_article-title">siRNAs: applications in functional genomics and potential as therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=318-329&author=Y.+Dorsettauthor=T.+Tuschl&title=siRNAs%3A+applications+in+functional+genomics+and+potential+as+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDorsett%26aufirst%3DY.%26aulast%3DTuschl%26aufirst%3DT.%26atitle%3DsiRNAs%253A%2520applications%2520in%2520functional%2520genomics%2520and%2520potential%2520as%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D318%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Schmitz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">â</span> <span class="NLM_lpage">1435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1431-1435&author=J.+C.+Schmitzauthor=T.+M.+Chenauthor=E.+Chu&title=Small+interfering+double-stranded+RNAs+as+therapeutic+molecules+to+restore+chemosensitivity+to+thymidylate+synthase+inhibitor+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitz%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DSmall%2520interfering%2520double-stranded%2520RNAs%2520as%2520therapeutic%2520molecules%2520to%2520restore%2520chemosensitivity%2520to%2520thymidylate%2520synthase%2520inhibitor%2520compounds%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1431%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Shirasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakehata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurotaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagihashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinkawa, H.</span><span> </span><span class="NLM_article-title">Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=348&author=T.+Shirasakiauthor=S.+Maruyaauthor=H.+Mizukamiauthor=S.+Kakehataauthor=H.+Kurotakiauthor=S.+Yagihashiauthor=H.+Shinkawa&title=Effects+of+small+interfering+RNA+targeting+thymidylate+synthase+on+survival+of+ACC3+cells+from+salivary+adenoid+cystic+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShirasaki%26aufirst%3DT.%26aulast%3DMaruya%26aufirst%3DS.%26aulast%3DMizukami%26aufirst%3DH.%26aulast%3DKakehata%26aufirst%3DS.%26aulast%3DKurotaki%26aufirst%3DH.%26aulast%3DYagihashi%26aufirst%3DS.%26aulast%3DShinkawa%26aufirst%3DH.%26atitle%3DEffects%2520of%2520small%2520interfering%2520RNA%2520targeting%2520thymidylate%2520synthase%2520on%2520survival%2520of%2520ACC3%2520cells%2520from%2520salivary%2520adenoid%2520cystic%2520carcinoma%26jtitle%3DBMC%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. F.</span><span> </span><span class="NLM_article-title">Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">â</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2Fsj.cgt.7700880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=16052228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsLnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=107-114&author=Z.+Yangauthor=A.+Cloudauthor=D.+Hughesauthor=L.+F.+Johnson&title=Stable+inhibition+of+human+thymidylate+synthase+expression+following+retroviral+introduction+of+an+siRNA+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene</span></div><div class="casAuthors">Yang, Z.; Cloud, A.; Hughes, D.; Johnson, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is an essential enzyme that synthesizes thymidylic acid in the de novo biosynthetic pathway.  Inhibiting TS enzyme activity with substrate or cofactor analogs leads to inhibition of DNA replication and cell death.  For this reason, TS is an important target enzyme for cancer chemotherapeutic drugs.  We describe an alternative approach to reducing cellular TS enzyme activity using short interfering RNA (siRNA) technol. to lower TS mRNA levels.  Plasmids that direct the synthesis of siRNAs that target nucleotides 898-916 and 965-983 (relative to the A of the translational start codon) of human TS mRNA were highly effective at reducing TS enzyme levels in transient transfection assays.  Infection of HeLa cells with retroviruses that contain the effective siRNA genes led to a stable 80-95% redn. of TS enzyme and mRNA.  A similar percent redn. in TS expression was obsd. in a cell line that overproduces TS enzyme 100-fold due to TS gene amplification.  Cells that exhibited the greatest redn. in TS enzyme level grew poorly in medium that lacked thymidine.  These observations suggest that siRNA approaches may provide an alternative therapeutic strategy to reduce TS enzyme levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-7T_sbBVcLVg90H21EOLACvtfcHk0ljmLjpmNGqDpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsLnF&md5=95da1a7d925fde2f3c4baf032c7bcb61</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700880%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DCloud%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DL.%2BF.%26atitle%3DStable%2520inhibition%2520of%2520human%2520thymidylate%2520synthase%2520expression%2520following%2520retroviral%2520introduction%2520of%2520an%2520siRNA%2520gene%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2006%26volume%3D13%26spage%3D107%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takechi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">The effect of reducing reagents on binding of thymidylate synthase protein to thymidylate synthase messenger RNA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">20289</span><span class="NLM_x">â</span> <span class="NLM_lpage">20293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=20289-20293&author=E.+Chuauthor=D.+M.+Voellerauthor=P.+F.+Morrisonauthor=K.+L.+Jonesauthor=T.+Takechiauthor=G.+F.+Maleyauthor=F.+Maleyauthor=C.+J.+Allegra&title=The+effect+of+reducing+reagents+on+binding+of+thymidylate+synthase+protein+to+thymidylate+synthase+messenger+RNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DMorrison%26aufirst%3DP.%2BF.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DTakechi%26aufirst%3DT.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520effect%2520of%2520reducing%2520reagents%2520on%2520binding%2520of%2520thymidylate%2520synthase%2520protein%2520to%2520thymidylate%2520synthase%2520messenger%2520RNA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D20289%26epage%3D20293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthase</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">â</span> <span class="NLM_lpage">4887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=4882-4887&author=X.+Linauthor=J.+Liuauthor=F.+Maleyauthor=E.+Chu&title=Role+of+cysteine+amino+acid+residues+on+the+RNA+binding+activity+of+human+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DRole%2520of%2520cysteine%2520amino%2520acid%2520residues%2520on%2520the%2520RNA%2520binding%2520activity%2520of%2520human%2520thymidylate%2520synthase%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D4882%26epage%3D4887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac-Kaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=24-31&author=D.+M.+Voellerauthor=M.+Zajac-Kayeauthor=R.+J.+Fisherauthor=C.+J.+Allegra&title=The+identification+of+thymidylate+synthase+peptide+domains+located+in+the+interface+region+that+bind+thymidylate+synthase+mRNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DZajac-Kaye%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520identification%2520of%2520thymidylate%2520synthase%2520peptide%2520domains%2520located%2520in%2520the%2520interface%2520region%2520that%2520bind%2520thymidylate%2520synthase%2520mRNA%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D297%26spage%3D24%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">In vitro selected peptides bind with thymidylate synthase mRNA and inhibit its translation</span> <span class="citation_source-journal">Sci. China, Ser. C: Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">â</span> <span class="NLM_lpage">636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs11427-007-0078-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17879061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGgtbfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=630-636&author=S.+Yanauthor=R.+Niuauthor=Z.+Wangauthor=X.+Lin&title=In+vitro+selected+peptides+bind+with+thymidylate+synthase+mRNA+and+inhibit+its+translation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro selected peptides bind with thymidylate synthase mRNA and inhibit its translation</span></div><div class="casAuthors">Yan, Song; Niu, RongLi; Wang, Zheng; Lin, XiuKun</div><div class="citationInfo"><span class="NLM_cas:title">Science in China, Series C: Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">630-636</span>CODEN:
                <span class="NLM_cas:coden">SCCLFO</span>;
        ISSN:<span class="NLM_cas:issn">1006-9305</span>.
    
            (<span class="NLM_cas:orgname">Science in China Press</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS), an essential enzyme for catalyzing the biosynthesis of thymidylate, is a crit. therapeutic target in cancer therapy.  Recent studies have shown that TS functions as an RNA-binding protein by interacting with two different sequences on its own mRNA, thus, repressing translational efficiency.  In this study, peptides binding TS RNA with high affinity were isolated using mRNA display from a large peptide library (>1013 different sequences).  The randomized library was subjected up to twelve rounds of in vitro selection and amplification.  Comparing the amino acid compn. of the selected peptides (12th round, R12) with those from the initial random library (round zero, R0), the basic and arom. residues in the selected peptides were enriched significantly, suggesting that these peptide regions might be important in the peptide-TS mRNA interaction.  Categorizing the amino acids at each random position based on their physicochem. properties and comparing the distributions with those of the initial random pool, an obvious basic charge characteristic was found at positions 1, 12, 17 and 18, suggesting that basic side chains participate in RNA binding.  Secondary structure prediction showed that the selected peptides of R12 pool represented a helical propensity compared with R0 pool, and the regions were rich in basic residues.  The electrophoretic gel mobility shift and in vitro translation assays showed that the peptides selected using mRNA display could bind TS RNA specifically and inhibit the translation of TS mRNA.  The authors' results suggested that the identified peptides could be used as new TS inhibitors and developed to a novel class of anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1s-yLrntdbVg90H21EOLACvtfcHk0lhPVfZKrZ67cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGgtbfJ&md5=c063b8fb361cc813b9c721691b0bdb70</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2Fs11427-007-0078-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11427-007-0078-1%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DIn%2520vitro%2520selected%2520peptides%2520bind%2520with%2520thymidylate%2520synthase%2520mRNA%2520and%2520inhibit%2520its%2520translation%26jtitle%3DSci.%2520China%252C%2520Ser.%2520C%253A%2520Life%2520Sci.%26date%3D2007%26volume%3D50%26spage%3D630%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Chiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokosuka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imazeki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saisho, H.</span><span> </span><span class="NLM_article-title">Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">â</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=481-491&author=T.+Chibaauthor=O.+Yokosukaauthor=K.+Fukaiauthor=H.+Kojimaauthor=M.+Tadaauthor=M.+Araiauthor=F.+Imazekiauthor=H.+Saisho&title=Cell+growth+inhibition+and+gene+expression+induced+by+the+histone+deacetylase+inhibitor%2C+trichostatin+A%2C+on+human+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DYokosuka%26aufirst%3DO.%26aulast%3DFukai%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DTada%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DM.%26aulast%3DImazeki%26aufirst%3DF.%26aulast%3DSaisho%26aufirst%3DH.%26atitle%3DCell%2520growth%2520inhibition%2520and%2520gene%2520expression%2520induced%2520by%2520the%2520histone%2520deacetylase%2520inhibitor%252C%2520trichostatin%2520A%252C%2520on%2520human%2520hepatoma%2520cells%26jtitle%3DOncology%26date%3D2004%26volume%3D66%26spage%3D481%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Joseph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudduluru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vashistha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajitkumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somasundaram, K.</span><span> </span><span class="NLM_article-title">Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6304</span><span class="NLM_x">â</span> <span class="NLM_lpage">6315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=6304-6315&author=J.+Josephauthor=G.+Mudduluruauthor=S.+Antonyauthor=S.+Vashisthaauthor=P.+Ajitkumarauthor=K.+Somasundaram&title=Expression+profiling+of+sodium+butyrate+%28NaB%29-treated+cells%3A+identification+of+regulation+of+genes+related+to+cytokine+signaling+and+cancer+metastasis+by+NaB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DMudduluru%26aufirst%3DG.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DVashistha%26aufirst%3DS.%26aulast%3DAjitkumar%26aufirst%3DP.%26aulast%3DSomasundaram%26aufirst%3DK.%26atitle%3DExpression%2520profiling%2520of%2520sodium%2520butyrate%2520%2528NaB%2529-treated%2520cells%253A%2520identification%2520of%2520regulation%2520of%2520genes%2520related%2520to%2520cytokine%2520signaling%2520and%2520cancer%2520metastasis%2520by%2520NaB%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D6304%26epage%3D6315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.4161%2Fcbt.2.2.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12589032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Wktbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=151-163&author=K.+B.+Glaserauthor=M.+J.+Staverauthor=J.+F.+Waringauthor=J.+Stenderauthor=R.+G.+Ulrichauthor=S.+K.+Davidsen&title=Gene+expression+profiling+of+multiple+histone+deacetylase+%28HDAC%29+inhibitors%3A+defining+a+common+gene+set+produced+by+HDAC+inhibition+in+T24+and+MDA+carcinoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Gene Expression Profiling of Multiple Histone Deacetylase (HDAC) Inhibitors: Defining a Common Gene Set Produced by HDAC Inhibition in T24 and MDA Carcinoma Cell Lines</span></div><div class="casAuthors">Glaser, Keith B.; Staver, Michael J.; Waring, Jeffrey F.; Stender, Joshua; Ulrich, Roger G.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-163</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Acetylation of histones in chromatin is one mechanism involved in the regulation of gene transcription and is tightly controlled by the balance of acetyltransferase and deacetylase (HDAC) activities.  In cancer, some genes are repressed by the inappropriate recruitment of HDACs, e.g., tumor suppressor genes.  To understand the genomic effects of HDAC inhibition on gene transcription we studied the gene expression profiles of T24 bladder and MDA breast carcinoma cells treated with three HDAC inhibitors, suberoylanilide hydroxamic acid, trichostatin A, and MS-27-275.  The gene expression profiles of the HDAC inhibitors were generally similar to one another and differed substantially from those produced by structurally related inactive analogs; consequently, the changes in gene expression are mechanism-based.  Hierarchical clustering of expression profiles demonstrated a greater similarity between the two hydroxamate-contg. inhibitors (suberoylanilide hydroxamic acid and trichostatin A) than with MS-27-275.  This difference was also supported by cell phenotypic expts.  As many genes were down-regulated as up-regulated by HDAC inhibitor treatment.  Comparison of the data sets defined a common ("core") set of 13 genes regulated by all of the HDAC inhibitors in three cell lines, 8 up-regulated and 5 down-regulated.  Ten of 13 genes were confirmed in dose response studies in T24 cells by quant.-PCR.  The core regulated genes are involved predominantly in cell cycle/apoptosis and DNA synthesis in response to HDAC inhibitors.  These data will aide in understanding the complex set of events in cells in response to chromatin remodeling induced by HDAC inhibition, which may be responsible for antitumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrObsWYbi10s7Vg90H21EOLACvtfcHk0lhPVfZKrZ67cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Wktbk%253D&md5=233ab984a51fe7e33afe39e23e4d56d4</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.4161%2Fcbt.2.2.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.2.2.349%26sid%3Dliteratum%253Aachs%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DStaver%26aufirst%3DM.%2BJ.%26aulast%3DWaring%26aufirst%3DJ.%2BF.%26aulast%3DStender%26aufirst%3DJ.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DGene%2520expression%2520profiling%2520of%2520multiple%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%253A%2520defining%2520a%2520common%2520gene%2520set%2520produced%2520by%2520HDAC%2520inhibition%2520in%2520T24%2520and%2520MDA%2520carcinoma%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D151%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3085</span><span class="NLM_x">â</span> <span class="NLM_lpage">3095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1158%2F1535-7163.MCT-06-0419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17172411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=3085-3095&author=J.+H.+Leeauthor=J.+H.+Parkauthor=Y.+Jungauthor=J.+H.+Kimauthor=H.+S.+Jongauthor=T.+Y.+Kimauthor=Y.+J.+Bang&title=Histone+deacetylase+inhibitor+enhances+5-fluorouracil+cytotoxicity+by+down-regulating+thymidylate+synthase+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells</span></div><div class="casAuthors">Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3085-3095</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.  TS is also acutely up-regulated with 5-FU treatment, and, thus, novel strategies targeting TS down-regulation seem to be promising in terms of modulating 5-FU resistance.  Here, we report that histone deacetylase inhibitors can reverse 5-FU resistance by down-regulating TS.  By using cDNA microarrays and validation expts., we found that trichostatin A reduced the expression of both TS mRNA and TS protein.  Cotreatment with trichostatin A and cycloheximide restored TS mRNA expression, suggesting that TS mRNA is repressed through new protein synthesis.  On the other hand, TS protein expression was significantly reduced by lower doses of trichostatin A (50 nmol/L).  Mechanistically, TS protein was found to interact with heat shock protein (Hsp) complex, and trichostatin A treatment induced chaperonic Hsp90 acetylation and subsequently enhanced Hsp70 binding to TS, which led to the proteasomal degrdn. of TS protein.  Of note, combined treatment with low-dose trichostatin A and 5-FU enhanced 5-FU-mediated cytotoxicity in 5-FU-resistant cancer cells in accordance with TS protein down-regulation.  We conclude that a combinatorial approach using histone deacetylase inhibitors may be useful at overcoming 5-FU resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouIBtxuKajMrVg90H21EOLACvtfcHk0lguM402HCM9Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrJ&md5=ded2a1c396bb4c63980caf5c5e560762</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0419%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJong%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520enhances%25205-fluorouracil%2520cytotoxicity%2520by%2520down-regulating%2520thymidylate%2520synthase%2520in%2520human%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D3085%26epage%3D3095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Fazzone, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labonte, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, R. D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">â</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fijc.24403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=19384949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1alsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2009&pages=463-473&author=W.+Fazzoneauthor=P.+M.+Wilsonauthor=M.+J.+Labonteauthor=H.+J.+Lenzauthor=R.+D.+Ladner&title=Histone+deacetylase+inhibitors+suppress+thymidylate+synthase+gene+expression+and+synergize+with+the+fluoropyrimidines+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells</span></div><div class="casAuthors">Fazzone, William; Wilson, Peter M.; La Bonte, Melissa J.; Lenz, Heinz-Josef; Ladner, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-473</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Despite recent therapeutic advances, the response rates to chemotherapy for patients with metastatic colon cancer remain at â¼50% with the fluoropyrimidine, 5-fluorouracil (5-FU), continuing to serve as the foundation chemotherapeutic agent for the treatment of this disease.  Previous studies have demonstrated that overexpression of thymidylate synthase (TS) is a key determinant of resistance to 5-FU-based chemotherapy.  Therefore, there is a significant need to develop alternative therapeutic strategies to overcome TS-mediated resistance.  In this study, we demonstrate that the histone deacetylase inhibitors (HDACi) vorinostat and LBH589 significantly downregulate TS gene expression in a panel of colon cancer cell lines.  Downregulation of TS was independent of p53, p21 and HDAC2 expression and was achievable in vivo as demonstrated by mouse xenograft models.  We provide evidence that HDACi treatment leads to a potent transcriptional repression of the TS gene.  Combination of the fluoropyrimidines 5-FU or FUdR with both vorinostat and LBH589 enhanced cell cycle arrest and growth inhibition.  Importantly, the downstream effects of TS inhibition were significantly enhanced by this combination including the inhibition of acute TS induction and the enhanced accumulation of the cytotoxic nucleotide intermediate dUTP.  These data demonstrate that HDACi repress TS expression at the level of transcription and provides the first evidence suggesting a direct mechanistic link between TS downregulation and the synergistic interaction obsd. between HDACi and 5-FU.  This study provides rationale for the continued clin. evaluation of HDACi in combination with 5-FU-based therapies as a strategy to overcome TS-mediated resistance.  Â© 2009 UICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgVTmfMlPeLVg90H21EOLACvtfcHk0lguM402HCM9Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1alsr4%253D&md5=a5ac1aab01cccf6435ce1c125e4d0c17</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fijc.24403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24403%26sid%3Dliteratum%253Aachs%26aulast%3DFazzone%26aufirst%3DW.%26aulast%3DWilson%26aufirst%3DP.%2BM.%26aulast%3DLabonte%26aufirst%3DM.%2BJ.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DLadner%26aufirst%3DR.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520suppress%2520thymidylate%2520synthase%2520gene%2520expression%2520and%2520synergize%2520with%2520the%2520fluoropyrimidines%2520in%2520colon%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2009%26volume%3D125%26spage%3D463%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejligbjerg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, J. W.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">â</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs00280-006-0374-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17124594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFSktb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=275-283&author=A.+Tumberauthor=L.+S.+Collinsauthor=K.+D.+Petersenauthor=A.+Thougaardauthor=S.+J.+Christiansenauthor=M.+Dejligbjergauthor=P.+B.+Jensenauthor=M.+Sehestedauthor=J.+W.+Ritchie&title=The+histone+deacetylase+inhibitor+PXD101+synergises+with+5-fluorouracil+to+inhibit+colon+cancer+cell+growth+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The histone deacetylase inhibitor PXD101 synergizes with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo</span></div><div class="casAuthors">Tumber, Anthony; Collins, Laura S.; Petersen, Kamille Dumong; Thougaard, Annemette; Christiansen, Sanne J.; Dejligbjerg, Marielle; Jensen, Peter Buhl; Sehested, Maxwell; Ritchie, James W. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-283</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACi) inhibit the growth of cancer cells, and combinations of HDACi with established chemotherapeutics can lead to synergistic effects.  We have investigated effects of PXD101 (HDACi in phase II clin. trials) in combination with 5-fluorouracil, on tumor cell proliferation and apoptosis both in vitro and in vivo.  HCT116 cells were studied using proliferation and clonogenic assays.  Synergistic inhibition of proliferation and clonogenicity was detd. by incubation with PXD101 and 5-fluorouracil, and anal. using CalcuSyn software.  The effect of combining PXD101 and 5-fluorouracil on apoptosis was examd. in vitro using PARP-cleavage and TUNEL.  Finally, the effectiveness of combining PXD101 and 5-fluorouracil in vivo was tested using both HT-29 and HCT116 xenograft models.  Synergistic inhibition of proliferation and clonogenicity was obtained when HCT116 cells were incubated with PXD101 and 5-fluorouracil. 5-fluorouracil combined with PXD101 also increased DNA fragmentation and PARP cleavage in HCT116 cells.  Incubation with PXD101 down regulated thymidylate synthase expression in HCT116 cells.  In vivo studies, using mouse HT29 and HCT116 xenograft models, showed improved redns. in tumor vol. compared to single compd., when PXD101 and 5-fluorouracil were combined.  PXD101 and 5-fluorouracil synergistically combine in their antitumor effects against colon cancer cells in vitro and show enhanced activity when combined in vivo.  Based on the results presented herein, a rationale for the use of PXD101 and 5-fluorouracil in combination in the clinic has been demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprUVcvv3EFHbVg90H21EOLACvtfcHk0lguM402HCM9Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFSktb8%253D&md5=e0be2de4a9657a408a94fff99b85d03f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs00280-006-0374-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-006-0374-7%26sid%3Dliteratum%253Aachs%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DL.%2BS.%26aulast%3DPetersen%26aufirst%3DK.%2BD.%26aulast%3DThougaard%26aufirst%3DA.%26aulast%3DChristiansen%26aufirst%3DS.%2BJ.%26aulast%3DDejligbjerg%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DRitchie%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520PXD101%2520synergises%2520with%25205-fluorouracil%2520to%2520inhibit%2520colon%2520cancer%2520cell%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D60%26spage%3D275%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Phiel, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenther, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span> </span><span class="NLM_article-title">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">36734</span><span class="NLM_x">â</span> <span class="NLM_lpage">36741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1074%2Fjbc.M101287200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11473107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=36734-36741&author=C.+J.+Phielauthor=F.+Zhangauthor=E.+Y.+Huangauthor=M.+G.+Guentherauthor=M.+A.+Lazarauthor=P.+S.+Klein&title=Histone+deacetylase+is+a+direct+target+of+valproic+acid%2C+a+potent+anticonvulsant%2C+mood+stabilizer%2C+and+teratogen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span></div><div class="casAuthors">Phiel, Christopher J.; Zhang, Fang; Huang, Eric Y.; Guenther, Matthew G.; Lazar, Mitchell A.; Klein, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36734-36741</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Valproic acid is widely used to treat epilepsy and bipolar disorder and is also a potent teratogen, but its mechanisms of action in any of these settings are unknown.  We report that valproic acid activates Wnt-dependent gene expression, similar to lithium, the mainstay of therapy for bipolar disorder.  Valproic acid, however, acts through a distinct pathway that involves direct inhibition of histone deacetylase (IC50 for HDAC1=0.4 mM).  At therapeutic levels, valproic acid mimics the histone deacetylase inhibitor trichostatin A, causing hyperacetylation of histones in cultured cells.  Valproic acid, like trichostatin A, also activates transcription from diverse exogenous and endogenous promoters.  Furthermore, valproic acid and trichostatin A have remarkably similar teratogenic effects in vertebrate embryos, while non-teratogenic analogs of valproic acid do not inhibit histone deacetylase and do not activate transcription.  Based on these observations, we propose that inhibition of histone deacetylase provides a mechanism for valproic acid-induced birth defects and could also explain the efficacy of valproic acid in the treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZDcS-2BIhrVg90H21EOLACvtfcHk0lh6RJsjhMbOUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D&md5=6c1daa317cfb4c0cd8c8c2a21d4ed07c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M101287200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M101287200%26sid%3Dliteratum%253Aachs%26aulast%3DPhiel%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DE.%2BY.%26aulast%3DGuenther%26aufirst%3DM.%2BG.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DHistone%2520deacetylase%2520is%2520a%2520direct%2520target%2520of%2520valproic%2520acid%252C%2520a%2520potent%2520anticonvulsant%252C%2520mood%2520stabilizer%252C%2520and%2520teratogen%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D36734%26epage%3D36741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4592</span><span class="NLM_x">â</span> <span class="NLM_lpage">4597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4592-4597&author=A.+Saitoauthor=T.+Yamashitaauthor=Y.+Marikoauthor=Y.+Nosakaauthor=K.+Tsuchiyaauthor=T.+Andoauthor=T.+Suzukiauthor=T.+Tsuruoauthor=O.+Nakanishi&title=A+synthetic+inhibitor+of+histone+deacetylase%2C+MS-27-275%2C+with+marked+in+vivo+antitumor+activity+against+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DMariko%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DY.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DA%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520MS-27-275%252C%2520with%2520marked%2520in%2520vivo%2520antitumor%2520activity%2520against%2520human%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4592%26epage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Prasad, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasquez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J. E.</span><span> </span><span class="NLM_article-title">Histone acetylation resulting in resistance to methotrexate in choroid plexus cells</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">â</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs11060-008-9709-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=18853233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFemuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2009&pages=279-286&author=P.+Prasadauthor=H.+Vasquezauthor=C.+M.+Dasauthor=V.+Gopalakrishnanauthor=J.+E.+Wolff&title=Histone+acetylation+resulting+in+resistance+to+methotrexate+in+choroid+plexus+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Histone acetylation resulting in resistance to methotrexate in choroid plexus cells</span></div><div class="casAuthors">Prasad, Preethi; Vasquez, Hernan; Das, Chandra M.; Gopalakrishnan, Vidya; Wolff, Johannes E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-286</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Choroid plexus carcinomas are rare tumors that typically occur in young children.  Prognosis is poor, and very little information is available to optimize treatment protocols.  We used a cell culture model to evaluate whether combining chemotherapeutic agents such as methotrexate with histone deacetylase inhibitors (HDACI) such as valproic acid and MS-275 could improve efficacy.  Valproic acid increased the cytotoxicity of radiation and of all the chemotherapeutic agents in Z310 and SV11 mouse choroid plexus cell lines, with the exception of methotrexate.  Both HDACIs made choroid plexus cells resistant to this folate antagonist.  Searching for a mol. explanation, we found that thymidylate synthase was up regulated when the cells were incubated with HDACI.  We also confirmed this finding in human choroid plexus carcinoma cells.  Methotrexate should not be combined with HDACI in the treatment of choroid plexus carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrceiWihiATn7Vg90H21EOLACvtfcHk0lh6RJsjhMbOUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFemuw%253D%253D&md5=4d3c4ba48a3c0c32047167162ffb5a67</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs11060-008-9709-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-008-9709-z%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DP.%26aulast%3DVasquez%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DC.%2BM.%26aulast%3DGopalakrishnan%26aufirst%3DV.%26aulast%3DWolff%26aufirst%3DJ.%2BE.%26atitle%3DHistone%2520acetylation%2520resulting%2520in%2520resistance%2520to%2520methotrexate%2520in%2520choroid%2520plexus%2520cells%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2009%26volume%3D91%26spage%3D279%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Banerjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnieders, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertino, J. R.</span><span> </span><span class="NLM_article-title">Role of E2F-1 in chemosensitivity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4292</span><span class="NLM_x">â</span> <span class="NLM_lpage">4296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4292-4296&author=D.+Banerjeeauthor=B.+Schniedersauthor=J.+Z.+Fuauthor=D.+Adhikariauthor=S.+C.+Zhaoauthor=J.+R.+Bertino&title=Role+of+E2F-1+in+chemosensitivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DSchnieders%26aufirst%3DB.%26aulast%3DFu%26aufirst%3DJ.%2BZ.%26aulast%3DAdhikari%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DS.%2BC.%26aulast%3DBertino%26aufirst%3DJ.%2BR.%26atitle%3DRole%2520of%2520E2F-1%2520in%2520chemosensitivity%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4292%26epage%3D4296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Kasahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, K.</span><span> </span><span class="NLM_article-title">Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2707</span><span class="NLM_x">â</span> <span class="NLM_lpage">2711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=10914714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslent7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=2707-2711&author=M.+Kasaharaauthor=Y.+Takahashiauthor=T.+Nagataauthor=S.+Asaiauthor=T.+Eguchiauthor=Y.+Ishiiauthor=M.+Fujiiauthor=K.+Ishikawa&title=Thymidylate+synthase+expression+correlates+closely+with+E2F1+expression+in+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer</span></div><div class="casAuthors">Kasahara, Mitsuko; Takahashi, Yasuo; Nagata, Toshihito; Asai, Satoshi; Eguchi, Teruo; Ishii, Yukimoto; Fujii, Masashi; Ishikawa, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2707-2711</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is thought to be one of the target genes that the E2F1 transcription factor binds to and regulates.  However, the relationship between the expressions of TS and E2F1 in primary colon cancer specimens remains unclear.  The aim of this study was to define the relation of TS and E2F1 gene expressions in tumor samples from 23 colon cancer patients.  TS and E2F1 gene expressions were measured by TaqMan reverse transcription-PCR assay using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal std. and expressed as a TS:GAPDH or E2F1:GAPDH mRNA ratio.  A close relationship was found between TS gene expression and E2F1 gene expression (r2 = 0.598, P < 0.001) in 23 tumor samples analyzed.  Surprisingly, a high correlation between TS gene expression and E2F1 gene expression was obsd. even in advanced tumors from stage IV colon cancer patients.  These results suggest that transcription of the TS gene may be regulated by E2F1 in primary colon cancer specimens and that this gene-regulatory pathway from E2F1 to TS may be highly conserved during malignant progression.  Four of the 23 patients showed TS overexpression with increased E2F1 expression.  These results suggest that the ability of a tumor to increase TS expression may possibly be due to an over-expression of E2F1.  Although the no. of patients was relatively small, our study provides new insights into the mol. mechanisms underlying the regulation of TS expression in colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2WUpu1vYDvLVg90H21EOLACvtfcHk0lhSP8PCH4QQ3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslent7k%253D&md5=953be1f26734387a1832df737f0f6914</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasahara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DAsai%26aufirst%3DS.%26aulast%3DEguchi%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DK.%26atitle%3DThymidylate%2520synthase%2520expression%2520correlates%2520closely%2520with%2520E2F1%2520expression%2520in%2520colon%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D2707%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Abe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, M.</span><span> </span><span class="NLM_article-title">UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">â</span> <span class="NLM_lpage">1198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1111%2Fj.1349-7006.2000.tb00904.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11092986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVGrsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2000&pages=1192-1198&author=S.+Abeauthor=T.+Kubotaauthor=Y.+Otaniauthor=T.+Furukawaauthor=M.+Watanabeauthor=K.+Kumaiauthor=M.+Kitajima&title=UCN-01+%287-hydroxystaurosporine%29+enhances+5-fluorouracil+cytotoxicity+through+down-regulation+of+thymidylate+synthetase+messenger+RNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA</span></div><div class="casAuthors">Abe, Sadanori; Kubota, Tetsuro; Otani, Yoshihide; Furukawa, Toshiharu; Watanabe, Masahiko; Kumai, Koichiro; Kitajima, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1192-1198</span>CODEN:
                <span class="NLM_cas:coden">JJCREP</span>;
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">UCN-01 (7-hydroxystaurosporine) is a newly developed cell cycle inhibitor known to have several modes of action, including inhibition of cyclin-dependent kinase, induction of p21 and suppression of pRb phosphorylation.  In order to test a combination therapy of UCN-01 and 5-fluorouracil (5-FU), growth inhibition of CRL 1420 (MIA PaCa-2; undifferentiated pancreatic carcinoma) by four different treatments was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay.  The treatments used were UCN-01 alone, 5-FU alone, 5-FU followed by UCN-01 (5-FU/UCN-01) and UCN-01 followed by 5-FU (UCN-01/5-FU).  We also assessed changes in thymidylate synthetase (TS) mRNA levels, TS activity, and 5-FU incorporation by RNA (F-RNA) for each treatment.  Although treatment with UCN-01 alone, 5-FU alone, and 5-FU/UCN-01 inhibited CRL 1420 growth in a concn.-dependent manner, treatment with UCN-01/5-FU inhibited the growth of CRL 1420 synergistically at less than 1 Î¼g/mL drug concn.  The down-regulation of TS mRNA by UCN-01 resulted in stable total TS and decreased free TS, and UCN-01/5-FU resulted in enhanced thymidylate synthetase inhibition rate (TSIR) compared to UCN-01 alone and 5-FU/UCN-01.  This increased TSIR due to UCN-01 pretreatment was accompanied by elevated F-RNA concns. in the UCN-01/5-FU treatment.  The suppression of TS mRNA and TS activity by UCN-01 may lead to higher sensitivity of tumor cells to 5-FU and may explain the synergistic antitumor effect of UCN-01/5-FU.  In conclusion, low concns. of UCN-01 (from 0.01 to 1 Î¼g/mL) may be clin. useful, affording low cytotoxicity of UCN-01, while enhancing the antitumor effect of 5-FU.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMMmiqbxphbLVg90H21EOLACvtfcHk0lhSP8PCH4QQ3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVGrsbw%253D&md5=00c49b03b6c95f0f3394ef3b232dc689</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2000.tb00904.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2000.tb00904.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DS.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DOtani%26aufirst%3DY.%26aulast%3DFurukawa%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DKumai%26aufirst%3DK.%26aulast%3DKitajima%26aufirst%3DM.%26atitle%3DUCN-01%2520%25287-hydroxystaurosporine%2529%2520enhances%25205-fluorouracil%2520cytotoxicity%2520through%2520down-regulation%2520of%2520thymidylate%2520synthetase%2520messenger%2520RNA%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D2000%26volume%3D91%26spage%3D1192%26epage%3D1198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Hsueh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2201</span><span class="NLM_x">â</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9748140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1cXmslCjsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2201-2206&author=C.+T.+Hsuehauthor=D.+Kelsenauthor=G.+K.+Schwartz&title=UCN-01+suppresses+thymidylate+synthase+gene+expression+and+enhances+5-fluorouracil-induced+apoptosis+in+a+sequence-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner</span></div><div class="casAuthors">Hsueh, Chung-Tsen; Kelsen, David; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2201-2206</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">UCN-01, a protein kinase C/cyclin-dependent kinase inhibitor, suppressed thymidylate synthase (TS) protein expression in a dose-dependent manner with near complete suppression at 1 Î¼M after a 24-h exposure in human gastric cancer cell line SK-GT5.  Other protein kinase C/cyclin-dependent kinase inhibitors, including flavopiridol and safingol, has a similar effect on TS protein expression, but to a lesser degree.  Moreover, UCN-01 repressed the induction of TS after 5-fluorouracil (FU) exposure by 90-95% and significantly enhanced the induction of apoptosis by FU from 4-8% with either FU or UCN-01 alone to 46Â±1% (P < 0.005 vs. either single drug, reverse sequence, or the combination) when UCN-01 was given after FU.  The effect of UCN-01 on TS was assocd. with a dose-dependent suppression of the E2F-1 protein, a transcriptional activator of TS.  Northern blot anal. revealed that TS mRNA levels decreased gradually as the concn. of UCN-01 increased, but that E2F-1 mRNA levels remained relatively unchanged.  UCN-01 may provide a novel way to enhance cellular sensitivity toward FU by means of suppressing TS expression mediated mainly by down-regulation of E2F-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnPdAGouTdUbVg90H21EOLACvtfcHk0lhSP8PCH4QQ3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslCjsL0%253D&md5=1ac3b728bfa620b9072d98661f6305ae</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DC.%2BT.%26aulast%3DKelsen%26aufirst%3DD.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DUCN-01%2520suppresses%2520thymidylate%2520synthase%2520gene%2520expression%2520and%2520enhances%25205-fluorouracil-induced%2520apoptosis%2520in%2520a%2520sequence-dependent%2520manner%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D2201%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Giacinti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, A.</span><span> </span><span class="NLM_article-title">RB and cell cycle progression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5220</span><span class="NLM_x">â</span> <span class="NLM_lpage">5227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5220-5227&author=C.+Giacintiauthor=A.+Giordano&title=RB+and+cell+cycle+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiacinti%26aufirst%3DC.%26aulast%3DGiordano%26aufirst%3DA.%26atitle%3DRB%2520and%2520cell%2520cycle%2520progression%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5220%26epage%3D5227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Kim, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span> </span><span class="NLM_article-title">Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_elocation-id">e5933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=H.+P.+Kimauthor=Y.+K.+Yoonauthor=J.+W.+Kimauthor=S.+W.+Hanauthor=H.+S.+Hurauthor=J.+Parkauthor=J.+H.+Leeauthor=D.+Y.+Ohauthor=S.+A.+Imauthor=Y.+J.+Bangauthor=T.+Y.+Kim&title=Lapatinib%2C+a+dual+EGFR+and+HER2+tyrosine+kinase+inhibitor%2C+downregulates+thymidylate+synthase+by+inhibiting+the+nuclear+translocation+of+EGFR+and+HER2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BP.%26aulast%3DYoon%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DHur%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DIm%26aufirst%3DS.%2BA.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DT.%2BY.%26atitle%3DLapatinib%252C%2520a%2520dual%2520EGFR%2520and%2520HER2%2520tyrosine%2520kinase%2520inhibitor%252C%2520downregulates%2520thymidylate%2520synthase%2520by%2520inhibiting%2520the%2520nuclear%2520translocation%2520of%2520EGFR%2520and%2520HER2%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Okabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukioka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span> </span><span class="NLM_article-title">Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">â</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1158%2F1535-7163.MCT-07-0567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=18347146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWgsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=599-606&author=T.+Okabeauthor=I.+Okamotoauthor=S.+Tsukiokaauthor=J.+Uchidaauthor=T.+Iwasaauthor=T.+Yoshidaauthor=E.+Hatashitaauthor=Y.+Yamadaauthor=T.+Satohauthor=K.+Tamuraauthor=M.+Fukuokaauthor=K.+Nakagawa&title=Synergistic+antitumor+effect+of+S-1+and+the+epidermal+growth+factor+receptor+inhibitor+gefitinib+in+non-small+cell+lung+cancer+cell+lines%3A+role+of+gefitinib-induced+down-regulation+of+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase</span></div><div class="casAuthors">Okabe, Takafumi; Okamoto, Isamu; Tsukioka, Sayaka; Uchida, Junji; Iwasa, Tsutomu; Yoshida, Takeshi; Hatashita, Erina; Yamada, Yuki; Satoh, Taroh; Tamura, Kenji; Fukuoka, Masahiro; Nakagawa, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatic mutations in the epidermal growth factor receptor (EGFR) gene are assocd. with the therapeutic response to EGFR tyrosine kinase inhibitors (TKI) in patients with advanced non-small cell lung cancer (NSCLC).  The response rate to these drugs remains low, however, in NSCLC patients with wild-type EGFR alleles.  Combination therapies with EGFR-TKIs and cytotoxic agents are considered a therapeutic option for patients with NSCLC expressing wild-type EGFR.  We investigated the antiproliferative effect of the combination of the oral fluorouracil S-1 and the EGFR-TKI gefitinib in NSCLC cells of differing EGFR status.  The combination of 5-fluorouracil and gefitinib showed a synergistic antiproliferative effect in vitro in all NSCLC cell lines tested.  Combination chemotherapy with S-1 and gefitinib in vivo also had a synergistic antitumor effect on NSCLC xenografts regardless of the absence or presence of EGFR mutations.  Gefitinib inhibited the expression of the transcription factor E2F-1, resulting in the down-regulation of thymidylate synthase at the mRNA and protein levels.  These observations suggest that gefitinib-induced down-regulation of thymidylate synthase is responsible, at least in part, for the synergistic antitumor effect of combined treatment with S-1 and gefitinib and provide a basis for clin. evaluation of combination chemotherapy with S-1 and EGFR-TKIs in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgRKGk_6XgyrVg90H21EOLACvtfcHk0lg6MxRWo0hvTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWgsr4%253D&md5=fcc52c6b30f6a8b7a0bb45669bb7dec4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0567%26sid%3Dliteratum%253Aachs%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DI.%26aulast%3DTsukioka%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DJ.%26aulast%3DIwasa%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DHatashita%26aufirst%3DE.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DFukuoka%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DK.%26atitle%3DSynergistic%2520antitumor%2520effect%2520of%2520S-1%2520and%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520gefitinib%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cell%2520lines%253A%2520role%2520of%2520gefitinib-induced%2520down-regulation%2520of%2520thymidylate%2520synthase%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D599%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gaetano Marverti, Chiara Marraccini, Andrea Martello, Domenico DâArca, Salvatore Pacifico, Remo Guerrini, Francesca Spyrakis, Gaia Gozzi, Angela Lauriola, Matteo Santucci, Giuseppe Cannazza, Lorenzo Tagliazucchi, Addolorata Stefania Cazzato, Lorena Losi, Stefania Ferrari, Glauco Ponterini, <span class="NLM_string-name hlFld-ContribAuthor">Maria P. Costi</span>. </span><span class="cited-content_cbyCitation_article-title">Folic AcidâPeptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3204-3221. <a href="https://doi.org/10.1021/acs.jmedchem.0c02107" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02107%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFolic%252BAcid%2525E2%252580%252593Peptide%252BConjugates%252BCombine%252BSelective%252BCancer%252BCell%252BInternalization%252Bwith%252BThymidylate%252BSynthase%252BDimer%252BInterface%252BTargeting%26aulast%3DMarverti%26aufirst%3DGaetano%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12122020%26date%3D12032021%26volume%3D64%26issue%3D6%26spage%3D3204%26epage%3D3221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Outi M. H.  Salo-Ahen</span>, <span class="hlFld-ContribAuthor ">Anna  Tochowicz</span>, <span class="hlFld-ContribAuthor ">Cecilia  Pozzi</span>, <span class="hlFld-ContribAuthor ">Daniela  Cardinale</span>, <span class="hlFld-ContribAuthor ">Stefania  Ferrari</span>, <span class="hlFld-ContribAuthor ">Yap  Boum</span>, <span class="hlFld-ContribAuthor ">Stefano  Mangani</span>, <span class="hlFld-ContribAuthor ">Robert M.  Stroud</span>, <span class="hlFld-ContribAuthor ">Puneet  Saxena</span>, <span class="hlFld-ContribAuthor ">Hannu  Myllykallio</span>, <span class="hlFld-ContribAuthor ">Maria Paola  Costi</span>, <span class="hlFld-ContribAuthor ">Glauco  Ponterini</span>, and <span class="hlFld-ContribAuthor ">Rebecca C.  Wade</span>  . </span><span class="cited-content_cbyCitation_article-title">Hotspots in an Obligate Homodimeric Anticancer Target. Structural and Functional Effects of Interfacial Mutations in Human Thymidylate Synthase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (8)
                                     , 3572-3581. <a href="https://doi.org/10.1021/acs.jmedchem.5b00137" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00137%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHotspots%252Bin%252Ban%252BObligate%252BHomodimeric%252BAnticancer%252BTarget.%252BStructural%252Band%252BFunctional%252BEffects%252Bof%252BInterfacial%252BMutations%252Bin%252BHuman%252BThymidylate%252BSynthase%26aulast%3DSalo-Ahen%26aufirst%3DOuti%2BM.%2BH.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D24012015%26date%3D01042015%26date%3D23042015%26date%3D23032015%26volume%3D58%26issue%3D8%26spage%3D3572%26epage%3D3581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefania  Ferrari</span>, <span class="hlFld-ContribAuthor ">Samuele  CalÃ²</span>, <span class="hlFld-ContribAuthor ">Rosalida  Leone</span>, <span class="hlFld-ContribAuthor ">Rosaria  Luciani</span>, <span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Susan  Sammak</span>, <span class="hlFld-ContribAuthor ">Flavio  Di Pisa</span>, <span class="hlFld-ContribAuthor ">Cecilia  Pozzi</span>, <span class="hlFld-ContribAuthor ">Stefano  Mangani</span>, and <span class="hlFld-ContribAuthor ">M. Paola  Costi</span>  . </span><span class="cited-content_cbyCitation_article-title">2â²-Deoxyuridine 5â²-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (22)
                                     , 9356-9360. <a href="https://doi.org/10.1021/jm4014086" title="DOI URL">https://doi.org/10.1021/jm4014086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4014086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4014086%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2%2525E2%252580%2525B2-Deoxyuridine%252B5%2525E2%252580%2525B2-Monophosphate%252BSubstrate%252BDisplacement%252Bin%252BThymidylate%252BSynthase%252Bthrough%252B6-Hydroxy-2H-naphtho%25255B1%25252C8-bc%25255Dfuran-2-one%252BDerivatives%26aulast%3DFerrari%26aufirst%3DStefania%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D12092013%26date%3D13112013%26date%3D27112013%26date%3D22102013%26volume%3D56%26issue%3D22%26spage%3D9356%26epage%3D9360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankur  Vaidya</span>, <span class="hlFld-ContribAuthor ">Devender  Pathak</span>, <span class="hlFld-ContribAuthor ">Kamal  Shah</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,4âoxadiazole and its derivatives: A review on recent progress in anticancer activities. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 572-591. <a href="https://doi.org/10.1111/cbdd.13795" title="DOI URL">https://doi.org/10.1111/cbdd.13795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13795%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3D1%25252C3%25252C4%2525E2%252580%252590oxadiazole%252Band%252Bits%252Bderivatives%25253A%252BA%252Breview%252Bon%252Brecent%252Bprogress%252Bin%252Banticancer%252Bactivities%26aulast%3DVaidya%26aufirst%3DAnkur%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D572%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meredith S.  Showler</span>, <span class="hlFld-ContribAuthor ">Brian P.  Weiser</span>. </span><span class="cited-content_cbyCitation_article-title">A possible link to uracil DNA glycosylase in the synergistic action of HDAC inhibitors and thymidylate synthase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Translational Medicine</span><span> <strong>2020,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12967-020-02555-x" title="DOI URL">https://doi.org/10.1186/s12967-020-02555-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12967-020-02555-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12967-020-02555-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Translational%2520Medicine%26atitle%3DA%252Bpossible%252Blink%252Bto%252Buracil%252BDNA%252Bglycosylase%252Bin%252Bthe%252Bsynergistic%252Baction%252Bof%252BHDAC%252Binhibitors%252Band%252Bthymidylate%252Bsynthase%252Binhibitors%26aulast%3DShowler%26aufirst%3DMeredith%2BS.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geeta Sai  Mani</span>, <span class="hlFld-ContribAuthor ">Pratibha  Anchi</span>, <span class="hlFld-ContribAuthor ">Satish  Sunkari</span>, <span class="hlFld-ContribAuthor ">Kavitha  Donthiboina</span>, <span class="hlFld-ContribAuthor ">Chandraiah  Godugu</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (Z)-3-(arylamino)-1-(3-phenylimidazo[1,5-a]pyridin-1-yl)prop-2-en-1-ones as potential cytotoxic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (18)
                                     , 127432. <a href="https://doi.org/10.1016/j.bmcl.2020.127432" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127432%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B%252528Z%252529-3-%252528arylamino%252529-1-%2525283-phenylimidazo%25255B1%25252C5-a%25255Dpyridin-1-yl%252529prop-2-en-1-ones%252Bas%252Bpotential%252Bcytotoxic%252Bagents%26aulast%3DMani%26aufirst%3DGeeta%2BSai%26date%3D2020%26volume%3D30%26issue%3D18%26spage%3D127432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Aubets</span>, <span class="hlFld-ContribAuthor ">Alex  J. FÃ©lix</span>, <span class="hlFld-ContribAuthor ">Miguel  GaravÃ­s</span>, <span class="hlFld-ContribAuthor ">Laura  Reyes</span>, <span class="hlFld-ContribAuthor ">Anna  AviÃ±Ã³</span>, <span class="hlFld-ContribAuthor ">RamÃ³n  Eritja</span>, <span class="hlFld-ContribAuthor ">Carlos J.  Ciudad</span>, <span class="hlFld-ContribAuthor ">VÃ©ronique  NoÃ©</span>. </span><span class="cited-content_cbyCitation_article-title">Detection of a G-Quadruplex as a Regulatory Element in Thymidylate synthase for Gene Silencing Using Polypurine Reverse Hoogsteen Hairpins. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (14)
                                     , 5028. <a href="https://doi.org/10.3390/ijms21145028" title="DOI URL">https://doi.org/10.3390/ijms21145028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21145028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21145028%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDetection%252Bof%252Ba%252BG-Quadruplex%252Bas%252Ba%252BRegulatory%252BElement%252Bin%252BThymidylate%252Bsynthase%252Bfor%252BGene%252BSilencing%252BUsing%252BPolypurine%252BReverse%252BHoogsteen%252BHairpins%26aulast%3DAubets%26aufirst%3DEva%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D14%26spage%3D5028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Fatemeh  Mousavi</span>, <span class="hlFld-ContribAuthor ">Mohammad Hossein  Fatemi</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the binding mechanism of capecitabine to human serum albumin using spectrometric methods, molecular modeling, and chemometrics approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>90 </em>, 103037. <a href="https://doi.org/10.1016/j.bioorg.2019.103037" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DProbing%252Bthe%252Bbinding%252Bmechanism%252Bof%252Bcapecitabine%252Bto%252Bhuman%252Bserum%252Balbumin%252Busing%252Bspectrometric%252Bmethods%25252C%252Bmolecular%252Bmodeling%25252C%252Band%252Bchemometrics%252Bapproach%26aulast%3DMousavi%26aufirst%3DS.%2BFatemeh%26date%3D2019%26volume%3D90%26spage%3D103037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreea  Sodolescu</span>, <span class="hlFld-ContribAuthor ">Cyril  Dian</span>, <span class="hlFld-ContribAuthor ">Laurent  Terradot</span>, <span class="hlFld-ContribAuthor ">Latifa  Bouzhir-Sima</span>, <span class="hlFld-ContribAuthor ">Roxane  Lestini</span>, <span class="hlFld-ContribAuthor ">Hannu  Myllykallio</span>, <span class="hlFld-ContribAuthor ">StÃ©phane  Skouloubris</span>, <span class="hlFld-ContribAuthor ">Ursula  Liebl</span>, . </span><span class="cited-content_cbyCitation_article-title">Structural and functional insight into serine hydroxymethyltransferase from Helicobacter pylori. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (12)
                                     , e0208850. <a href="https://doi.org/10.1371/journal.pone.0208850" title="DOI URL">https://doi.org/10.1371/journal.pone.0208850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0208850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0208850%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DStructural%252Band%252Bfunctional%252Binsight%252Binto%252Bserine%252Bhydroxymethyltransferase%252Bfrom%252BHelicobacter%252Bpylori%26aulast%3DSodolescu%26aufirst%3DAndreea%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D12%26spage%3De0208850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charansingh H.  Gill</span>, <span class="hlFld-ContribAuthor ">Asha V.  Chate</span>, <span class="hlFld-ContribAuthor ">Gajanan Y.  Shinde</span>, <span class="hlFld-ContribAuthor ">Aniket P.  Sarkate</span>, <span class="hlFld-ContribAuthor ">Shailee V.  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot, four-component synthesis and SAR STUDIES of spiro[pyrimido[5,4-b]quinoline-10,5â²-pyrrolo[2,3-d]pyrimidine] derivatives catalyzed by Î²-cyclodextrin in water as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2018,</strong> <em>44 </em>
                                    (7)
                                     , 4029-4043. <a href="https://doi.org/10.1007/s11164-018-3353-9" title="DOI URL">https://doi.org/10.1007/s11164-018-3353-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-018-3353-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-018-3353-9%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DOne-pot%25252C%252Bfour-component%252Bsynthesis%252Band%252BSAR%252BSTUDIES%252Bof%252Bspiro%25255Bpyrimido%25255B5%25252C4-b%25255Dquinoline-10%25252C5%2525E2%252580%2525B2-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine%25255D%252Bderivatives%252Bcatalyzed%252Bby%252B%2525CE%2525B2-cyclodextrin%252Bin%252Bwater%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DGill%26aufirst%3DCharansingh%2BH.%26date%3D2018%26date%3D2018%26volume%3D44%26issue%3D7%26spage%3D4029%26epage%3D4043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hala O.  El-Mesallamy</span>, <span class="hlFld-ContribAuthor ">Hekmat M.  El Magdoub</span>, <span class="hlFld-ContribAuthor ">James M.  Chapman</span>, <span class="hlFld-ContribAuthor ">Nadia M.  Hamdy</span>, <span class="hlFld-ContribAuthor ">Mona F.  Schaalan</span>, <span class="hlFld-ContribAuthor ">Lamiaa N.  Hammad</span>, <span class="hlFld-ContribAuthor ">Sondra H.  Berger</span>, . </span><span class="cited-content_cbyCitation_article-title">Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (3)
                                     , e0193810. <a href="https://doi.org/10.1371/journal.pone.0193810" title="DOI URL">https://doi.org/10.1371/journal.pone.0193810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0193810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0193810%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DBiomolecular%252Bstudy%252Bof%252Bhuman%252Bthymidylate%252Bsynthase%252Bconformer-selective%252Binhibitors%25253A%252BNew%252Bchemotherapeutic%252Bapproach%26aulast%3DEl-Mesallamy%26aufirst%3DHala%2BO.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D3%26spage%3De0193810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra Jordano  Conforte</span>, <span class="hlFld-ContribAuthor ">Milena  MagalhÃ£es</span>, <span class="hlFld-ContribAuthor ">Tatiana Martins  Tilli</span>, <span class="hlFld-ContribAuthor ">Fabricio Alves Barbosa  da Silva</span>, <span class="hlFld-ContribAuthor ">Nicolas  Carels</span>. </span><span class="cited-content_cbyCitation_article-title">The Challenge of Translating System Biology into Targeted Therapy of Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 175-194. <a href="https://doi.org/10.1007/978-3-319-74974-7_10" title="DOI URL">https://doi.org/10.1007/978-3-319-74974-7_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-74974-7_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-74974-7_10%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BChallenge%252Bof%252BTranslating%252BSystem%252BBiology%252Binto%252BTargeted%252BTherapy%252Bof%252BCancer%26aulast%3DConforte%26aufirst%3DAlessandra%2BJordano%26date%3D2018%26date%3D2018%26spage%3D175%26epage%3D194%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTheoretical%252Band%252BApplied%252BAspects%252Bof%252BSystems%252BBiology%26aulast%3DAlves%2BBarbosa%2Bda%2BSilva%26aufirst%3DFabricio%26date%3D2018%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefania  Ferrari</span>, <span class="hlFld-ContribAuthor ">Leda  Severi</span>, <span class="hlFld-ContribAuthor ">Cecilia  Pozzi</span>, <span class="hlFld-ContribAuthor ">Antonio  Quotadamo</span>, <span class="hlFld-ContribAuthor ">Glauco  Ponterini</span>, <span class="hlFld-ContribAuthor ">Lorena  Losi</span>, <span class="hlFld-ContribAuthor ">Gaetano  Marverti</span>, <span class="hlFld-ContribAuthor ">Maria Paola  Costi</span>. </span><span class="cited-content_cbyCitation_article-title">Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 473-513. <a href="https://doi.org/10.1016/bs.vh.2017.12.002" title="DOI URL">https://doi.org/10.1016/bs.vh.2017.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.vh.2017.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.vh.2017.12.002%26sid%3Dliteratum%253Aachs%26atitle%3DHuman%252BThymidylate%252BSynthase%252BInhibitors%252BHalting%252BOvarian%252BCancer%252BGrowth%26aulast%3DFerrari%26aufirst%3DStefania%26date%3D2018%26spage%3D473%26epage%3D513%26pub%3DElsevier%26atitle%3DOvarian%252BCycle%26date%3D2018%26volume%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Deschamps</span>, <span class="hlFld-ContribAuthor ">S.  RÃ©ty</span>, <span class="hlFld-ContribAuthor ">J.  Bareille</span>, <span class="hlFld-ContribAuthor ">N.  Leulliot</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of the active form of native human thymidylate synthase in the absence of bound substrates. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section F Structural Biology Communications</span><span> <strong>2017,</strong> <em>73 </em>
                                    (6)
                                     , 336-341. <a href="https://doi.org/10.1107/S2053230X17007233" title="DOI URL">https://doi.org/10.1107/S2053230X17007233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053230X17007233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053230X17007233%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520F%2520Structural%2520Biology%2520Communications%26atitle%3DCrystal%252Bstructure%252Bof%252Bthe%252Bactive%252Bform%252Bof%252Bnative%252Bhuman%252Bthymidylate%252Bsynthase%252Bin%252Bthe%252Babsence%252Bof%252Bbound%252Bsubstrates%26aulast%3DDeschamps%26aufirst%3DP.%26date%3D2017%26date%3D2017%26volume%3D73%26issue%3D6%26spage%3D336%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bailey  Nelson</span>, <span class="hlFld-ContribAuthor ">Jane V.  Carter</span>, <span class="hlFld-ContribAuthor ">Maurice R.  Eichenberger</span>, <span class="hlFld-ContribAuthor ">Uri  Netz</span>, <span class="hlFld-ContribAuthor ">Susan  Galandiuk</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic polymorphisms in 5-Fluorouracilârelated enzymes predict pathologic response after neoadjuvant chemoradiation for rectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Surgery</span><span> <strong>2016,</strong> <em>160 </em>
                                    (5)
                                     , 1326-1332. <a href="https://doi.org/10.1016/j.surg.2016.05.017" title="DOI URL">https://doi.org/10.1016/j.surg.2016.05.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.surg.2016.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.surg.2016.05.017%26sid%3Dliteratum%253Aachs%26jtitle%3DSurgery%26atitle%3DGenetic%252Bpolymorphisms%252Bin%252B5-Fluorouracil%2525E2%252580%252593related%252Benzymes%252Bpredict%252Bpathologic%252Bresponse%252Bafter%252Bneoadjuvant%252Bchemoradiation%252Bfor%252Brectal%252Bcancer%26aulast%3DNelson%26aufirst%3DBailey%26date%3D2016%26volume%3D160%26issue%3D5%26spage%3D1326%26epage%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">AndrÃ©  Schultz</span>, <span class="hlFld-ContribAuthor ">Amina A.  Qutub</span>, . </span><span class="cited-content_cbyCitation_article-title">Reconstruction of Tissue-Specific Metabolic Networks Using CORDA. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2016,</strong> <em>12 </em>
                                    (3)
                                     , e1004808. <a href="https://doi.org/10.1371/journal.pcbi.1004808" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1004808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1004808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1004808%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DReconstruction%252Bof%252BTissue-Specific%252BMetabolic%252BNetworks%252BUsing%252BCORDA%26aulast%3DSchultz%26aufirst%3DAndr%25C3%25A9%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D3%26spage%3De1004808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Sacchetti</span>, <span class="hlFld-ContribAuthor ">Chiara  Marraccini</span>, <span class="hlFld-ContribAuthor ">Domenico  DâArca</span>, <span class="hlFld-ContribAuthor ">Michela  PelÃ </span>, <span class="hlFld-ContribAuthor ">Diego  Pinetti</span>, <span class="hlFld-ContribAuthor ">Eleonora  Maretti</span>, <span class="hlFld-ContribAuthor ">Miriam  Hanuskova</span>, <span class="hlFld-ContribAuthor ">Valentina  Iannuccelli</span>, <span class="hlFld-ContribAuthor ">Maria Paola  Costi</span>, <span class="hlFld-ContribAuthor ">Eliana  Leo</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery. </span><span class="cited-content_cbyCitation_journal-name">Colloids and Surfaces B: Biointerfaces</span><span> <strong>2015,</strong> <em>136 </em>, 346-354. <a href="https://doi.org/10.1016/j.colsurfb.2015.09.040" title="DOI URL">https://doi.org/10.1016/j.colsurfb.2015.09.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.colsurfb.2015.09.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.colsurfb.2015.09.040%26sid%3Dliteratum%253Aachs%26jtitle%3DColloids%2520and%2520Surfaces%2520B%253A%2520Biointerfaces%26atitle%3DEnhanced%252Banti-hyperproliferative%252Bactivity%252Bof%252Bhuman%252Bthymidylate%252Bsynthase%252Binhibitor%252Bpeptide%252Bby%252Bsolid%252Blipid%252Bnanoparticle%252Bdelivery%26aulast%3DSacchetti%26aufirst%3DFrancesca%26date%3D2015%26volume%3D136%26spage%3D346%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Taddia</span>, <span class="hlFld-ContribAuthor ">Domenico  DâArca</span>, <span class="hlFld-ContribAuthor ">Stefania  Ferrari</span>, <span class="hlFld-ContribAuthor ">Chiara  Marraccini</span>, <span class="hlFld-ContribAuthor ">Leda  Severi</span>, <span class="hlFld-ContribAuthor ">Glauco  Ponterini</span>, <span class="hlFld-ContribAuthor ">Yahuda G.  Assaraf</span>, <span class="hlFld-ContribAuthor ">Gaetano  Marverti</span>, <span class="hlFld-ContribAuthor ">Maria Paola  Costi</span>. </span><span class="cited-content_cbyCitation_article-title">Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2015,</strong> <em>23 </em>, 20-54. <a href="https://doi.org/10.1016/j.drup.2015.10.003" title="DOI URL">https://doi.org/10.1016/j.drup.2015.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2015.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2015.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DInside%252Bthe%252Bbiochemical%252Bpathways%252Bof%252Bthymidylate%252Bsynthase%252Bperturbed%252Bby%252Banticancer%252Bdrugs%25253A%252BNovel%252Bstrategies%252Bto%252Bovercome%252Bcancer%252Bchemoresistance%26aulast%3DTaddia%26aufirst%3DLaura%26date%3D2015%26volume%3D23%26spage%3D20%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chada Narsimha  Reddy</span>, <span class="hlFld-ContribAuthor ">V. Lakshma  Nayak</span>, <span class="hlFld-ContribAuthor ">Geeta Sai  Mani</span>, <span class="hlFld-ContribAuthor ">Jeevak Sopanrao  Kapure</span>, <span class="hlFld-ContribAuthor ">Praveen Reddy  Adiyala</span>, <span class="hlFld-ContribAuthor ">Ram Awatar  Maurya</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of spiro[cyclopropane-1,3â²-indolin]-2â²-ones as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4580-4586. <a href="https://doi.org/10.1016/j.bmcl.2015.08.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.08.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.08.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.08.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bspiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-ones%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DReddy%26aufirst%3DChada%2BNarsimha%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4580%26epage%3D4586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pouyan  Ghaffari</span>, <span class="hlFld-ContribAuthor ">Adil  Mardinoglu</span>, <span class="hlFld-ContribAuthor ">Anna  Asplund</span>, <span class="hlFld-ContribAuthor ">Saeed  Shoaie</span>, <span class="hlFld-ContribAuthor ">Caroline  Kampf</span>, <span class="hlFld-ContribAuthor ">Mathias  Uhlen</span>, <span class="hlFld-ContribAuthor ">Jens  Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep08183" title="DOI URL">https://doi.org/10.1038/srep08183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep08183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep08183%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIdentifying%252Banti-growth%252Bfactors%252Bfor%252Bhuman%252Bcancer%252Bcell%252Blines%252Bthrough%252Bgenome-scale%252Bmetabolic%252Bmodeling%26aulast%3DGhaffari%26aufirst%3DPouyan%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anastassia  Serguienko</span>, <span class="hlFld-ContribAuthor ">Iwona  Grad</span>, <span class="hlFld-ContribAuthor ">Anna B.  WennerstrÃ¸m</span>, <span class="hlFld-ContribAuthor ">Leonardo A.  Meza-Zepeda</span>, <span class="hlFld-ContribAuthor ">Bernd  Thiede</span>, <span class="hlFld-ContribAuthor ">Eva W.  Stratford</span>, <span class="hlFld-ContribAuthor ">Ola  Myklebost</span>, <span class="hlFld-ContribAuthor ">Else  Munthe</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic reprogramming of metastatic breast cancer and melanoma by
              let-7a
              microRNA. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 2451-2465. <a href="https://doi.org/10.18632/oncotarget.3235" title="DOI URL">https://doi.org/10.18632/oncotarget.3235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.3235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.3235%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DMetabolic%252Breprogramming%252Bof%252Bmetastatic%252Bbreast%252Bcancer%252Band%252Bmelanoma%252Bby%252Blet-7a%252BmicroRNA%26aulast%3DSerguienko%26aufirst%3DAnastassia%26date%3D2015%26date%3D2014%26volume%3D6%26issue%3D4%26spage%3D2451%26epage%3D2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">NicholasÂ D.  Brunn</span>, <span class="hlFld-ContribAuthor ">SergeyÂ M.  Dibrov</span>, <span class="hlFld-ContribAuthor ">MelodyÂ B.  Kao</span>, <span class="hlFld-ContribAuthor ">Majid  Ghassemian</span>, <span class="hlFld-ContribAuthor ">Thomas  Hermann</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of mRNA recognition by human thymidylate synthase. </span><span class="cited-content_cbyCitation_journal-name">Bioscience Reports</span><span> <strong>2014,</strong> <em>34 </em>
                                    (6)
                                     <a href="https://doi.org/10.1042/BSR20140137" title="DOI URL">https://doi.org/10.1042/BSR20140137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BSR20140137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBSR20140137%26sid%3Dliteratum%253Aachs%26jtitle%3DBioscience%2520Reports%26atitle%3DAnalysis%252Bof%252BmRNA%252Brecognition%252Bby%252Bhuman%252Bthymidylate%252Bsynthase%26aulast%3DBrunn%26aufirst%3DNicholas%25C2%25A0D.%26date%3D2014%26date%3D2014%26volume%3D34%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Liggi</span>, <span class="hlFld-ContribAuthor ">Georgios  Drakakis</span>, <span class="hlFld-ContribAuthor ">Alexios  Koutsoukas</span>, <span class="hlFld-ContribAuthor ">Isidro  CortesâCiriano</span>, <span class="hlFld-ContribAuthor ">Patricia  MartÃ­nezâAlonso</span>, <span class="hlFld-ContribAuthor ">ThÃ©rÃ¨se E  Malliavin</span>, <span class="hlFld-ContribAuthor ">Adrian  Velazquez-Campoy</span>, <span class="hlFld-ContribAuthor ">Suzanne C  Brewerton</span>, <span class="hlFld-ContribAuthor ">Michael J  Bodkin</span>, <span class="hlFld-ContribAuthor ">David A  Evans</span>, <span class="hlFld-ContribAuthor ">Robert C  Glen</span>, <span class="hlFld-ContribAuthor ">JosÃ© Alberto  Carrodeguas</span>, <span class="hlFld-ContribAuthor ">Andreas  Bender</span>. </span><span class="cited-content_cbyCitation_article-title">Extending
              in silico
              mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (18)
                                     , 2029-2056. <a href="https://doi.org/10.4155/fmc.14.137" title="DOI URL">https://doi.org/10.4155/fmc.14.137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.137%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DExtending%252Bin%252Bsilico%252Bmechanism-of-action%252Banalysis%252Bby%252Bannotating%252Btargets%252Bwith%252Bpathways%25253A%252Bapplication%252Bto%252Bcellular%252Bcytotoxicity%252Breadouts%26aulast%3DLiggi%26aufirst%3DSonia%26date%3D2014%26volume%3D6%26issue%3D18%26spage%3D2029%26epage%3D2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rasmus  Agren</span>, <span class="hlFld-ContribAuthor ">Adil  Mardinoglu</span>, <span class="hlFld-ContribAuthor ">Anna  Asplund</span>, <span class="hlFld-ContribAuthor ">Caroline  Kampf</span>, <span class="hlFld-ContribAuthor ">Mathias  Uhlen</span>, <span class="hlFld-ContribAuthor ">Jens  Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of anticancer drugs for hepatocellular carcinoma through personalized genomeâscale metabolic modeling. </span><span class="cited-content_cbyCitation_journal-name">Molecular Systems Biology</span><span> <strong>2014,</strong> <em>10 </em>
                                    (3)
                                     , 721. <a href="https://doi.org/10.1002/msb.145122" title="DOI URL">https://doi.org/10.1002/msb.145122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/msb.145122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmsb.145122%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Systems%2520Biology%26atitle%3DIdentification%252Bof%252Banticancer%252Bdrugs%252Bfor%252Bhepatocellular%252Bcarcinoma%252Bthrough%252Bpersonalized%252Bgenome%2525E2%252580%252590scale%252Bmetabolic%252Bmodeling%26aulast%3DAgren%26aufirst%3DRasmus%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D3%26spage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian-Ru  Du</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Ya-Zhou  Pi</span>, <span class="hlFld-ContribAuthor ">Jing-Ran  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Fei  Fang</span>, <span class="hlFld-ContribAuthor ">Wei-Qing  Zhong</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Gong</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (8)
                                     , 2286-2297. <a href="https://doi.org/10.1016/j.bmc.2013.02.008" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B1%25252C3%25252C4-oxadiazole%252Bthioether%252Bderivatives%252Btargeting%252Bthymidylate%252Bsynthase%252Bas%252Bdual%252Banticancer%25252Fantimicrobial%252Bagents%26aulast%3DDu%26aufirst%3DQian-Ru%26date%3D2013%26volume%3D21%26issue%3D8%26spage%3D2286%26epage%3D2297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divita  Garg</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Beribisky</span>, <span class="hlFld-ContribAuthor ">Glauco  Ponterini</span>, <span class="hlFld-ContribAuthor ">Alessio  Ligabue</span>, <span class="hlFld-ContribAuthor ">Gaetano  Marverti</span>, <span class="hlFld-ContribAuthor ">Andrea  Martello</span>, <span class="hlFld-ContribAuthor ">M. Paola  Costi</span>, <span class="hlFld-ContribAuthor ">Michael  Sattler</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Wade</span>. </span><span class="cited-content_cbyCitation_article-title">Translational repression of thymidylate synthase by targeting its mRNA. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2013,</strong> <em>41 </em>
                                    (7)
                                     , 4159-4170. <a href="https://doi.org/10.1093/nar/gkt098" title="DOI URL">https://doi.org/10.1093/nar/gkt098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkt098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkt098%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DTranslational%252Brepression%252Bof%252Bthymidylate%252Bsynthase%252Bby%252Btargeting%252Bits%252BmRNA%26aulast%3DGarg%26aufirst%3DDivita%26date%3D2013%26date%3D2013%26volume%3D41%26issue%3D7%26spage%3D4159%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamara  Basta</span>, <span class="hlFld-ContribAuthor ">Yap  Boum</span>, <span class="hlFld-ContribAuthor ">Julien  Briffotaux</span>, <span class="hlFld-ContribAuthor ">Hubert F.  Becker</span>, <span class="hlFld-ContribAuthor ">Isabelle  Lamarre-Jouenne</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Lambry</span>, <span class="hlFld-ContribAuthor ">Stephane  Skouloubris</span>, <span class="hlFld-ContribAuthor ">Ursula  Liebl</span>, <span class="hlFld-ContribAuthor ">Marc  Graille</span>, <span class="hlFld-ContribAuthor ">Herman  van Tilbeurgh</span>, <span class="hlFld-ContribAuthor ">Hannu  Myllykallio</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic and structural basis for inhibition of thymidylate synthase ThyX. </span><span class="cited-content_cbyCitation_journal-name">Open Biology</span><span> <strong>2012,</strong> <em>2 </em>
                                    (10)
                                     , 120120. <a href="https://doi.org/10.1098/rsob.120120" title="DOI URL">https://doi.org/10.1098/rsob.120120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsob.120120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsob.120120%26sid%3Dliteratum%253Aachs%26jtitle%3DOpen%2520Biology%26atitle%3DMechanistic%252Band%252Bstructural%252Bbasis%252Bfor%252Binhibition%252Bof%252Bthymidylate%252Bsynthase%252BThyX%26aulast%3DBasta%26aufirst%3DTamara%26date%3D2012%26date%3D2012%26volume%3D2%26issue%3D10%26spage%3D120120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Mei  Hu</span>, <span class="hlFld-ContribAuthor ">Ming-Tyng  Yeh</span>, <span class="hlFld-ContribAuthor ">Ning  Tsao</span>, <span class="hlFld-ContribAuthor ">Chih-Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Quan-Ze  Gao</span>, <span class="hlFld-ContribAuthor ">Chia-Yun  Chang</span>, <span class="hlFld-ContribAuthor ">Ming-Hsiang  Lee</span>, <span class="hlFld-ContribAuthor ">Jim-Min  Fang</span>, <span class="hlFld-ContribAuthor ">Sheh-Yi  Sheu</span>, <span class="hlFld-ContribAuthor ">Chow-Jaw  Lin</span>, <span class="hlFld-ContribAuthor ">Mei-Chun  Tseng</span>, <span class="hlFld-ContribAuthor ">Yu-Ju  Chen</span>, <span class="hlFld-ContribAuthor ">Zee-Fen  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Cells Require Thymidylate Kinase to Prevent dUTP Incorporation during DNA Repair. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 36-50. <a href="https://doi.org/10.1016/j.ccr.2012.04.038" title="DOI URL">https://doi.org/10.1016/j.ccr.2012.04.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2012.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2012.04.038%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DTumor%252BCells%252BRequire%252BThymidylate%252BKinase%252Bto%252BPrevent%252BdUTP%252BIncorporation%252Bduring%252BDNA%252BRepair%26aulast%3DHu%26aufirst%3DChun-Mei%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D36%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  GoÅos</span>, <span class="hlFld-ContribAuthor ">Magdalena  DÄbrowska</span>, <span class="hlFld-ContribAuthor ">ElÅ¼bieta  WaÅajtys-Rode</span>, <span class="hlFld-ContribAuthor ">Zbigniew  ZieliÅski</span>, <span class="hlFld-ContribAuthor ">Patrycja  WiÅska</span>, <span class="hlFld-ContribAuthor ">Joanna  CieÅla</span>, <span class="hlFld-ContribAuthor ">ElÅ¼bieta  Jagielska</span>, <span class="hlFld-ContribAuthor ">Tadeusz  MoczoÅ</span>, <span class="hlFld-ContribAuthor ">Wojciech  Rode</span>. </span><span class="cited-content_cbyCitation_article-title">Immunofluorescent localization of thymidylate synthase in the development of Trichinella spiralis and Caenorhabditis elegans. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Biochemical Parasitology</span><span> <strong>2012,</strong> <em>183 </em>
                                    (1)
                                     , 63-69. <a href="https://doi.org/10.1016/j.molbiopara.2012.02.002" title="DOI URL">https://doi.org/10.1016/j.molbiopara.2012.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molbiopara.2012.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molbiopara.2012.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Biochemical%2520Parasitology%26atitle%3DImmunofluorescent%252Blocalization%252Bof%252Bthymidylate%252Bsynthase%252Bin%252Bthe%252Bdevelopment%252Bof%252BTrichinella%252Bspiralis%252Band%252BCaenorhabditis%252Belegans%26aulast%3DGo%25C5%2582os%26aufirst%3DBarbara%26date%3D2012%26volume%3D183%26issue%3D1%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C  MuÃ±oz-Pinedo</span>, <span class="hlFld-ContribAuthor ">N  El Mjiyad</span>, <span class="hlFld-ContribAuthor ">J-E  Ricci</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer metabolism: current perspectives and future directions. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2012,</strong> <em>3 </em>
                                    (1)
                                     , e248-e248. <a href="https://doi.org/10.1038/cddis.2011.123" title="DOI URL">https://doi.org/10.1038/cddis.2011.123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2011.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2011.123%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DCancer%252Bmetabolism%25253A%252Bcurrent%252Bperspectives%252Band%252Bfuture%252Bdirections%26aulast%3DMu%25C3%25B1oz-Pinedo%26aufirst%3DC%26date%3D2012%26date%3D2012%26volume%3D3%26issue%3D1%26spage%3De248%26epage%3De248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Outi M. H.  Salo-Ahen</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Wade</span>. </span><span class="cited-content_cbyCitation_article-title">The active-inactive transition of human thymidylate synthase: Targeted molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2011,</strong> <em>79 </em>
                                    (10)
                                     , 2886-2899. <a href="https://doi.org/10.1002/prot.23123" title="DOI URL">https://doi.org/10.1002/prot.23123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.23123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.23123%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DThe%252Bactive-inactive%252Btransition%252Bof%252Bhuman%252Bthymidylate%252Bsynthase%25253A%252BTargeted%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DSalo-Ahen%26aufirst%3DOuti%2BM.%2BH.%26date%3D2011%26date%3D2011%26volume%3D79%26issue%3D10%26spage%3D2886%26epage%3D2899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanisms of inhibition of hTS by drugs (green) and of drug resistance (red). From left to right: The TYMS gene is transcribed to TS mRNA which is translated to hTS protein which catalyzes the conversion of dUMP and mTHF to dTMP and dihydrofolate (DHF). The TS protein is shown in its monomeric and dimeric forms, as it has been suggested to exist in a monomerâhomodimer equilibrium (black arrows) in nature (<contrib-group>Voeller</contrib-group>et al. <cite>Biochem. Biophys. Res. Commun.</cite> <span class="NLM_year">2002</span>, <em>297</em>, 24â31). The dimeric form is obligatory for its catalytic activity; which of the two forms binds to the TS mRNA is, however, debatable. Drug resistance by gene amplification and by interruption of the proteinâmRNA binding can occur independently of each other.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Mechanism of Activation of Capecitabine and Tegafur to TS Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>CDHP: 5-chloro-2,4-dihydroxypyridine. The enzymes involved are CE, CD, TP, Cyp 450, UP, UK, OPRT, and TK.</p></p></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Mechanism of Activation and Targeting Pathway of Multitarget Folate Analogue Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>The known inhibitor pemetrexed is pentaglutamated by FPGS for potent inhibitory activity, whereas some of the experimental dual TS-DHFR inhibitors do not need glutamation. THF: tetrahydrofolate. fTHF: formyltetrahydrofolate.</p></p></figure><figure data-id="cht2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Examples of Dual TS-DHFR Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Cartoon representation of the superimposed monomeric subunits (from the crystallized dimers) of human thymidylate synthase in active (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HVY">1HVY</a>) (yellow) and inactive (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ONB">2ONB</a>) (gray) conformations. The active conformation of the active site loop is shown in green and the inactive conformation in red. The catalytic cysteine, C195, is highlighted with stick representation on the loops. The small domain visible in the active crystal structure is shown in brown. dUMP (cyan sticks) and a folate analogue raltitrexed (dark-blue sticks) are present in the active site, whereas PDPA (ball-and-stick representation) is located in an allosteric position. (b) Interactions of dUMP with the protein. Dashed lines represent direct hydrogen bonds between amino acid residues and the ligand. Solid line between Cys195 and dUMP represents a covalent bond. (c) Interactions of folate analogue raltitrexed with the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/medium/jm-2009-01869w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901869w/production/images/large/jm-2009-01869w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901869w&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 91 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">McGuire, J. J.</span><span> </span><span class="NLM_article-title">Anticancer antifolates: current status and future directions</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">â</span> <span class="NLM_lpage">2613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.2174%2F1381612033453712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=14529544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=2593-2613&author=J.+J.+McGuire&title=Anticancer+antifolates%3A+current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer antifolates: Current status and future directions</span></div><div class="casAuthors">McGuire, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">2593-2613</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Antifolates are the oldest of the antimetabolite class of anticancer agents and were one of the first modern anticancer drugs.  The first clin. useful antifolate, described in 1947, was 2,4-diamino-pteroylglutamate (4-amino-folic acid; aminopterin; AMT) which yielded the first-ever remissions in childhood leukemia.  AMT was soon superseded by its 10-Me congener, methotrexate (MTX), based on toxicity considerations; MTX remains, with one limited exception, the only antifolate anticancer agent in clin. use to this date.  Because of the safety and utility of MTX, considerable effort has been invested in attempting to design more therapeutically selective antifolates or antifolates with a wider tumor spectrum.  Initially, the design was based on the burgeoning knowledge of folate-dependent pathways and the determinants of the mechanism of action of MTX.  These determinants include transport, the tight-binding inhibition of its target (the folate-dependent enzyme dihydrofolate reductase (DHFR)), and metab. of MTX to poly-Î³-glutamate (Glun) metabolites.  These early studies led to the development of other antifolate DHFR inhibitors of two types: (1) "classical" analogs that use the same cellular transport systems as MTX and are also metabolized to Glun; and (2) "nonclassical" (i.e., lipophilic) analogs that do not require transport systems and that are not metabolized to Glun.  Although several of these analogs have undergone clin. trial, none is proved superior to MTX.  Detailed examn. of the mechanisms of cytotoxicity and selectivity of MTX showed that inhibition of both dTMP synthesis and de novo purine synthesis, secondary to DHFR inhibition, led to DNA synthesis inhibition and subsequent cell death; inhibition of other folate-dependent pathways did not appear necessary for cell death.  Further studies showed that the contribution of inhibition of dTMP or purine synthesis to cell death varied in different cell types.  These data suggested that inhibition of one of these pathways individually might (at least in some cases) be therapeutically superior to the dual inhibition induced by MTX.  Thus in rational design and in structure-based design studies, two new classes of antifolate enzyme inhibitors were elaborated-direct inhibitors of thymidylate synthase (TMPS) and direct inhibitors of one or both of the two folate-dependent enzymes of de novo purine synthesis.  Members of each class included both classical and nonclassical types.  After preclin. evaluation, several of these have moved into clin. trials.  To date only one new TMPS inhibitor has successfully completed clin. trials and been approved for routine use; this drug, Tomudex (D1694, raltitrexed) is currently approved only in Europe and only for the treatment of colon cancer.  This still represents a step forward for antifolates, however, since MTX is well-known to be ineffective in colon cancer; thus Tomudex extends the tumor range of antifolates.  Antifolate development continues.  Based on the immense body of knowledge now extant on antifolates, specific aspects of the mechanism of action have been the focus.  Newer antifolates have been described that inhibit more than one pathway in folate metab., that have improved delivery, or that inhibit other targets in folate metab.  These new analogs are in various stages of preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGwUdwGzF0rVg90H21EOLACvtfcHk0lh1eF-wd7VwgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D&md5=3e9aef8e71a32144ad5bcb661df3fa47</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1381612033453712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033453712%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26atitle%3DAnticancer%2520antifolates%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D2593%26epage%3D2613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Werkheiser, W. C.</span><span> </span><span class="NLM_article-title">Specific binding of 4-amino folic acid analogues by folic acid reductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">â</span> <span class="NLM_lpage">893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1961&pages=888-893&author=W.+C.+Werkheiser&title=Specific+binding+of+4-amino+folic+acid+analogues+by+folic+acid+reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWerkheiser%26aufirst%3DW.%2BC.%26atitle%3DSpecific%2520binding%2520of%25204-amino%2520folic%2520acid%2520analogues%2520by%2520folic%2520acid%2520reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1961%26volume%3D236%26spage%3D888%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaumont, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baugh, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, B. T.</span><span> </span><span class="NLM_article-title">Interaction of polyglutamyl derivatives of methotrexate, 10-deazaaminopterin, and dihydrofolate with dihydrofolate reductase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5020</span><span class="NLM_x">â</span> <span class="NLM_lpage">5023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=5020-5023&author=P.+Kumarauthor=R.+L.+Kisliukauthor=Y.+Gaumontauthor=M.+G.+Nairauthor=C.+M.+Baughauthor=B.+T.+Kaufman&title=Interaction+of+polyglutamyl+derivatives+of+methotrexate%2C+10-deazaaminopterin%2C+and+dihydrofolate+with+dihydrofolate+reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26aulast%3DGaumont%26aufirst%3DY.%26aulast%3DNair%26aufirst%3DM.%2BG.%26aulast%3DBaugh%26aufirst%3DC.%2BM.%26aulast%3DKaufman%26aufirst%3DB.%2BT.%26atitle%3DInteraction%2520of%2520polyglutamyl%2520derivatives%2520of%2520methotrexate%252C%252010-deazaaminopterin%252C%2520and%2520dihydrofolate%2520with%2520dihydrofolate%2520reductase%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D5020%26epage%3D5023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Allegra, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodbard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivet, J.</span><span> </span><span class="NLM_article-title">Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">9720</span><span class="NLM_x">â</span> <span class="NLM_lpage">9726</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=2410416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaL2MXltlCltL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=9720-9726&author=C.+J.+Allegraauthor=B.+A.+Chabnerauthor=J.+C.+Drakeauthor=R.+Lutzauthor=D.+Rodbardauthor=J.+Jolivet&title=Enhanced+inhibition+of+thymidylate+synthase+by+methotrexate+polyglutamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates</span></div><div class="casAuthors">Allegra, Carmen J.; Chabner, Bruce A.; Drake, James C.; Lutz, Rudolf; Rodbard, David; Jolivet, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9720-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The effects of methotrexate (MTX-Glu1)  [59-05-2] and the polyglutamate derivs. of methotrexate (MTXPGs) on the catalytic activity of thymidylate synthase  [9031-61-2] purified from MCF-7 human breast cancer cells and on the kinetics of the ternary complex formation by 5-fluoro-2'-deoxyuridine 5'-monophosphate  [134-46-3], folate cofactor, and thymidylate synthase were studied.  MTX-Glu1 exhibited uncompetitive inhibition of thymidylate synthase when reaction kinetics were analyzed by either double reciprocal plots or a computerized math. model based on nonlinear least-squares curve fitting.  The Ki for MTX-Glu1 inhibition was 13 Î¼M and the I50 was 22 Î¼M, irresp. of the degree of polyglutamation of the folate.  In contrast, the polyglutamated derivs. of MTX all acted as noncompetitive inhibitors.  The MTXPGs had 75-300-fold greater potency than MTX-Glu1 as inhibitors of thymidylate synthase catalytic activity, with K1 values from 0.17 to 0.047 Î¼M for MTX-Glu2 to MTX-Glu5  [80801-53-2], resp.  Neither MTX-Glu1 nor MTXPGs promoted the formation of a charcoal-stable ternary complex with thymidylate synthase and 5-fluoro-2'-deoxyuridine 5'-monophosphate CH2-H4PteGlu5  [98258-47-0] (where PteGlu represents pteroylglutamic acid) was 40-fold more potent than CH2-H4PteGlu1  [5786-82-3] in participating in the formation of a ternary complex, and 10 Î¼M MTX-Glu5 inhibited the formation of a ternary complex contg. this folate as cofactor.  The inhibition was detd. to be due to a redn. in the kon.  The potency of this inhibition was markedly greater in the presence of CH2-H4PteGlu1 as compared to CH2-H4PteGlu5.  This finding suggests that the degree of interference with complex formation in intact cells would depend on the state of polyglutamation of available folate cofactor.  Ternary complex formation with H2PteGlu5 as the folate cofactor was also investigated, and a 50% redn. in complex formation was found in the presence of a 2 Î¼M concn. of MTX-Glu5.  These findings have significant implications regarding the mechanism of action of MTX-Glu1 and contribute to an understanding of the complex interactions of MTX-Glu1 and 5-fluorouracil  [51-21-8].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzNfRBATHwE7Vg90H21EOLACvtfcHk0lhx6Da0S0TGEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltlCltL8%253D&md5=fa585e8ce3144af2a0f8032bb99ac9a2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DLutz%26aufirst%3DR.%26aulast%3DRodbard%26aufirst%3DD.%26aulast%3DJolivet%26aufirst%3DJ.%26atitle%3DEnhanced%2520inhibition%2520of%2520thymidylate%2520synthase%2520by%2520methotrexate%2520polyglutamates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D9720%26epage%3D9726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Allegra, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B. A.</span><span> </span><span class="NLM_article-title">Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">4881</span><span class="NLM_x">â</span> <span class="NLM_lpage">4885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1073%2Fpnas.82.15.4881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=3860829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaL2MXltFGrt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=4881-4885&author=C.+J.+Allegraauthor=J.+C.+Drakeauthor=J.+Jolivetauthor=B.+A.+Chabner&title=Inhibition+of+phosphoribosylaminoimidazolecarboxamide+transformylase+by+methotrexate+and+dihydrofolic+acid+polyglutamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates</span></div><div class="casAuthors">Allegra, Carmen J.; Drake, James C.; Jolivet, Jacques; Chabner, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4881-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The enhanced inhibitory potency of methotrexate polyglutamate (MTX polyglutamate)  [82334-40-5] and dihydrofolate pentaglutamate  [98204-33-2] on the catalytic activity of phosphoribosylaminoimidazolecarboxamide transformylase (AICAR transformylase)  [9032-03-5] purified from MCF-7 human breast cancer cells was detd.  MTX  [59-05-2] and dihydrofolate  [4033-27-6] both monoglutamates, were weak competitive inhibitors of AICAR transformylase with Ki of 143 and 63 Î¼M, resp., and their inhibitory capacity was largely unaffected by the glutamated state of the folate cosubstrate.  In contrast, MTX polyglutamates were potent competitive inhibitors, with an â10-fold increase in inhibitory potency with the addn. of each glutamate group up to 4 (i.e., the pentaglutamate deriv.  [80801-53-2]).  MTX tetraglutamate  [80801-54-3] and MTX pentaglutamates were the most potent, with equiv. Kis of 5.6 Ã 10-8 M; they were 2500-fold more potent than MTX.  Dihydrofolate pentaglutamate was as potent an inhibitor as MTX pentaglutamate, with a Ki of 4.3 Ã 10-8 M.  The potent inhibitory effects demonstrated by the polyglutamate compds., when tested against the folate monoglutamate substrate were sharply curtailed when folate pentaglutamate was used as the substrate.  MTX and dehydrofolate pentaglutamates were only 7- and 25-fold more potent than their monoglutamate counterparts under these conditions.  A model depicting these complex interactions is postulated.  These findings have significant implications regarding the antitumor mechanism of action of MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdj6Jb-DzFrVg90H21EOLACvtfcHk0lhx6Da0S0TGEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltFGrt7k%253D&md5=2e89e65beda64b5972a7dd689b928311</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.15.4881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.15.4881%26sid%3Dliteratum%253Aachs%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DJolivet%26aufirst%3DJ.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520phosphoribosylaminoimidazolecarboxamide%2520transformylase%2520by%2520methotrexate%2520and%2520dihydrofolic%2520acid%2520polyglutamates%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1985%26volume%3D82%26spage%3D4881%26epage%3D4885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Heidelberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danneberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesbach, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duschinsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitzer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleven, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiner, J.</span><span> </span><span class="NLM_article-title">Fluorinated pyrimidines, a new class of tumour-inhibitory compounds</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2F179663a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=13418758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaG1cXislyn" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1957&pages=663-666&author=C.+Heidelbergerauthor=N.+K.+Chaudhuriauthor=P.+Dannebergauthor=D.+Moorenauthor=L.+Griesbachauthor=R.+Duschinskyauthor=R.+J.+Schnitzerauthor=E.+Plevenauthor=J.+Scheiner&title=Fluorinated+pyrimidines%2C+a+new+class+of+tumour-inhibitory+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated pyrimidines, a new class of tumor-inhibitory compounds</span></div><div class="casAuthors">Heidelberger, Charles; Chaudhuri, N. K.; Danneberg, Peter; Mooren, Dorothy; Griesbach, Lois; Duschinsky, Robert; Schnitzer, R. J.; Pleven, E.; Scheiner, J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">663-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">5-Fluorouracil (I) and 5-fluoro.ovrddot.orotic acid (II) have demonstrated growth-inhibitory activity against the following transplanted tumors in rats and mice: Flexner-Jobling carcinoma, Walker 256 carcinosarcoma, Yoshida ascites tumor, Shay's chloroleukemia, sarcoma 180, Ehrlich ascites carcinoma, L-1210 leukemia, EO771, mammary adenocarcinoma 755, and sarcoma A-1.  Where compared in solid tumors, I was more effective than II and a more pronounced effect was observed with repeated rather than single doses.  With the L-1210 leukemia II gave a consistently greater prolongation of life than I.  A combination of equal quantities of I and 6-mercaptopurine showed a synergistic effect against transplanted tumors.  I also exhibited marked in vitro antimicrobial activity.  Against Proteus vulgaris activity was half that of streptomycin.  Radioactive tracer studies with mice indicated that I was incorporated into the nucleic acids as such.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn21WsyVXk3rVg90H21EOLACvtfcHk0lhx6Da0S0TGEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXislyn&md5=f6f48dd10339e9ec06dbcb2fb7834d99</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F179663a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F179663a0%26sid%3Dliteratum%253Aachs%26aulast%3DHeidelberger%26aufirst%3DC.%26aulast%3DChaudhuri%26aufirst%3DN.%2BK.%26aulast%3DDanneberg%26aufirst%3DP.%26aulast%3DMooren%26aufirst%3DD.%26aulast%3DGriesbach%26aufirst%3DL.%26aulast%3DDuschinsky%26aufirst%3DR.%26aulast%3DSchnitzer%26aufirst%3DR.%2BJ.%26aulast%3DPleven%26aufirst%3DE.%26aulast%3DScheiner%26aufirst%3DJ.%26atitle%3DFluorinated%2520pyrimidines%252C%2520a%2520new%2520class%2520of%2520tumour-inhibitory%2520compounds%26jtitle%3DNature%26date%3D1957%26volume%3D179%26spage%3D663%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Rutman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantarow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschkis, K. E.</span><span> </span><span class="NLM_article-title">Studies in 2-acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=13126946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaG2cXmvV2gtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1954&pages=119-123&author=R.+J.+Rutmanauthor=A.+Cantarowauthor=K.+E.+Paschkis&title=Studies+in+2-acetylaminofluorene+carcinogenesis.+III.+The+utilization+of+uracil-2-C14+by+preneoplastic+rat+liver+and+rat+hepatoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">2-Acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma</span></div><div class="casAuthors">Rutman, Robert J.; Cantarow, Abraham; Paschkis, Karl E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1954</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-23</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">During the process of liver carcinogenesis by I (preneoplastic liver and hepatoma), exogenous uracil-2-C14 (IV) was utilized for nucleic acid formation, although no such utilization occurred in normal rats.  IV was an effective precursor of uridylic acid, but not of the purine nucleotides.  IV did not serve as a precursor of the deoxypentose pyrimidine nucleotides in either preneoplastic liver or hepatoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp468flHH4m47Vg90H21EOLACvtfcHk0lhx6Da0S0TGEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXmvV2gtQ%253D%253D&md5=61db9fcd3cb74bdc2eca4e7859b54cc4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRutman%26aufirst%3DR.%2BJ.%26aulast%3DCantarow%26aufirst%3DA.%26aulast%3DPaschkis%26aufirst%3DK.%2BE.%26atitle%3DStudies%2520in%25202-acetylaminofluorene%2520carcinogenesis.%2520III.%2520The%2520utilization%2520of%2520uracil-2-C14%2520by%2520preneoplastic%2520rat%2520liver%2520and%2520rat%2520hepatoma%26jtitle%3DCancer%2520Res.%26date%3D1954%26volume%3D14%26spage%3D119%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHenry, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, H.</span><span> </span><span class="NLM_article-title">Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00700a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1974&pages=471-481&author=D.+V.+Santiauthor=C.+S.+McHenryauthor=H.+Sommer&title=Mechanism+of+interaction+of+thymidylate+synthetase+with+5-fluorodeoxyuridylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi00700a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00700a012%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DMcHenry%26aufirst%3DC.%2BS.%26aulast%3DSommer%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520interaction%2520of%2520thymidylate%2520synthetase%2520with%25205-fluorodeoxyuridylate%26jtitle%3DBiochemistry%26date%3D1974%26volume%3D13%26spage%3D471%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">The role of thymidylate synthase in cellular regulation</span> <span class="citation_source-journal">Adv Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1996&pages=143-163&author=E.+Chuauthor=C.+J.+Allegra&title=The+role+of+thymidylate+synthase+in+cellular+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520role%2520of%2520thymidylate%2520synthase%2520in%2520cellular%2520regulation%26jtitle%3DAdv%2520Enzyme%2520Regul.%26date%3D1996%26volume%3D36%26spage%3D143%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elwood, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">8977</span><span class="NLM_x">â</span> <span class="NLM_lpage">8981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=8977-8981&author=E.+Chuauthor=D.+M.+Koellerauthor=J.+L.+Caseyauthor=J.+C.+Drakeauthor=B.+A.+Chabnerauthor=P.+C.+Elwoodauthor=S.+Zinnauthor=C.+J.+Allegra&title=Autoregulation+of+human+thymidylate+synthase+messenger+RNA+translation+by+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DKoeller%26aufirst%3DD.%2BM.%26aulast%3DCasey%26aufirst%3DJ.%2BL.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DElwood%26aufirst%3DP.%2BC.%26aulast%3DZinn%26aufirst%3DS.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DAutoregulation%2520of%2520human%2520thymidylate%2520synthase%2520messenger%2520RNA%2520translation%2520by%2520thymidylate%2520synthase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D8977%26epage%3D8981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen-Lane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Regulation of p53 expression by thymidylate synthase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">â</span> <span class="NLM_lpage">3774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=3769-3774&author=J.+Juauthor=J.+Pedersen-Laneauthor=F.+Maleyauthor=E.+Chu&title=Regulation+of+p53+expression+by+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DPedersen-Lane%26aufirst%3DJ.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DRegulation%2520of%2520p53%2520expression%2520by%2520thymidylate%2520synthase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D3769%26epage%3D3774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takechi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">â</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1128%2FMCB.15.1.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=7799924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK2MXislamsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=179-185&author=E.+Chuauthor=T.+Takechiauthor=K.+L.+Jonesauthor=D.+M.+Voellerauthor=S.+M.+Copurauthor=G.+F.+Maleyauthor=F.+Maleyauthor=S.+Segalauthor=C.+J.+Allegra&title=Thymidylate+synthase+binds+to+c-myc+RNA+in+human+colon+cancer+cells+and+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro</span></div><div class="casAuthors">Chu, Edward; Takechi, Teiji; Jones, Kristen L.; Voeller, Donna M.; Copur, Sitki M.; Maley, Gladys F.; Maley, Frank; Segal, Shoshana; Allegra, Carmen J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-85</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Using an immunopptn.-reverse transcription-PCR technique, the authors characterized a thymidylate synthase (TS) ribonucleoprotein complex in cultured human colon cancer cells that consists of TS protein and the mRNA of the nuclear oncogene c-myc.  TS protein is complexed in intact cells with the C-terminal coding region of c-myc mRNA that includes nucleotide positions 1625 to 1790.  RNA electrophoretic gel mobility shift assays confirm a specific interaction between TS protein and c-myc mRNA and provide addnl. evidence that the C-terminal coding region represents an important cis-acting regulatory element.  Further evidence demonstrates that the in vitro translational efficiency of c-myc mRNA is inhibited as a result of its direct interaction with TS protein.  In addn., the presence of exogenous c-myc mRNA specifically relieves the inhibitory effects of TS protein on TS mRNA translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVjwYx4fwcbVg90H21EOLACvtfcHk0liXTzxqPAw5OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislamsbc%253D&md5=100a67320c658ed4519e13198b26d1e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.15.1.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.15.1.179%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DTakechi%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DCopur%26aufirst%3DS.%2BM.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DSegal%26aufirst%3DS.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThymidylate%2520synthase%2520binds%2520to%2520c-myc%2520RNA%2520in%2520human%2520colon%2520cancer%2520cells%2520and%2520in%2520vitro%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1995%26volume%3D15%26spage%3D179%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Identification of an RNA binding site for human thymidylate synthase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">â</span> <span class="NLM_lpage">521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=517-521&author=E.+Chuauthor=D.+Voellerauthor=D.+M.+Koellerauthor=J.+C.+Drakeauthor=C.+H.+Takimotoauthor=G.+F.+Maleyauthor=F.+Maleyauthor=C.+J.+Allegra&title=Identification+of+an+RNA+binding+site+for+human+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DVoeller%26aufirst%3DD.%26aulast%3DKoeller%26aufirst%3DD.%2BM.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DTakimoto%26aufirst%3DC.%2BH.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520RNA%2520binding%2520site%2520for%2520human%2520thymidylate%2520synthase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D517%26epage%3D521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsels, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">â</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1381-1389&author=X.+Linauthor=L.+A.+Parselsauthor=D.+M.+Voellerauthor=C.+J.+Allegraauthor=G.+F.+Maleyauthor=F.+Maleyauthor=E.+Chu&title=Characterization+of+a+cis-acting+regulatory+element+in+the+protein+coding+region+of+thymidylate+synthase+mRNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DParsels%26aufirst%3DL.%2BA.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DCharacterization%2520of%2520a%2520cis-acting%2520regulatory%2520element%2520in%2520the%2520protein%2520coding%2520region%2520of%2520thymidylate%2520synthase%2520mRNA%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D1381%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khleif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizunuma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1582</span><span class="NLM_x">â</span> <span class="NLM_lpage">1594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1128%2FMCB.19.2.1582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9891091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVKgs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=1582-1594&author=E.+Chuauthor=S.+M.+Copurauthor=J.+Juauthor=T.+M.+Chenauthor=S.+Khleifauthor=D.+M.+Voellerauthor=N.+Mizunumaauthor=M.+Patelauthor=G.+F.+Maleyauthor=F.+Maleyauthor=C.+J.+Allegra&title=Thymidylate+synthase+protein+and+p53+mRNA+form+an+in+vivo+ribonucleoprotein+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex</span></div><div class="casAuthors">Chu, Edward; Copur, Sitki M.; Ju, Jingfang; Chen, Tian-Men; Khleif, Samir; Voeller, Donna M.; Mizunuma, Nobuyuki; Patel, Mahendra; Maley, Gladys F.; Maley, Frank; Allegra, Carmen J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1582-1594</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A thymidylate synthase (TS)-ribonucleoprotein (RNP) complex composed of TS protein and the mRNA of the tumor suppressor gene p53 was isolated from cultured human colon cancer cells.  RNA gel shift assays confirmed a specific interaction between TS protein and the protein-coding region of p53 mRNA, and in vitro translation studies demonstrated that this interaction resulted in the specific repression of p53 mRNA translation.  To demonstrate the potential biol. role of the TS protein-p53 mRNA interaction, Western immunoblot anal. revealed nearly undetectable levels of p53 protein in TS-overexpressing human colon cancer H630-R10 and rat hepatoma H35(F/F) cell lines compared to the levels in their resp. parent H630 and H35 cell lines.  Polysome anal. revealed that the p53 mRNA was assocd. with higher-mol.-wt. polysomes in H35 cells compared to H35(F/F) cells.  While the level of p53 mRNA expression was identical in parent and TS-overexpressing cell lines, the level of p53 RNA bound to TS in the form of RNP complexes was significantly higher in TS-overexpressing cells.  The effect of TS on p53 expression was also investigated with human colon cancer RKO cells by use of a tetracycline-inducible system.  Treatment of RKO cells with a tetracycline deriv., doxycycline, resulted in 15-fold-induced expression of TS protein and nearly complete suppression of p53 protein expression.  However, p53 mRNA levels were identical in transfected RKO cells in the absence and presence of doxycycline.  Taken together, these findings suggest that TS regulates the expression of p53 at the translational level.  This study identifies a novel pathway for regulating p53 gene expression and expands current understanding of the potential role of TS as a regulator of cellular gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrosb2vurSeF7Vg90H21EOLACvtfcHk0lhr5EeV6Yf7Pw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVKgs7c%253D&md5=68eaf9eae69db31512211c7e9420acd1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.2.1582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.2.1582%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DCopur%26aufirst%3DS.%2BM.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%2BM.%26aulast%3DKhleif%26aufirst%3DS.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DMizunuma%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThymidylate%2520synthase%2520protein%2520and%2520p53%2520mRNA%2520form%2520an%2520in%2520vivo%2520ribonucleoprotein%2520complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D1582%26epage%3D1594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rahman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac-Kaye, M.</span><span> </span><span class="NLM_article-title">Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=341-351&author=L.+Rahmanauthor=D.+Voellerauthor=M.+Rahmanauthor=S.+Lipkowitzauthor=C.+Allegraauthor=J.+C.+Barrettauthor=F.+J.+Kayeauthor=M.+Zajac-Kaye&title=Thymidylate+synthase+as+an+oncogene%3A+a+novel+role+for+an+essential+DNA+synthesis+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DL.%26aulast%3DVoeller%26aufirst%3DD.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DLipkowitz%26aufirst%3DS.%26aulast%3DAllegra%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DZajac-Kaye%26aufirst%3DM.%26atitle%3DThymidylate%2520synthase%2520as%2520an%2520oncogene%253A%2520a%2520novel%2520role%2520for%2520an%2520essential%2520DNA%2520synthesis%2520enzyme%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D341%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hasnat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichenkova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J.</span><span> </span><span class="NLM_article-title">Fluorescence spectroscopic and (19)F NMR studies of human thymidylate synthase with its cognate RNA</span> <span class="citation_source-journal">J. Biomol. Struct. Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">â</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1080%2F07391102.2007.10507174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17937487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7nO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=253-270&author=A.+Hasnatauthor=E.+Bichenkovaauthor=X.+Yuauthor=J.+R.+Arnoldauthor=J.+Fisherauthor=O.+Fedorovaauthor=J.+Andrews&title=Fluorescence+spectroscopic+and+%2819%29F+NMR+studies+of+human+thymidylate+synthase+with+its+cognate+RNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence spectroscopic and 19F NMR studies of human thymidylate synthase with its cognate RNA</span></div><div class="casAuthors">Hasnat, Abul; Bichenkova, Elena; Yu, Xuan; Arnold, J. R. P.; Fisher, Julie; Fedorova, Olga; Andrews, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-269</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Adenine Press</span>)
        </div><div class="casAbstract">In order to investigate the interaction between hTS protein and its cognate mRNA, a 29nt fragment of TS mRNA was synthesized.  This region has been suggested as a putative stem-loop involved in translational autoregulation.  The melting temp. of the 29ntRNA was 65 Â°C, suggesting that this region does indeed form a stem-loop.  Fluorescence spectroscopy was used to monitor the RNA: hTS protein interaction [dissocn. const. (Kd) 3.9 Â± 0.8 nM; stoichiometry of binding 1dimeric hTS: 1RNA].  When hTS was titrated against FdUMP, this gave the expected stoichiometry of 1dimeric hTS: 1.7 FdUMP but in the presence of the 29ntRNA, the stoichiometry of binding changed to 1dimeric hTS: 1RNA: 1FdUMP.  Expts. using methotrexate (MTX) gave a stoichiometry of 1dimeric hTS: 1MTX and in the presence of 29ntRNA, the stoichiometry was unchanged.  19F-NMR spectra of human TS: FdUMP complexes were found to be strikingly similar to analogous NMR spectra of complexes formed by L.casei TS and mouse TS.  In the presence of FdUMP, spectra exhibited two addnl. resonances (-1.50ppm and -34.4ppm).  The resonance at -1.50ppm represents non-covalently bound FdUMP, the peak at -34.4ppm represents covalently bound FdUMP.  The addn. of methotrexate to the binary TS-FdUMP complex caused a displacement of the internal equil., with only the covalently-bound form seen, and with a slightly disturbed 19F chem. shift (-36.5ppm).  Similar results were found when MTX was replaced by folinic or folic acid.  The addn. of 29ntRNA caused no changes to the 19F spectra of either the binary or ternary complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhsNo9DyATZ7Vg90H21EOLACvtfcHk0lgw72pOCklizg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7nO&md5=0fe6bd0c0a231ae0a92c35b2b2a46a1b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F07391102.2007.10507174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2007.10507174%26sid%3Dliteratum%253Aachs%26aulast%3DHasnat%26aufirst%3DA.%26aulast%3DBichenkova%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DArnold%26aufirst%3DJ.%2BR.%26aulast%3DFisher%26aufirst%3DJ.%26aulast%3DFedorova%26aufirst%3DO.%26aulast%3DAndrews%26aufirst%3DJ.%26atitle%3DFluorescence%2520spectroscopic%2520and%2520%252819%2529F%2520NMR%2520studies%2520of%2520human%2520thymidylate%2520synthase%2520with%2520its%2520cognate%2520RNA%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2007%26volume%3D25%26spage%3D253%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kitchens, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsthoefel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafique, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. G.</span><span> </span><span class="NLM_article-title">Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization. Implications for autoregulation of translation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">12544</span><span class="NLM_x">â</span> <span class="NLM_lpage">12547</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=12544-12547&author=M.+E.+Kitchensauthor=A.+M.+Forsthoefelauthor=Z.+Rafiqueauthor=H.+T.+Spencerauthor=F.+G.+Berger&title=Ligand-mediated+induction+of+thymidylate+synthase+occurs+by+enzyme+stabilization.+Implications+for+autoregulation+of+translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitchens%26aufirst%3DM.%2BE.%26aulast%3DForsthoefel%26aufirst%3DA.%2BM.%26aulast%3DRafique%26aufirst%3DZ.%26aulast%3DSpencer%26aufirst%3DH.%2BT.%26aulast%3DBerger%26aufirst%3DF.%2BG.%26atitle%3DLigand-mediated%2520induction%2520of%2520thymidylate%2520synthase%2520occurs%2520by%2520enzyme%2520stabilization.%2520Implications%2520for%2520autoregulation%2520of%2520translation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D12544%26epage%3D12547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Berger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. G.</span><span> </span><span class="NLM_article-title">Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=461-467&author=S.+H.+Bergerauthor=C.+H.+Jenhauthor=L.+F.+Johnsonauthor=F.+G.+Berger&title=Thymidylate+synthase+overproduction+and+gene+amplification+in+fluorodeoxyuridine-resistant+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DS.%2BH.%26aulast%3DJenh%26aufirst%3DC.%2BH.%26aulast%3DJohnson%26aufirst%3DL.%2BF.%26aulast%3DBerger%26aufirst%3DF.%2BG.%26atitle%3DThymidylate%2520synthase%2520overproduction%2520and%2520gene%2520amplification%2520in%2520fluorodeoxyuridine-resistant%2520human%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D1985%26volume%3D28%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Iacopetta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsaleh, H.</span><span> </span><span class="NLM_article-title">A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">â</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1054%2Fbjoc.2001.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11556832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1KisLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2001&pages=827-830&author=B.+Iacopettaauthor=F.+Grieuauthor=D.+Josephauthor=H.+Elsaleh&title=A+polymorphism+in+the+enhancer+region+of+the+thymidylate+synthase+promoter+influences+the+survival+of+colorectal+cancer+patients+treated+with+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil</span></div><div class="casAuthors">Iacopetta, B.; Grieu, F.; Joseph, D.; Elsaleh, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">High levels of thymidylate synthase (TS) expression have been assocd. with poor survival of colorectal cancer (CRC) patients to 5-fluorouracil (5-FU)-based chemotherapy.  Recent evidence suggests that a polymorphism within the enhancer region of the TS gene promoter can influence TS expression, with the triple repeat homozygote (3R/3R) being assocd. with significantly higher tumor TS levels than either the double repeat homozygote (2R/2R) or heterozygotes (2R/3R).  In the present study we investigated whether TS genotype was assocd. with the degree of survival benefit from chemotherapy in 221 Dukes' C stage CRC patients.  Patients with the 3R/3R polymorphism (n = 58, 26%) showed no significant long-term survival benefit from chemotherapy (RR = 0.62, 95% CI: 0.30-1.25, P = 0.18), whereas those with the 2R/2R or 2R/3R genotype (n = 163, 74%) showed significant gains in survival from this treatment (RR = 0.52, 95% CI: 0.52-0.82, P = 0.005).  These results demonstrate that a polymorphism within the TS gene, probably through its effect on TS expression levels, can influence the survival benefit obtained by CRC patients from 5-FU-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMYfvjISbY_LVg90H21EOLACvtfcHk0lgw72pOCklizg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1KisLY%253D&md5=ef22f00e4eff28aee5116d3e9a990dc4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.2001.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.2001.2007%26sid%3Dliteratum%253Aachs%26aulast%3DIacopetta%26aufirst%3DB.%26aulast%3DGrieu%26aufirst%3DF.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DElsaleh%26aufirst%3DH.%26atitle%3DA%2520polymorphism%2520in%2520the%2520enhancer%2520region%2520of%2520the%2520thymidylate%2520synthase%2520promoter%2520influences%2520the%2520survival%2520of%2520colorectal%2520cancer%2520patients%2520treated%2520with%25205-fluorouracil%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2001%26volume%3D85%26spage%3D827%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kawakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salonga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danenberg, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brabender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danenberg, P. V.</span><span> </span><span class="NLM_article-title">Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">4096</span><span class="NLM_x">â</span> <span class="NLM_lpage">4101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11751507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFShsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=4096-4101&author=K.+Kawakamiauthor=D.+Salongaauthor=J.+M.+Parkauthor=K.+D.+Danenbergauthor=H.+Uetakeauthor=J.+Brabenderauthor=K.+Omuraauthor=G.+Watanabeauthor=P.+V.+Danenberg&title=Different+lengths+of+a+polymorphic+repeat+sequence+in+the+thymidylate+synthase+gene+affect+translational+efficiency+but+not+its+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression</span></div><div class="casAuthors">Kawakami, Kazuyuki; Salonga, Dennis; Park, Ji Min; Danenberg, Kathleen D.; Uetake, Hiroyuki; Brabender, Jan; Omura, Kenji; Watanabe, Go; Danenberg, Peter V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4096-4101</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is a target enzyme of 5-fluorouracil.  Recently, the TS gene has been shown to contain a polymorphic tandem repeat sequence.  The aim of this study was to det. whether differences in the no. of tandem repeats could affect gene expression or mRNA translation.  We quantified TS mRNA isolated from 130 colorectal cancer tissues by real-time reverse transcription-PCR and TS protein in 92 available samples by the fluoro-dUMP binding assay.  These values were compared with TS genotypes of the samples detd. by a PCR assay.  There was no relation between TS genotype and mRNA expression level.  On the other hand, cancer tissues with the 3R/3R genotype had a significantly higher TS protein expression level than did those with the 2R/3R genotype.  These results suggest that the efficiency of TS mRNA translation is responsible for the genotype-dependent difference in TS protein expression.  Further anal. using TS 5'-untranslated region-luciferase reporter constructs showed that the RNA with the three-repeat sequence was translated three to four times more efficiently than that with two-repeat sequence.  From the results of both in vitro and in vivo study, we conclude that TS mRNA with a three-repeat sequence has greater translation efficiency than that with the two-repeat sequence.  The results provide the rationale for comprehensive usage of TS genotyping with quantitation of TS mRNA or TS protein to predict the patient's response to 5-fluorouracil-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8L7CZyv23dLVg90H21EOLACvtfcHk0ljZdVhiUAh-pw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFShsg%253D%253D&md5=c836f16aac25d4fd186db62de9183c43</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DSalonga%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DDanenberg%26aufirst%3DK.%2BD.%26aulast%3DUetake%26aufirst%3DH.%26aulast%3DBrabender%26aufirst%3DJ.%26aulast%3DOmura%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DG.%26aulast%3DDanenberg%26aufirst%3DP.%2BV.%26atitle%3DDifferent%2520lengths%2520of%2520a%2520polymorphic%2520repeat%2520sequence%2520in%2520the%2520thymidylate%2520synthase%2520gene%2520affect%2520translational%2520efficiency%2520but%2520not%2520its%2520gene%2520expression%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D4096%26epage%3D4101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Marsh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, H. L.</span><span> </span><span class="NLM_article-title">Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">â</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11445856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslSmtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=383-386&author=S.+Marshauthor=J.+A.+McKayauthor=J.+Cassidyauthor=H.+L.+McLeod&title=Polymorphism+in+the+thymidylate+synthase+promoter+enhancer+region+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer</span></div><div class="casAuthors">Marsh, Sharon; McKay, Judith A.; Cassidy, James; McLeod, Howard L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-386</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is an important target for chemotherapy drugs such as 5-fluorouracil and raltitrexed.  Over-expression of TS has been linked to chemotherapy resistance.  A polymorphic tandem repeat sequence in the 5' untranslated region (5'UTR) of the human TS gene (TSER) has been shown to influence TS expression.  The presence of a triple tandem repeat (TSER*3) increases in vitro TS expression compared to a double tandem repeat (TSER*2) and is assocd. with higher in vivo tumor TS activity.  The polymorphism of this promoter enhancer region has not been extensively studied in patients with cancer and may represent a possible mechanism of intrinsic resistance to TS inhibitors.  In this study, PCR anal. of genomic DNA from 121 patients with colorectal cancer demonstrated 29% of patients were homozygous for TSER*3, 16% were homozygous for TSER*2 and 55% were heterozygous.  In 44/45 microdissected tumors the TS enhancer genotype was identical between paired samples of colorectal tumor and normal tissue.  In 24 patients receiving a bolus/infusion 5-fluorouracil (5FU) regimen for metastatic colorectal cancer, 22% of non-responders to chemotherapy were homozygous for TSER*2 compared with 40% of responders.  Median survival dropped from 16 mo for homozygous TSER*2 to 12 mo for homozygous TSER*3.  This is consistent with previous studies where higher TS expression was assocd. with poor response to TS inhibitors.  Prospective anal. of the influence of the TS polymorphism on patient outcome is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogYmDCgryQmrVg90H21EOLACvtfcHk0ljZdVhiUAh-pw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslSmtLw%253D&md5=78ef25df7e88f511aa19ceb78676b5e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsh%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DJ.%2BA.%26aulast%3DCassidy%26aufirst%3DJ.%26aulast%3DMcLeod%26aufirst%3DH.%2BL.%26atitle%3DPolymorphism%2520in%2520the%2520thymidylate%2520synthase%2520promoter%2520enhancer%2520region%2520in%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2001%26volume%3D19%26spage%3D383%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lorenz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wescott, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnyder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinchuk, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Car, B. D.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1494</span><span class="NLM_x">â</span> <span class="NLM_lpage">1502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1016%2FS0301-472X%2899%2900087-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=10517490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1MXmslWmtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1494-1502&author=M.+Lorenzauthor=H.+S.+Slaughterauthor=D.+M.+Wescottauthor=S.+I.+Carterauthor=B.+Schnyderauthor=J.+E.+Dinchukauthor=B.+D.+Car&title=Cyclooxygenase-2+is+essential+for+normal+recovery+from+5-fluorouracil-induced+myelotoxicity+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice</span></div><div class="casAuthors">Lorenz, Meike; Slaughter, Helen S.; Wescott, Debra M.; Carter, Sherryann I.; Schnyder, Bruno; Dinchuk, Joseph E.; Car, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1494-1502</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Cyclooxygenase (COX) plays a key regulatory role in prostaglandin synthesis.  COX-2 is inducible and is the major isoform of inflammatory cells.  COX-2-deficient mice were shown to have normal basal hematopoiesis and hematol.  We hypothesized that COX-2 induction plays a role in the recovery phase of 5-fluorouracil (5-FU) induced bone marrow injury, because significant macrophage-driven phagocytic removal of necrotic debris and stromal cell reorganization of repopulating marrow occur after 5-FU induction of bone marrow necrosis.  Hematol. recovery was markedly delayed with moderately severe leukopenia, thrombocytopenia and reticulocytopenia compared to heterozygotes on day 8 or 12 in Cox-2-/- mice.  Mild anemia was present in 5-FU-treated Cox-2-/- and Cox-2+/- mice on days 8 and 12, which was more severe in Cox-2-/- mice.  Cox-2-/- mice had markedly decreased bone marrow cell counts per femur and reduced nos. of erythroid and myeloid colony-forming cells compared to heterozygote mice on days 8 and 12 post 5-FU.  Histol. examn. of 5-FU-treated Cox-2-/- mice revealed a failure to repopulate the intact marrow stroma with hematopoietic cells.  Accelerated erythropoiesis following phenylhydrazine-induced hemolytic anemia, however, was comparable between Cox-2-/- and Cox+/- mice, as were induced levels of renal erythropoietin mRNA.  COX-2 induction is likely a central event in the accelerated hematopoiesis following myelotoxic injury, because recovery from 5-FU-induced myeloablation is markedly impaired in Cox-2-/- mice but is normal after phenylhydrazine induction of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriiypcLAh867Vg90H21EOLACvtfcHk0ljZdVhiUAh-pw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslWmtbo%253D&md5=dc92a30f1e0a66a6b8091061fd339c11</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0301-472X%2899%2900087-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-472X%252899%252900087-9%26sid%3Dliteratum%253Aachs%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DSlaughter%26aufirst%3DH.%2BS.%26aulast%3DWescott%26aufirst%3DD.%2BM.%26aulast%3DCarter%26aufirst%3DS.%2BI.%26aulast%3DSchnyder%26aufirst%3DB.%26aulast%3DDinchuk%26aufirst%3DJ.%2BE.%26aulast%3DCar%26aufirst%3DB.%2BD.%26atitle%3DCyclooxygenase-2%2520is%2520essential%2520for%2520normal%2520recovery%2520from%25205-fluorouracil-induced%2520myelotoxicity%2520in%2520mice%26jtitle%3DExp.%2520Hematol.%26date%3D1999%26volume%3D27%26spage%3D1494%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Jackman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrap, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span> </span><span class="NLM_article-title">ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">31A</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">â</span> <span class="NLM_lpage">1282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31A&publication_year=1995&pages=1277-1282&author=A.+L.+Jackmanauthor=D.+C.+Farrugiaauthor=W.+Gibsonauthor=R.+Kimbellauthor=K.+R.+Harrapauthor=T.+C.+Stephensauthor=M.+Azabauthor=F.+T.+Boyle&title=ZD1694+%28Tomudex%29%3A+a+new+thymidylate+synthase+inhibitor+with+activity+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackman%26aufirst%3DA.%2BL.%26aulast%3DFarrugia%26aufirst%3DD.%2BC.%26aulast%3DGibson%26aufirst%3DW.%26aulast%3DKimbell%26aufirst%3DR.%26aulast%3DHarrap%26aufirst%3DK.%2BR.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26aulast%3DAzab%26aufirst%3DM.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26atitle%3DZD1694%2520%2528Tomudex%2529%253A%2520a%2520new%2520thymidylate%2520synthase%2520inhibitor%2520with%2520activity%2520in%2520colorectal%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1995%26volume%3D31A%26spage%3D1277%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rafi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvete, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clendeninn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span> </span><span class="NLM_article-title">Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">â</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9508200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1cXitVKit7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=1131-1141&author=I.+Rafiauthor=A.+V.+Boddyauthor=J.+A.+Calveteauthor=G.+A.+Taylorauthor=D.+R.+Newellauthor=N.+P.+Baileyauthor=M.+J.+Lindauthor=M.+Greenauthor=J.+Hinesauthor=A.+Johnstoneauthor=N.+Clendeninnauthor=A.+H.+Calvert&title=Preclinical+and+phase+I+clinical+studies+with+the+nonclassical+antifolate+thymidylate+synthase+inhibitor+nolatrexed+dihydrochloride+given+by+prolonged+administration+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors</span></div><div class="casAuthors">Rafi, Imran; Boddy, Alan V.; Calvete, Joanne A.; Taylor, Gordon A.; Newell, David R.; Bailey, Nigel P.; Lind, Michael J.; Green, Mark; Hines, John; Johnstone, Amanda; Clendeninn, Neil; Calvert, A. Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1131-1141</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A phase I, multicenter trial of the thymidylate synthase (TS) inhibitor THYMITAQ (nolatrexed dihydrochloride; Agouron Pharmaceuticals, Inc, San Diego, CA) given by 5-day continuous infusion was performed to establish the max.-tolerated dose (MTD) and to investigate pharmacokinetics, pharmaco-dynamics, and antitumor effects.  In vitro and in vivo preclin. studies demonstrated increased activity with prolonged nolatrexed exposure.  In 32 patients, nolatrexed was given as a 5-day infusion at 96 to 1,040 mg/m2/d for 5 days.  Pharmacokinetics were detd. from high-performance liq. chromatog. (HPLC) analyses of plasma and urine.  In addn. to studying toxicity, plasma deoxyuridine (UdR) elevations were measured as a marker of TS inhibition.  The MTD was 904 mg/m2/d for 5 days and the recommended phase II dose is 800 mg/m2/d for 5 days.  The dose-limiting toxicity was neutropenia with clin. significant thrombocytopenia and mucositis.  These antiproliferative toxicities of nolatrexed were predictable and reversible.  A partial response that lasted 3 mo occurred in a patient with metastatic colorectal cancer.  Pharmacokinetics were nonlinear, with the median plasma clearance (Cl) decreasing from 151 mL/min/m2 (range, 124 to 211) at 96 mg/m2/d for 5 days to 49 mL/min/m2 (range, 30 to 84) at 768 mg/m2/d for 5 days.  The half-life (t1/2) was 173 min (range, 43 to 784) and 18% (range, 9% to 35%) of the dose was excreted unchanged in the urine.  Plasma UdR increased, but returned to pretreatment levels after the end of infusion.  Hematol. toxicity was significantly related to nolatrexed plasma concns. and dose.  Nolatrexed can be safely administered to patients at a dose of 800 mg/m2/d over 5 days by continuous i.v. infusion and this schedule is assocd. with antitumor effects.  The phase II evaluation of nolatrexed is ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9u49TpGLuorVg90H21EOLACvtfcHk0ljZd1mrPFyBuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitVKit7s%253D&md5=ef6a7787d20b95e4b17585de5e8f2fff</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRafi%26aufirst%3DI.%26aulast%3DBoddy%26aufirst%3DA.%2BV.%26aulast%3DCalvete%26aufirst%3DJ.%2BA.%26aulast%3DTaylor%26aufirst%3DG.%2BA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DBailey%26aufirst%3DN.%2BP.%26aulast%3DLind%26aufirst%3DM.%2BJ.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DJohnstone%26aufirst%3DA.%26aulast%3DClendeninn%26aufirst%3DN.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26atitle%3DPreclinical%2520and%2520phase%2520I%2520clinical%2520studies%2520with%2520the%2520nonclassical%2520antifolate%2520thymidylate%2520synthase%2520inhibitor%2520nolatrexed%2520dihydrochloride%2520given%2520by%2520prolonged%2520administration%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1998%26volume%3D16%26spage%3D1131%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Miwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umeda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitsuka, H.</span><span> </span><span class="NLM_article-title">Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">â</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=1274-1281&author=M.+Miwaauthor=M.+Uraauthor=M.+Nishidaauthor=N.+Sawadaauthor=T.+Ishikawaauthor=K.+Moriauthor=N.+Shimmaauthor=I.+Umedaauthor=H.+Ishitsuka&title=Design+of+a+novel+oral+fluoropyrimidine+carbamate%2C+capecitabine%2C+which+generates+5-fluorouracil+selectively+in+tumours+by+enzymes+concentrated+in+human+liver+and+cancer+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiwa%26aufirst%3DM.%26aulast%3DUra%26aufirst%3DM.%26aulast%3DNishida%26aufirst%3DM.%26aulast%3DSawada%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DUmeda%26aufirst%3DI.%26aulast%3DIshitsuka%26aufirst%3DH.%26atitle%3DDesign%2520of%2520a%2520novel%2520oral%2520fluoropyrimidine%2520carbamate%252C%2520capecitabine%252C%2520which%2520generates%25205-fluorouracil%2520selectively%2520in%2520tumours%2520by%2520enzymes%2520concentrated%2520in%2520human%2520liver%2520and%2520cancer%2520tissue%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1998%26volume%3D34%26spage%3D1274%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hardy, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer-Moore, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montfort, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span> </span><span class="NLM_article-title">Atomic structure of thymidylate synthase: target for rational drug design</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">â</span> <span class="NLM_lpage">455</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=448-455&author=L.+W.+Hardyauthor=J.+S.+Finer-Mooreauthor=W.+R.+Montfortauthor=M.+O.+Jonesauthor=D.+V.+Santiauthor=R.+M.+Stroud&title=Atomic+structure+of+thymidylate+synthase%3A+target+for+rational+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DL.%2BW.%26aulast%3DFiner-Moore%26aufirst%3DJ.%2BS.%26aulast%3DMontfort%26aufirst%3DW.%2BR.%26aulast%3DJones%26aufirst%3DM.%2BO.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DAtomic%2520structure%2520of%2520thymidylate%2520synthase%253A%2520target%2520for%2520rational%2520drug%2520design%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D448%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Longley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span> </span><span class="NLM_article-title">5-Fluorouracil: mechanisms of action and clinical strategies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">â</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2Fnrc1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12724731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlals70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=330-338&author=D.+B.+Longleyauthor=D.+P.+Harkinauthor=P.+G.+Johnston&title=5-Fluorouracil%3A+mechanisms+of+action+and+clinical+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">5-Fluorouracil: mechanisms of action and clinical strategies</span></div><div class="casAuthors">Longley, Daniel B.; Harkin, D. Paul; Johnston, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">330-338</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  5-Fluorouracil (5-FU) is widely used in the treatment of cancer.  Over the past 20 yr, increased understanding of the mechanism of action of 5-FU has led to the development of strategies that increase its anticancer activity.  Despite these advances, drug resistance remains a significant limitation to the clin. use of 5-FU.  Emerging technologies, such as DNA microarray profiling, have the potential to identify novel genes that are involved in mediating resistance to 5-FU.  Such target genes might prove to be therapeutically valuable as new targets for chemotherapy, or as predictive biomarkers of response to 5-FU-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnuu833TFVrVg90H21EOLACvtfcHk0linPv9t_agxrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlals70%253D&md5=79095f6753c79f281bc9548c9c1c8bd5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrc1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1074%26sid%3Dliteratum%253Aachs%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DHarkin%26aufirst%3DD.%2BP.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3D5-Fluorouracil%253A%2520mechanisms%2520of%2520action%2520and%2520clinical%2520strategies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D330%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Reigner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidekamm, E.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics of capecitabine</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">â</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.2165%2F00003088-200140020-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11286326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislansrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=85-104&author=B.+Reignerauthor=K.+Bleschauthor=E.+Weidekamm&title=Clinical+pharmacokinetics+of+capecitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of capecitabine</span></div><div class="casAuthors">Reigner, Bruno; Blesch, Karen; Weidekamm, Erhard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-104</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 58 refs.  Capecitabine is a novel oral fluoropyrimidine carbamate that is preferentially converted to the cytotoxic moiety fluorouracil (5-fluorouracil; 5-FU) in target tumor tissue through a series of 3 metabolic steps.  After oral administration of 1250 mg/m2, capecitabine is rapidly and extensively absorbed from the gastrointestinal tract [with a time to reach peak concn. (tmax) of 2 h and peak plasma drug concn. (Cmax) of 3 to 4 mg/L] and has a relatively short elimination half-life (t1/2) [0.55 to 0.89h].  Recovery of drug-related material in urine and feces is nearly 100%.  Plasma concns. of the cytotoxic moiety fluorouracil are very low [with a Cmax of 0.22 to 0.31 mg/L and area under the concn.-time curve (AUC) of 0.461 to 0.698 mg â¢ h/L].  The apparent t1/2 of fluorouracil after capecitabine administration is similar to that of the parent compd.  Comparison of fluorouracil concns. in primary colorectal tumor and adjacent healthy tissues after capecitabine administration demonstrates that capecitabine is preferentially activated to fluorouracil in colorectal tumor, with the av. concn. of fluorouracil being 3.2-fold higher than in adjacent healthy tissue (p = 0.002).  This tissue concn. differential does not hold for liver metastasis, although concns. of fluorouracil in liver metastases are sufficient for antitumor activity to occur.  The tumor-preferential activation of capecitabine to fluorouracil is explained by tissue differences in the activity of cytidine deaminase and thymidine phosphorylase, key enzymes in the conversion process.  As with other cytotoxic drugs, the interpatient variability of the pharmacokinetic parameters of capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine and fluorouracil, is high (27 to 89%) and is likely to be primarily due to variability in the activity of the enzymes involved in capecitabine metab.  Capecitabine and the fluorouracil precursors 5'-deoxy-5-fluorocytidine and 5'-deoxy-5-fluorouridine do not accumulate significantly in plasma after repeated administration.  Plasma concns. of fluorouracil increase by 10 to 60% during long term administration, but this time-dependency is assumed to be not clin. relevant.  A potential drug interaction of capecitabine with warfarin has been obsd.  There is no evidence of pharmacokinetic interactions between capecitabine and leucovorin, docetaxel or paclitaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6-xy5Lm9HrVg90H21EOLACvtfcHk0linPv9t_agxrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislansrs%253D&md5=80bda92090968db47a7f67a42abc1c92</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2165%2F00003088-200140020-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200140020-00002%26sid%3Dliteratum%253Aachs%26aulast%3DReigner%26aufirst%3DB.%26aulast%3DBlesch%26aufirst%3DK.%26aulast%3DWeidekamm%26aufirst%3DE.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520capecitabine%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2001%26volume%3D40%26spage%3D85%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Gressett, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanford, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwicke, F.</span><span> </span><span class="NLM_article-title">Management of handâfoot syndrome induced by capecitabine</span> <span class="citation_source-journal">J. Oncol. Pharm. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1177%2F1078155206069242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17022868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSksrfL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=131-141&author=S.+M.+Gressettauthor=B.+L.+Stanfordauthor=F.+Hardwicke&title=Management+of+hand%E2%88%92foot+syndrome+induced+by+capecitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Management of hand-foot syndrome induced by capecitabine</span></div><div class="casAuthors">Gressett, Sarah M.; Stanford, Brad L.; Hardwicke, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Oncology Pharmacy Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-141</span>CODEN:
                <span class="NLM_cas:coden">JOPPFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-1552</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Capecitabine (Xeloda) is a systemic prodrug of 5-fluorouracil (5-FU), which is administered in an oral formulation.  Hand-foot syndrome (HFS) has proven to be a chronic dose-limiting toxicity of capecitabine, leading to significant morbidity in patients receiving this agent.  The purpose of this review is to define the pathophysiol., risk factors, incidence and management of capecitabine-induced HFS.  Literature for this review article was collected from the following databases: PubMed, CINAHL, and the proceedings of the American Society of Clin. Oncol. (ASCO) confined to the years 1995-2006.  The following key terms were used in the search: hand-foot syndrome, palmar-plantar erythrodysesthesia, capecitabine, Xeloda, colorectal cancer, and metastatic breast cancer.  HFS assocd. with capecitabine is a serious dose-limiting toxicity.  Incidence of grade 3/4 toxicity is of extreme significance, and introduces the need for dose redns. and/or interruptions in capecitabine therapy.  Drug-related therapies studied include topical emollients and creams, systemic and topical corticosteroids, nicotine patch, vitamin E, pyridoxine, and COX-2 inhibitors.  However, due to the lack of randomized, controlled trials with these therapies, the current mainstay of treatment for the management of this toxicity is interruption of therapy and, if necessary, dose redn.  Treatment interruption or dose redn. remain the only methods shown to effectively manage HFS, but supportive measures to reduce pain and discomfort and prevent secondary infection are very important.  Many other prophylactic and treatment strategies have been investigated, with pyridoxine and COX-2 inhibitors being the most promising in case reports and retrospective studies; therefore, prospective, randomized, controlled trials are needed to prove their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAkpNbAgrQdLVg90H21EOLACvtfcHk0linPv9t_agxrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSksrfL&md5=1fe11c88f027b20b1af1a4680488ac52</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1078155206069242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1078155206069242%26sid%3Dliteratum%253Aachs%26aulast%3DGressett%26aufirst%3DS.%2BM.%26aulast%3DStanford%26aufirst%3DB.%2BL.%26aulast%3DHardwicke%26aufirst%3DF.%26atitle%3DManagement%2520of%2520hand%25E2%2588%2592foot%2520syndrome%2520induced%2520by%2520capecitabine%26jtitle%3DJ.%2520Oncol.%2520Pharm.%2520Pract.%26date%3D2006%26volume%3D12%26spage%3D131%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hiller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuk, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lidak, M. Y.</span><span> </span><span class="NLM_article-title">Analogs of pyrimidine nucleosides. I. <i>N</i>1-(Î±-furanidyl) derivatives of natural pyrimidine bases and their antimetabolites</span> <span class="citation_source-journal">Dokl. Akad. Nauk Uzb. USSR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">â</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=1967&pages=332-335&author=S.+A.+Hillerauthor=R.+A.+Zhukauthor=M.+Y.+Lidak&title=Analogs+of+pyrimidine+nucleosides.+I.+N1-%28%CE%B1-furanidyl%29+derivatives+of+natural+pyrimidine+bases+and+their+antimetabolites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DS.%2BA.%26aulast%3DZhuk%26aufirst%3DR.%2BA.%26aulast%3DLidak%26aufirst%3DM.%2BY.%26atitle%3DAnalogs%2520of%2520pyrimidine%2520nucleosides.%2520I.%2520N1-%2528%25CE%25B1-furanidyl%2529%2520derivatives%2520of%2520natural%2520pyrimidine%2520bases%2520and%2520their%2520antimetabolites%26jtitle%3DDokl.%2520Akad.%2520Nauk%2520Uzb.%2520USSR%26date%3D1967%26volume%3D176%26spage%3D332%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshisue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, Y.</span><span> </span><span class="NLM_article-title">Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4409</span><span class="NLM_x">â</span> <span class="NLM_lpage">4415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11106261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVSgu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=4409-4415&author=K.+Ikedaauthor=K.+Yoshisueauthor=E.+Matsushimaauthor=S.+Nagayamaauthor=K.+Kobayashiauthor=C.+A.+Tysonauthor=K.+Chibaauthor=Y.+Kawaguchi&title=Bioactivation+of+tegafur+to+5-fluorouracil+is+catalyzed+by+cytochrome+P-450+2A6+in+human+liver+microsomes+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of Tegafur to 5-fluorouracil is catalyzed by cytochrome P 450 2A6 in human liver microsomes in vitro</span></div><div class="casAuthors">Ikeda, Kazumasa; Yoshisue, Kunihiro; Matsushima, Eiji; Nagayama, Sekio; Kobayashi, Kaoru; Tyson, Charles A.; Chiba, Kan; Kawaguchi, Yasuro</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4409-4415</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tegafur is a prodrug of 5-fluorouracil (5-FU) consisting of a new class of oral chemotherapeutic agents, Tegafur/uracil and S-1, which are classified as dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines.  It is bioactivated to 5-FU via 5'-hydroxylation mediated by cytochrome P 450 (CYP).  However, which isoform(s) of CYP is responsible for the bioactivation process of Tegafur remains unclear.  The purpose of the present study was to identify the human CYP isoform(s) involved in the metabolic activation of Tegafur using human liver microsomes and cDNA-expressed human CYPs.  The formation of 5-FU from Tegafur in human liver microsomes showed bi-phase kinetics with Km and Vmax values for the high-affinity component of 0.43 Â± 0.05 mM and 4.02 Â± 1.70 nmol/mg/min (mean Â± SD, n = 4), resp.  In the correlation study using a panel of 10 human liver microsomes, the formation of 5-FU from Tegafur showed a significant correlation (r = 0.98; P < 0.001) with coumarin 7-hydroxylation, a marker activity of CYP2A6.  In addn., a specific substrate of CYP2A6 and anti-CYP2A6 antibody inhibited the formation of 5-FU by 90% in human liver microsomes.  Moreover, cDNA-expressed CYP2A6 showed the highest activity for the formation of 5-FU among 10 cDNA-expressed CYPs, with a Km value similar to that found for the high-affinity component in human liver microsomes.  These findings clearly suggest that CYP2A6 is a principal enzyme responsible for the bioactivation process of Tegafur in human liver microsomes.  However, to what extent the bioactivation of Tegafur by CYP2A6 accounts for the formation of 5-FU in vivo remains unclear, because the formation of 5-FU from Tegafur is also catalyzed by the sol. fraction of a 100,000 Ã g supernatant and also derived from spontaneous degrdn. of Tegafur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrixYHiy9fSb7Vg90H21EOLACvtfcHk0li29bQXbK-0FQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVSgu7k%253D&md5=b58a79ca070032ac1aa709285ca744f0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DYoshisue%26aufirst%3DK.%26aulast%3DMatsushima%26aufirst%3DE.%26aulast%3DNagayama%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DTyson%26aufirst%3DC.%2BA.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DKawaguchi%26aufirst%3DY.%26atitle%3DBioactivation%2520of%2520tegafur%2520to%25205-fluorouracil%2520is%2520catalyzed%2520by%2520cytochrome%2520P-450%25202A6%2520in%2520human%2520liver%2520microsomes%2520in%2520vitro%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D4409%26epage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikenaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirasaka, T.</span><span> </span><span class="NLM_article-title">Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents</span> <span class="citation_source-journal">Gann</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1979&pages=209-214&author=S.+Fujiiauthor=S.+Kitanoauthor=K.+Ikenakaauthor=T.+Shirasaka&title=Effect+of+coadministration+of+uracil+or+cytosine+on+the+anti-tumor+activity+of+clinical+doses+of+1-%282-tetrahydrofuryl%29-5-fluorouracil+and+level+of+5-fluorouracil+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DS.%26aulast%3DIkenaka%26aufirst%3DK.%26aulast%3DShirasaka%26aufirst%3DT.%26atitle%3DEffect%2520of%2520coadministration%2520of%2520uracil%2520or%2520cytosine%2520on%2520the%2520anti-tumor%2520activity%2520of%2520clinical%2520doses%2520of%25201-%25282-tetrahydrofuryl%2529-5-fluorouracil%2520and%2520level%2520of%25205-fluorouracil%2520in%2520rodents%26jtitle%3DGann%26date%3D1979%26volume%3D70%26spage%3D209%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Shirasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshimo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, M.</span><span> </span><span class="NLM_article-title">Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas</span> <span class="citation_source-journal">Jpn. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1093%2Fjjco%2Fhyn127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=19052037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FgsFehtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=2-15&author=T.+Shirasakaauthor=Y.+Shimamatoauthor=H.+Ohshimoauthor=M.+Yamaguchiauthor=T.+Katoauthor=K.+Yonekuraauthor=M.+Fukushima&title=Development+history+and+concept+of+an+oral+anticancer+agent+S-1+%28TS-1%29%3A+its+clinical+usefulness+and+future+vistas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas</span></div><div class="casAuthors">Shirasaka Tetsuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Japanese journal of clinical oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dushinsky et al. left a great gift to human beings with the discovery of 5-fluorouracil (5-FU).  Approximately 50 years have elapsed from that discovery to the development of S-1 (TS-1).  The concept of developing an anticancer agent that simultaneously possesses both efficacy-enhancing and adverse reaction-reducing effects could be achieved only with a three-component combination drug.  S-1 is an oral anticancer agent containing two biochemical modulators for 5-FU and tegafur (FT), a metabolically activated prodrug of 5-FU.  The first modulator, 5-chloro-2,4-dihydroxypyridine (CDHP), enhances the pharmacological actions of 5-FU by potently inhibiting its degradation.  The second modulator, potassium oxonate (Oxo), localizing in mucosal cells of the gastrointestinal (GI) tract after oral administration, reduces the incidence of GI toxicities by suppressing the activation of 5-FU in the GI tract.  Thus, S-1 combines FT, CDHP and Oxo at a molar ratio of 1:0.4:1.  In 1999-2007, S-1 was approved for the treatment of the following seven cancers: gastric, head and neck, colorectal, non-small cell lung, breast, pancreatic and biliary tract cancers. 'S-1 and low-dose cisplatin therapy' without provoking Grade 3 non-hematologic toxicities was proposed to enhance its clinical usefulness.  Furthermore, 'alternate-day S-1 regimen' may improve the dosing schedule for 5-FU by utilizing its strongly time-dependent mode of action; the former is characterized by the low incidences of myelotoxicity and non-hematologic toxicities (e.g. < or =Grade 1 anorexia, fatigue, stomatitis, nausea, vomiting and taste alteration).  These two approaches are considered to allow long-lasting therapy with S-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTD8YPu8Cz4JkNoizSOkG_FfW6udTcc2eYeWk4166Pn_7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FgsFehtg%253D%253D&md5=013a729ca0f7009b295eb630c9d977e2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fjjco%2Fhyn127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjjco%252Fhyn127%26sid%3Dliteratum%253Aachs%26aulast%3DShirasaka%26aufirst%3DT.%26aulast%3DShimamato%26aufirst%3DY.%26aulast%3DOhshimo%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYonekura%26aufirst%3DK.%26aulast%3DFukushima%26aufirst%3DM.%26atitle%3DDevelopment%2520history%2520and%2520concept%2520of%2520an%2520oral%2520anticancer%2520agent%2520S-1%2520%2528TS-1%2529%253A%2520its%2520clinical%2520usefulness%2520and%2520future%2520vistas%26jtitle%3DJpn.%2520J.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D39%26spage%3D2%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Shirasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshimo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, M.</span><span> </span><span class="NLM_article-title">Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators</span> <span class="citation_source-journal">Anti-Cancer drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">548</span><span class="NLM_x">â</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=548-557&author=T.+Shirasakaauthor=Y.+Shimamatoauthor=H.+Ohshimoauthor=M.+Yamaguchiauthor=T.+Katoauthor=K.+Yonekuraauthor=M.+Fukushima&title=Development+of+a+novel+form+of+an+oral+5-fluorouracil+derivative+%28S-1%29+directed+to+the+potentiation+of+the+tumor+selective+cytotoxicity+of+5-fluorouracil+by+two+biochemical+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShirasaka%26aufirst%3DT.%26aulast%3DShimamato%26aufirst%3DY.%26aulast%3DOhshimo%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DYonekura%26aufirst%3DK.%26aulast%3DFukushima%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520form%2520of%2520an%2520oral%25205-fluorouracil%2520derivative%2520%2528S-1%2529%2520directed%2520to%2520the%2520potentiation%2520of%2520the%2520tumor%2520selective%2520cytotoxicity%2520of%25205-fluorouracil%2520by%2520two%2520biochemical%2520modulators%26jtitle%3DAnti-Cancer%2520drugs%26date%3D1996%26volume%3D7%26spage%3D548%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Senter, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C. J.</span><span> </span><span class="NLM_article-title">Selective activation of anticancer prodrugs by monoclonal antibodyâenzyme conjugates</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=247-264&author=P.+D.+Senterauthor=C.+J.+Springer&title=Selective+activation+of+anticancer+prodrugs+by+monoclonal+antibody%E2%88%92enzyme+conjugates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSenter%26aufirst%3DP.%2BD.%26aulast%3DSpringer%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520anticancer%2520prodrugs%2520by%2520monoclonal%2520antibody%25E2%2588%2592enzyme%2520conjugates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D53%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Phelan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermeier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, C. A.</span><span> </span><span class="NLM_article-title">Design and synthesis of a beta-lactamase activated 5-fluorouracil prodrug</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">â</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1261-1263&author=R.+M.+Phelanauthor=M.+Ostermeierauthor=C.+A.+Townsend&title=Design+and+synthesis+of+a+beta-lactamase+activated+5-fluorouracil+prodrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhelan%26aufirst%3DR.%2BM.%26aulast%3DOstermeier%26aufirst%3DM.%26aulast%3DTownsend%26aufirst%3DC.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520beta-lactamase%2520activated%25205-fluorouracil%2520prodrug%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1261%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Gmeiner, W. H.</span><span> </span><span class="NLM_article-title">Novel chemical strategies for thymidylate synthase inhibition</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=15638735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=191-202&author=W.+H.+Gmeiner&title=Novel+chemical+strategies+for+thymidylate+synthase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Novel chemical strategies for thymidylate synthase inhibition</span></div><div class="casAuthors">Gmeiner, W. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Thymidylate synthase (TS) is a well-validated target for cancer chemotherapy.  TS was established as the principal target of the widely used anticancer drug 5-fluorouracil (5FU).  The 5FU metabolite FdUMP forms a covalent complex with TS that is stabilized by 5-formyl tetrahydrofolate (leucovorin; LV).  Numerous chem. strategies were employed to develop novel TS inhibitors that are superior to 5FU/LV.  5FU is non-ideal as a TS-inhibitory drug because it is only inefficiently converted to FdUMP, while the remainder of the administered dose is converted to toxic metabolites.  My lab. has explored the utility of FdUMP[N] compds. (oligodeoxynucleotides comprised of FdUMP nucleotides) as FdUMP pro-drugs.  FdUMP[N] compds. result in potent TS-inhibition, and display many advantages relative to 5FU/LV.  A no. of other chem. strategies were also employed to develop pro-drugs, or metabolic precursors of FdUMP, and several of these strategies will be reviewed.  In addn. to chem. strategies to develop FdUMP pro-drugs, a no. of chem. strategies were devised to develop mols. that resemble the reduced folate co-factor required for TS catalysis.  The synthesis of antifolates that have TS-inhibitory activity, such as Raltitrexed, has resulted in compds. that are effective and specific TS-inhibitors and, in some cases, have clin. potential.  Chem. strategies that target TS mRNA for destruction are also being explored as potential chemotherapeutics.  These diverse chem. approaches to control TS activity in tumor cells for the treatment of cancer will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaxbcmUD33u7Vg90H21EOLACvtfcHk0lipBtE-eV5XyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOqtA%253D%253D&md5=6901ee803f118d4500b2f5a96e322c9d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGmeiner%26aufirst%3DW.%2BH.%26atitle%3DNovel%2520chemical%2520strategies%2520for%2520thymidylate%2520synthase%2520inhibition%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lackey, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groziak, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beryt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegram, M.</span><span> </span><span class="NLM_article-title">Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">â</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=179-189&author=D.+B.+Lackeyauthor=M.+P.+Groziakauthor=M.+Sergeevaauthor=M.+Berytauthor=C.+Boyerauthor=R.+M.+Stroudauthor=P.+Sayreauthor=J.+W.+Parkauthor=P.+Johnstonauthor=D.+Slamonauthor=H.+M.+Shepardauthor=M.+Pegram&title=Enzyme-catalyzed+therapeutic+agent+%28ECTA%29+design%3A+activation+of+the+antitumor+ECTA+compound+NB1011+by+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DD.%2BB.%26aulast%3DGroziak%26aufirst%3DM.%2BP.%26aulast%3DSergeeva%26aufirst%3DM.%26aulast%3DBeryt%26aufirst%3DM.%26aulast%3DBoyer%26aufirst%3DC.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DSayre%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DJohnston%26aufirst%3DP.%26aulast%3DSlamon%26aufirst%3DD.%26aulast%3DShepard%26aufirst%3DH.%2BM.%26aulast%3DPegram%26aufirst%3DM.%26atitle%3DEnzyme-catalyzed%2520therapeutic%2520agent%2520%2528ECTA%2529%2520design%253A%2520activation%2520of%2520the%2520antitumor%2520ECTA%2520compound%2520NB1011%2520by%2520thymidylate%2520synthase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D179%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, H. M.</span><span> </span><span class="NLM_article-title">A novel approach to thymidylate synthase as a target for cancer chemotherapy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">â</span> <span class="NLM_lpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=446-452&author=Q.+Liauthor=C.+Boyerauthor=J.+Y.+Leeauthor=H.+M.+Shepard&title=A+novel+approach+to+thymidylate+synthase+as+a+target+for+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DBoyer%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DShepard%26aufirst%3DH.%2BM.%26atitle%3DA%2520novel%2520approach%2520to%2520thymidylate%2520synthase%2520as%2520a%2520target%2520for%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D446%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Neuteboom, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beryt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, H. M.</span><span> </span><span class="NLM_article-title">Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">â</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12477050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=377-384&author=S.+T.+Neuteboomauthor=P.+L.+Karjianauthor=C.+R.+Boyerauthor=M.+Berytauthor=M.+Pegramauthor=G.+M.+Wahlauthor=H.+M.+Shepard&title=Inhibition+of+cell+growth+by+NB1011+requires+high+thymidylate+synthase+levels+and+correlates+with+p53%2C+p21%2C+bax%2C+and+GADD45+induction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, Bax, and GADD45 induction</span></div><div class="casAuthors">Neuteboom, Saskia T. C.; Karjian, Patricia L.; Boyer, Christopher R.; Beryt, Malgorzhata; Pegram, Mark; Wahl, Geoffrey M.; Shepard, H. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">377-384</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">NB1011, a phosphoramidate deriv. of (E)-5-(2-bromovinyl)-2'-deoxyuridine, is a novel small mol. anticancer agent.  NB1011 is selectively active against tumor cells expressing high levels of thymidylate synthase (TS), a crit. enzyme in DNA biosynthesis.  NB1011 is different from the current TS-targeted drugs, which require inhibition of TS to be effective, because NB1011 cytotoxicity depends upon activation by TS.  Here we report a dose-dependent, antitumor activity of NB1011 against established Tomudex-resistant breast cancer (MCF7TDX) xenografts in athymic mice.  Against 5-fluorouracil-resistant colon carcinoma (H630R10) xenografts, NB1011 was as efficacious as irinotecan, a drug recently approved for the treatment of 5-fluorouracil-resistant colon cancer.  To gain insight into the mechanisms NB1011 uses to suppress cellular growth, we analyzed the downstream mol. events in the high TS-expressing MCF7TDX and RKOTDX cell lines upon NB1011 treatment.  NB1011 treatment increased the mRNA levels of p21, Bax, and GADD45.  Furthermore, NB1011 induced p53, p21, and Bax proteins specifically in high TS-expressing tumor cells, whereas no induction was obsd. in low TS-expressing tumor cells (MCF7) or normal cells (WI38).  Cell cycle anal. demonstrated that NB1011 treatment of MCF7TDX and RKOTDX cells resulted in an accumulation of cells in the G2-M phase of the cell cycle.  Altogether, our data indicate that the induction of the p53 target genes p21, bax, and GADD45, with a concomitant deregulation of the cell cycle, may represent one of the mechanisms by which NB1011 exerts its growth-suppressive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu8wvk2rEnyLVg90H21EOLACvtfcHk0lipBtE-eV5XyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7w%253D&md5=7a940b42399757200361320490841f62</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DBoyer%26aufirst%3DC.%2BR.%26aulast%3DBeryt%26aufirst%3DM.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26aulast%3DShepard%26aufirst%3DH.%2BM.%26atitle%3DInhibition%2520of%2520cell%2520growth%2520by%2520NB1011%2520requires%2520high%2520thymidylate%2520synthase%2520levels%2520and%2520correlates%2520with%2520p53%252C%2520p21%252C%2520bax%252C%2520and%2520GADD45%2520induction%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D377%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Boyer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuteboom, S. T.</span><span> </span><span class="NLM_article-title">Nucleoside transport inhibitors, dipyridamole and <i>p</i>-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=29-36&author=C.+R.+Boyerauthor=P.+L.+Karjianauthor=G.+M.+Wahlauthor=M.+Pegramauthor=S.+T.+Neuteboom&title=Nucleoside+transport+inhibitors%2C+dipyridamole+and+p-nitrobenzylthioinosine%2C+selectively+potentiate+the+antitumor+activity+of+NB1011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DC.%2BR.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%26atitle%3DNucleoside%2520transport%2520inhibitors%252C%2520dipyridamole%2520and%2520p-nitrobenzylthioinosine%252C%2520selectively%2520potentiate%2520the%2520antitumor%2520activity%2520of%2520NB1011%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2002%26volume%3D13%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Pegram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeon, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottlieb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cossum, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, H. J.</span><span> </span><span class="NLM_article-title">Enzyme catalyzed therapeutic activation of NB1011 (N) selectively targets thymidylate synthase (TS)-overexpressing tumor cells: phase I results</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=3144&author=M.+Pegramauthor=C.+H.+Yeonauthor=N.+Kuauthor=C.+Gottliebauthor=M.+Shepardauthor=P.+Cossumauthor=E.+Johnauthor=S.+Iqbalauthor=A.+Garciaauthor=H.+J.+Lenz&title=Enzyme+catalyzed+therapeutic+activation+of+NB1011+%28N%29+selectively+targets+thymidylate+synthase+%28TS%29-overexpressing+tumor+cells%3A+phase+I+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DYeon%26aufirst%3DC.%2BH.%26aulast%3DKu%26aufirst%3DN.%26aulast%3DGottlieb%26aufirst%3DC.%26aulast%3DShepard%26aufirst%3DM.%26aulast%3DCossum%26aufirst%3DP.%26aulast%3DJohn%26aufirst%3DE.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26atitle%3DEnzyme%2520catalyzed%2520therapeutic%2520activation%2520of%2520NB1011%2520%2528N%2529%2520selectively%2520targets%2520thymidylate%2520synthase%2520%2528TS%2529-overexpressing%2520tumor%2520cells%253A%2520phase%2520I%2520results%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Congiatu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M. D.</span><span> </span><span class="NLM_article-title">Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: design, synthesis and biological evaluation</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">â</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1081%2FNCN-200061774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=16247976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGisb3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=485-489&author=C.+Congiatuauthor=C.+McGuiganauthor=W.+G.+Jiangauthor=G.+Daviesauthor=M.+D.+Mason&title=Naphthyl+phosphoramidate+derivatives+of+BVdU+as+potential+anticancer+agents%3A+design%2C+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: Design, synthesis and biological evaluation</span></div><div class="casAuthors">Congiatu, C.; McGuigan, C.; Jiang, W. G.; Davies, G.; Mason, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">485-489</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The phosphoramidate technol. has been recently applied to BVdU, leading to NB1011 (NewBiotics Inc., California), a novel potential anticancer compd. recently entered into phase 2 of the clin. trials for colon cancer.  A new series of derivs. contg. naphthol and amino acid moieties as aryl masking group on the phosphate moiety, e.g. I, which has shown a significant increase in anticancer activity in preliminary biol. evaluations, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon_axc3D-7hLVg90H21EOLACvtfcHk0lhuNKw8tX3wNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGisb3O&md5=8a994c7a7114d116b0a830a0d5caaccf</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1081%2FNCN-200061774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-200061774%26sid%3Dliteratum%253Aachs%26aulast%3DCongiatu%26aufirst%3DC.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26aulast%3DDavies%26aufirst%3DG.%26aulast%3DMason%26aufirst%3DM.%2BD.%26atitle%3DNaphthyl%2520phosphoramidate%2520derivatives%2520of%2520BVdU%2520as%2520potential%2520anticancer%2520agents%253A%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2005%26volume%3D24%26spage%3D485%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Adjei, A. A.</span><span> </span><span class="NLM_article-title">Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4276s</span><span class="NLM_x">â</span> <span class="NLM_lpage">4280s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4276s-4280s&author=A.+A.+Adjei&title=Pemetrexed+%28ALIMTA%29%2C+a+novel+multitargeted+antineoplastic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DPemetrexed%2520%2528ALIMTA%2529%252C%2520a%2520novel%2520multitargeted%2520antineoplastic%2520agent%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D4276s%26epage%3D4280s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habeck, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. M.</span><span> </span><span class="NLM_article-title">Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA)</span> <span class="citation_source-journal">Adv. Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1998&pages=135-152&author=C.+Shihauthor=L.+L.+Habeckauthor=L.+G.+Mendelsohnauthor=V.+J.+Chenauthor=R.+M.+Schultz&title=Multiple+folate+enzyme+inhibition%3A+mechanism+of+a+novel+pyrrolopyrimidine-based+antifolate+LY231514+%28MTA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DC.%26aulast%3DHabeck%26aufirst%3DL.%2BL.%26aulast%3DMendelsohn%26aufirst%3DL.%2BG.%26aulast%3DChen%26aufirst%3DV.%2BJ.%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26atitle%3DMultiple%2520folate%2520enzyme%2520inhibition%253A%2520mechanism%2520of%2520a%2520novel%2520pyrrolopyrimidine-based%2520antifolate%2520LY231514%2520%2528MTA%2529%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D1998%26volume%3D38%26spage%3D135%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3-<i>d</i>]pyrimidine antifolates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5789</span><span class="NLM_x">â</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006933" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5789-5797&author=A.+Gangjeeauthor=Y.+Qiuauthor=W.+Liauthor=R.+L.+Kisliuk&title=Potent+dual+thymidylate+synthase+and+dihydrofolate+reductase+inhibitors%3A+classical+and+nonclassical+2-amino-4-oxo-5-arylthio-substituted-6-methylthieno%5B2%2C3-d%5Dpyrimidine+antifolates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm8006933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006933%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DPotent%2520dual%2520thymidylate%2520synthase%2520and%2520dihydrofolate%2520reductase%2520inhibitors%253A%2520classical%2520and%2520nonclassical%25202-amino-4-oxo-5-arylthio-substituted-6-methylthieno%255B2%252C3-d%255Dpyrimidine%2520antifolates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5789%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J. J.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-yl)thio]benz oyl}-<span class="smallcaps smallerCapital">l</span>-glutamic acid and <i>N</i>-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-yl)thio]benzoyl}-<span class="smallcaps smallerCapital">l</span>-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">â</span> <span class="NLM_lpage">7222</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058234m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7215-7222&author=A.+Gangjeeauthor=X.+Linauthor=R.+L.+Kisliukauthor=J.+J.+McGuire&title=Synthesis+of+N-%7B4-%5B%282%2C4-diamino-5-methyl-4%2C7-dihydro-3H-pyrrolo%5B2%2C3-d%5Dpyrimidin-6-yl%29thio%5Dbenz+oyl%7D-l-glutamic+acid+and+N-%7B4-%5B%282-amino-4-oxo-5-methyl-4%2C7-dihydro-3H-pyrrolo%5B2%2C3-d%5Dpyrimidin-6-yl%29thio%5Dbenzoyl%7D-l-glutamic+acid+as+dual+inhibitors+of+dihydrofolate+reductase+and+thymidylate+synthase+and+as+potential+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm058234m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058234m%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520N-%257B4-%255B%25282%252C4-diamino-5-methyl-4%252C7-dihydro-3H-pyrrolo%255B2%252C3-d%255Dpyrimidin-6-yl%2529thio%255Dbenz%2520oyl%257D-l-glutamic%2520acid%2520and%2520N-%257B4-%255B%25282-amino-4-oxo-5-methyl-4%252C7-dihydro-3H-pyrrolo%255B2%252C3-d%255Dpyrimidin-6-yl%2529thio%255Dbenzoyl%257D-l-glutamic%2520acid%2520as%2520dual%2520inhibitors%2520of%2520dihydrofolate%2520reductase%2520and%2520thymidylate%2520synthase%2520and%2520as%2520potential%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7215%26epage%3D7222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-<i>d</i>]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">â</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701052u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=68-76&author=A.+Gangjeeauthor=W.+Liauthor=J.+Yangauthor=R.+L.+Kisliuk&title=Design%2C+synthesis%2C+and+biological+evaluation+of+classical+and+nonclassical+2-amino-4-oxo-5-substituted-6-methylpyrrolo%5B3%2C2-d%5Dpyrimidines+as+dual+thymidylate+synthase+and+dihydrofolate+reductase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm701052u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701052u%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520classical%2520and%2520nonclassical%25202-amino-4-oxo-5-substituted-6-methylpyrrolo%255B3%252C2-d%255Dpyrimidines%2520as%2520dual%2520thymidylate%2520synthase%2520and%2520dihydrofolate%2520reductase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D68%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Liani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothem, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assaraf, Y. G.</span><span> </span><span class="NLM_article-title">Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">â</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fijc.10829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12494465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFKgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=587-599&author=E.+Lianiauthor=L.+Rothemauthor=M.+A.+Bunniauthor=C.+A.+Smithauthor=G.+Jansenauthor=Y.+G.+Assaraf&title=Loss+of+folylpoly-gamma-glutamate+synthetase+activity+is+a+dominant+mechanism+of+resistance+to+polyglutamylation-dependent+novel+antifolates+in+multiple+human+leukemia+sublines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of folylpoly-Î³-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines</span></div><div class="casAuthors">Liani, Esti; Rothem, Lilah; Bunni, Marlene A.; Smith, Clyde A.; Jansen, Gerrit; Assaraf, Yehuda G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-599</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We have studied the mol. basis of drug resistance in human CCRF-CEM leukemia cells exposed to high dose intermittent pulses of novel polyglutamatable antifolates that target various folate-dependent enzymes.  These include the dihydrofolate reductase (DHFR) inhibitors edatrexate, methotrexate and aminopterin, the thymidylate synthase (TS) inhibitors ZD1694 and GW1843, the glycinamide ribonucleotide formyltransferase (GARTF) inhibitor DDATHF as well as the multitargeted antifolate LY231514 inhibiting both TS, DHFR and GARTF.  Fourteen antifolate-resistant sublines were isolated, 11 of which displayed a drug resistance phenotype that was based on impaired folylpoly-Î³-glutamate synthetase (FPGS) activity as these cell lines: (1) typically lost 90-99% of parental FPGS activity; (2) expressed 1.4-3.3-fold less FPGS mRNA (only 4 cell lines); (3) displayed up to 105-fold resistance to polyglutamylation-dependent antifolates including ZD1694 and MTA; (4) retained sensitivity to polyglutamylation-independent antifolates including ZD9331 and PT523; (5) were up to 19-fold hypersensitive to the lipid-sol. antifolates trimetrexate and AG377; (6) had a normal or a small decrease in [3H]MTX transport; and (7) had a 2.1-8.3-fold decreased cellular folate pools and a consequently increased folate growth requirement.  The remaining 3 antifolate-resistant sublines lost 94-97% of parental [3H]MTX transport and thus displayed a high level resistance to all hydrophilic antifolates.  To screen for mutations in the hFPGS gene, we devised an RT-PCR single strand conformational polymorphism (SSCP) assay.  RT-PCR-SSCP anal. and DNA sequencing showed that only a single FPGS-deficient subline harbored an FPGS mutation (Cys346Phe).  Three-dimensional modeling of the human FPGS based on the crystal structure of Lactobacillus casei FPGS suggested that this mutation maps to the active site and interferes with the catalytic activity of the enzyme due to a putative bulky clash between the mutant Phe346 and a native Phe350 within Î±-helix A10 in a highly conserved C-terminal hydrophobic core.  This was consistent with a 23-fold decreased affinity of the mutant Cys346Phe FPGS for L-glutamate.  We conclude that decreased FPGS activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates upon a high-dose intermittent exposure schedule.  The finding that cells may exhibit 5 orders of magnitude of resistance to polyglutamylation-dependent antifolates but in the same time retain parental sensitivity or hypersensitivity to polyglutamylation-independent antifolates or lipophilic antifolates offers a potentially promising treatment strategy in the overcoming of FPGS-based anticancer drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwGTrWc0hDLbVg90H21EOLACvtfcHk0lhrtwfmVVm1GA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFKgtg%253D%253D&md5=afd837df1d51f37f5ab7f37593da931e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fijc.10829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10829%26sid%3Dliteratum%253Aachs%26aulast%3DLiani%26aufirst%3DE.%26aulast%3DRothem%26aufirst%3DL.%26aulast%3DBunni%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BA.%26aulast%3DJansen%26aufirst%3DG.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26atitle%3DLoss%2520of%2520folylpoly-gamma-glutamate%2520synthetase%2520activity%2520is%2520a%2520dominant%2520mechanism%2520of%2520resistance%2520to%2520polyglutamylation-dependent%2520novel%2520antifolates%2520in%2520multiple%2520human%2520leukemia%2520sublines%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2003%26volume%3D103%26spage%3D587%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifton, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davisson, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span> </span><span class="NLM_article-title">Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">16279</span><span class="NLM_x">â</span> <span class="NLM_lpage">16287</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00050a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=16279-16287&author=C.+A.+Schifferauthor=I.+J.+Cliftonauthor=V.+J.+Davissonauthor=D.+V.+Santiauthor=R.+M.+Stroud&title=Crystal+structure+of+human+thymidylate+synthase%3A+a+structural+mechanism+for+guiding+substrates+into+the+active+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi00050a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00050a007%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DDavisson%26aufirst%3DV.%2BJ.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520thymidylate%2520synthase%253A%2520a%2520structural%2520mechanism%2520for%2520guiding%2520substrates%2520into%2520the%2520active%2520site%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D16279%26epage%3D16287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Phan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlap, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">14170</span><span class="NLM_x">â</span> <span class="NLM_lpage">14177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14170-14177&author=J.+Phanauthor=D.+J.+Steadmanauthor=S.+Koliauthor=W.+C.+Dingauthor=W.+Minorauthor=R.+B.+Dunlapauthor=S.+H.+Bergerauthor=L.+Lebioda&title=Structure+of+human+thymidylate+synthase+suggests+advantages+of+chemotherapy+with+noncompetitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DSteadman%26aufirst%3DD.%2BJ.%26aulast%3DKoli%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DW.%2BC.%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DDunlap%26aufirst%3DR.%2BB.%26aulast%3DBerger%26aufirst%3DS.%2BH.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DStructure%2520of%2520human%2520thymidylate%2520synthase%2520suggests%2520advantages%2520of%2520chemotherapy%2520with%2520noncompetitive%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14170%26epage%3D14177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Gibson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">The R163K mutant of human thymidylate synthase is stabilized in an active conformation: structural asymmetry and reactivity of cysteine 195</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4636</span><span class="NLM_x">â</span> <span class="NLM_lpage">4643</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7019386" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=4636-4643&author=L.+M.+Gibsonauthor=L.+L.+Lovelaceauthor=L.+Lebioda&title=The+R163K+mutant+of+human+thymidylate+synthase+is+stabilized+in+an+active+conformation%3A+structural+asymmetry+and+reactivity+of+cysteine+195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fbi7019386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7019386%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DL.%2BM.%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DThe%2520R163K%2520mutant%2520of%2520human%2520thymidylate%2520synthase%2520is%2520stabilized%2520in%2520an%2520active%2520conformation%253A%2520structural%2520asymmetry%2520and%2520reactivity%2520of%2520cysteine%2520195%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D4636%26epage%3D4643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Structure of human thymidylate synthase under low-salt conditions</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">â</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=622-627&author=L.+L.+Lovelaceauthor=W.+Minorauthor=L.+Lebioda&title=Structure+of+human+thymidylate+synthase+under+low-salt+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DStructure%2520of%2520human%2520thymidylate%2520synthase%2520under%2520low-salt%2520conditions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D61%26spage%3D622%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2823</span><span class="NLM_x">â</span> <span class="NLM_lpage">2830</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi061309j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFOlur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=2823-2830&author=L.+L.+Lovelaceauthor=L.+M.+Gibsonauthor=L.+Lebioda&title=Cooperative+inhibition+of+human+thymidylate+synthase+by+mixtures+of+active+site+binding+and+allosteric+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cooperative Inhibition of Human Thymidylate Synthase by Mixtures of Active Site Binding and Allosteric Inhibitors</span></div><div class="casAuthors">Lovelace, Leslie L.; Gibson, Lydia M.; Lebioda, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2823-2830</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is a target in the chemotherapy of colorectal cancer and some other neoplasms.  It catalyzes the transfer of a Me group from methylenetetrahydrofolate to dUMP to form dTMP.  On the basis of structural considerations, we have introduced 1,3-propanediphosphonic acid (PDPA) as an allosteric inhibitor of human TS (hTS); it is proposed that PDPA acts by stabilizing an inactive conformer of loop 181-197.  Kinetic studies showed that PDPA is a mixed (noncompetitive) inhibitor vs. dUMP.  In contrast, vs. methylenetrahydrofolate at concns. lower than 0.25 Î¼M, PDPA is an uncompetitive inhibitor, while at PDPA concns. higher than 1 Î¼M the inhibition is noncompetitive , as expected.  At the concns. corresponding to uncompetitive inhibition, PDPA shows pos. cooperativity with an antifolate inhibitor, ZD9331, which binds to the active conformer.  PDPA binding leads to the formation of hTS tetramers, but not higher oligomers.  These data are consistent with a model in which hTS exists preferably as an asym. dimer with one subunit in the active conformation of loop 181-197 and the other in the inactive conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptxszjn8zrlbVg90H21EOLACvtfcHk0lhDQoiCSlYidw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFOlur8%253D&md5=41716ed87998f22bd2f0a93d0fc43e02</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi061309j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061309j%26sid%3Dliteratum%253Aachs%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DGibson%26aufirst%3DL.%2BM.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DCooperative%2520inhibition%2520of%2520human%2520thymidylate%2520synthase%2520by%2520mixtures%2520of%2520active%2520site%2520binding%2520and%2520allosteric%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D2823%26epage%3D2830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Lovelace, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebioda, L.</span><span> </span><span class="NLM_article-title">Variants of human thymidylate synthase with loop 181â197 stabilized in the inactive conformation</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1628</span><span class="NLM_x">â</span> <span class="NLM_lpage">1636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fpro.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=19569192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Cmu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1628-1636&author=L.+L.+Lovelaceauthor=S.+R.+Johnsonauthor=L.+M.+Gibsonauthor=B.+J.+Bellauthor=S.+H.+Bergerauthor=L.+Lebioda&title=Variants+of+human+thymidylate+synthase+with+loop+181%E2%88%92197+stabilized+in+the+inactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation</span></div><div class="casAuthors">Lovelace, Leslie L.; Johnson, Saphronia R.; Gibson, Lydia M.; Bell, Brittnaie J.; Berger, Sondra H.; Lebioda, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1628-1636</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Loop 181-197 of human thymidylate synthase (hTS) populates two major conformations, essentially corresponding to the loop flipped by 180Â°.  In one of the conformations, the catalytic Cys195 residue lies distant from the active site making the enzyme inactive.  Ligands stabilizing this inactive conformation may function as allosteric inhibitors.  To facilitate the search for such inhibitors, we have expressed and characterized several mutants designed to shift the equil. toward the inactive conformer.  In most cases, the catalytic efficiency of the mutants was only somewhat impaired with values of kcat/Km reduced by factors in a 2-12 range.  One of the mutants, M190K, is however unique in having the value of kcat/Km smaller by a factor of â¼7500 than the wild type.  The crystal structure of this mutant is similar to that of the wt. hTS with loop 181-197 in the inactive conformation.  However, the direct vicinity of the mutation, residues 188-194 of this loop, assumes a different conformation with the positions of CÎ± shifted up to 7.2 Ã.  This affects region 116-128, which became ordered in M190K while it is disordered in wt.  The conformation of 116-128 is however different than that obsd. in hTS in the active conformation.  The side chain of Lys190 does not form contacts and is in solvent region.  The very low activity of M190K as compared to another mutant with a charged residue in this position, M190E, suggests that the protein is trapped in an inactive state that does not equilibrate easily with the active conformer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0ApTtd59BrVg90H21EOLACvtfcHk0lgMWRf_XU4LcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Cmu74%253D&md5=725b3648f21947a674ad0bef18dc534d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fpro.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.171%26sid%3Dliteratum%253Aachs%26aulast%3DLovelace%26aufirst%3DL.%2BL.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DGibson%26aufirst%3DL.%2BM.%26aulast%3DBell%26aufirst%3DB.%2BJ.%26aulast%3DBerger%26aufirst%3DS.%2BH.%26aulast%3DLebioda%26aufirst%3DL.%26atitle%3DVariants%2520of%2520human%2520thymidylate%2520synthase%2520with%2520loop%2520181%25E2%2588%2592197%2520stabilized%2520in%2520the%2520inactive%2520conformation%26jtitle%3DProtein%2520Sci.%26date%3D2009%26volume%3D18%26spage%3D1628%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doorneweerd, D. D.</span><span> </span><span class="NLM_article-title">Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">â</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar7000815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=120-129&author=P.+S.+Lowauthor=W.+A.+Henneauthor=D.+D.+Doorneweerd&title=Discovery+and+development+of+folic-acid-based+receptor+targeting+for+imaging+and+therapy+of+cancer+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases</span></div><div class="casAuthors">Low, Philip S.; Henne, Walter A.; Doorneweerd, Derek D.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-129</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of folic-acid-targeted drug delivery has grown rapidly over the past decade, with several applications currently in human clin. trials.  Owing to the small size of the vitamin, its high affinity for the folate receptor (Kd = 10-10 M), the limited distribution of its receptor in normal tissues (primarily in kidney proximal tubules), the overexpression of its receptor in pathol. cells (upregulated in cancer cells and activated macrophages/monocytes), and its ease of conjugation to imaging and therapeutic agents, the use of folate as a targeting ligand for selective delivery of attached mols. to tumor tissues and sites of inflammation has attracted considerable interest.  This account reviews the discovery of folic acid as a targeting ligand and its current use in the selective targeting of drugs to malignant masses and sites of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM5t9sRmCOBbVg90H21EOLACvtfcHk0lgMWRf_XU4LcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D&md5=20620eb124d19634b10c27a48ed46849</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Far7000815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far7000815%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHenne%26aufirst%3DW.%2BA.%26aulast%3DDoorneweerd%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520folic-acid-based%2520receptor%2520targeting%2520for%2520imaging%2520and%2520therapy%2520of%2520cancer%2520and%2520inflammatory%2520diseases%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D120%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Salazar, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span> </span><span class="NLM_article-title">The folate receptor: What does it promise in tissue-targeted therapeutics?</span> <span class="citation_source-journal">Cancer Metastasis Rev</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs10555-007-9048-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17333345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1KqtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=141-152&author=M.+D.+Salazarauthor=M.+Ratnam&title=The+folate+receptor%3A+What+does+it+promise+in+tissue-targeted+therapeutics%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The folate receptor: What does it promise in tissue-targeted therapeutics?</span></div><div class="casAuthors">Salazar, Marcela D'Alincourt; Ratnam, Manohar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-152</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  For over a decade the folate receptor has been intensively investigated as a means for tumor-specific delivery of a broad range of exptl. therapies including several conceptually new treatments.  Despite a few set backs in clin. trials, the literature is replete with encouraging in vitro and pre-clin. studies of gynecol. and other tumors and more therapeutic approaches are ready for clin. testing.  Recent studies have added myelogenous leukemias to the list of candidate cancers for FR-targeted therapies.  Each approach faces unique challenges in translation that could be addressed through a mechanistic understanding of the function and expression of the receptor in the appropriate exptl. systems and by improvements in the technol.  This review discusses FR in the context of pos. recent developments in broad areas of FR-targeted therapy and attempts to highlight its potential and the anticipated challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFSZ_TRHfku7Vg90H21EOLACvtfcHk0lgMWRf_XU4LcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1KqtLY%253D&md5=3511e865e6f19fb1680364758b558465</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9048-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9048-0%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DM.%2BD.%26aulast%3DRatnam%26aufirst%3DM.%26atitle%3DThe%2520folate%2520receptor%253A%2520What%2520does%2520it%2520promise%2520in%2520tissue-targeted%2520therapeutics%253F%26jtitle%3DCancer%2520Metastasis%2520Rev%26date%3D2007%26volume%3D26%26spage%3D141%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Bavetsias, V.; Jackman, A. L.</span><span> </span><span class="NLM_article-title">Use of Cyclopenta[<i>g</i>]quinazoline Derivatives for Treating Cancer</span>. WO Patent 03/020300 A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=V.+Bavetsias&author=A.+L.+Jackman&title=Use+of+Cyclopenta%5Bg%5Dquinazoline+Derivatives+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBavetsias%26aufirst%3DV.%26atitle%3DUse%2520of%2520Cyclopenta%255Bg%255Dquinazoline%2520Derivatives%2520for%2520Treating%2520Cancer%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Gibbs, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theti, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span> </span><span class="NLM_article-title">BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">11721</span><span class="NLM_x">â</span> <span class="NLM_lpage">11728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=11721-11728&author=D.+D.+Gibbsauthor=D.+S.+Thetiauthor=N.+Woodauthor=M.+Greenauthor=F.+Raynaudauthor=M.+Valentiauthor=M.+D.+Forsterauthor=F.+Mitchellauthor=V.+Bavetsiasauthor=E.+Hendersonauthor=A.+L.+Jackman&title=BGC+945%2C+a+novel+tumor-selective+thymidylate+synthase+inhibitor+targeted+to+alpha-folate+receptor-overexpressing+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DD.%2BD.%26aulast%3DTheti%26aufirst%3DD.%2BS.%26aulast%3DWood%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DForster%26aufirst%3DM.%2BD.%26aulast%3DMitchell%26aufirst%3DF.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DHenderson%26aufirst%3DE.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26atitle%3DBGC%2520945%252C%2520a%2520novel%2520tumor-selective%2520thymidylate%2520synthase%2520inhibitor%2520targeted%2520to%2520alpha-folate%2520receptor-overexpressing%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D11721%26epage%3D11728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Prasanna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharjya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaram, P.</span><span> </span><span class="NLM_article-title">Synthetic interface peptides as inactivators of multimeric enzymes: inhibitory and conformational properties of three fragments from <i>Lactobacillus casei</i> thymidylate synthase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">6883</span><span class="NLM_x">â</span> <span class="NLM_lpage">6893</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9720989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=6883-6893&author=V.+Prasannaauthor=S.+Bhattacharjyaauthor=P.+Balaram&title=Synthetic+interface+peptides+as+inactivators+of+multimeric+enzymes%3A+inhibitory+and+conformational+properties+of+three+fragments+from+Lactobacillus+casei+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fbi9720989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9720989%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanna%26aufirst%3DV.%26aulast%3DBhattacharjya%26aufirst%3DS.%26aulast%3DBalaram%26aufirst%3DP.%26atitle%3DSynthetic%2520interface%2520peptides%2520as%2520inactivators%2520of%2520multimeric%2520enzymes%253A%2520inhibitory%2520and%2520conformational%2520properties%2520of%2520three%2520fragments%2520from%2520Lactobacillus%2520casei%2520thymidylate%2520synthase%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D6883%26epage%3D6893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Roehr, B.</span><span> </span><span class="NLM_article-title">Fomivirsen approved for CMV retinitis</span> <span class="citation_source-journal">J. Int. Assoc. Physicians AIDS Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11365956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A280%3ADC%252BD3M3ot1Gltg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=14-16&author=B.+Roehr&title=Fomivirsen+approved+for+CMV+retinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Fomivirsen approved for CMV retinitis</span></div><div class="casAuthors">Roehr B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the International Association of Physicians in AIDS Care</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">14-6</span>
        ISSN:<span class="NLM_cas:issn">1081-454X</span>.
    </div><div class="casAbstract">Fomivirsen (Vitravene) is the first antisense drug to be approved by the Food and Drug Administration (FDA), and it will be used for the treatment of cytomegalovirus (CMV) retinitis.  Fomivirsen is administered by intravitreal injection, and it can be used to help patients who are resistant to other treatments for CMV.  Isis Pharmaceuticals, Inc., manufacturer of fomivirsen, had a difficult time recruiting people for its clinical trials, due to the decline in the incidence of opportunistic infections.  However, Isis still made a presentation to the FDA, providing clinical data about patients, treatment methods, and outcomes.  A detailed explanation of antisense drugs is included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyD7emN5KWMjUE-swuRqsHfW6udTcc2eY5i6gc692BPrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3ot1Gltg%253D%253D&md5=03982d8d684e448ac425bf7b5b14a77e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoehr%26aufirst%3DB.%26atitle%3DFomivirsen%2520approved%2520for%2520CMV%2520retinitis%26jtitle%3DJ.%2520Int.%2520Assoc.%2520Physicians%2520AIDS%2520Care%26date%3D1998%26volume%3D4%26spage%3D14%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Kurreck, J.</span><span> </span><span class="NLM_article-title">RNA interference: from basic research to therapeutic applications</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1378</span><span class="NLM_x">â</span> <span class="NLM_lpage">1398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fanie.200802092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFOrsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1378-1398&author=J.+Kurreck&title=RNA+interference%3A+from+basic+research+to+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">RNA interference: from basic research to therapeutic applications</span></div><div class="casAuthors">Kurreck, Jens</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1378-1398</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Only ten years ago Andrew Fire and Craig Mello were able to show that double-stranded RNA mols. could inhibit the expression of homologous genes in eukaryotes.  This process, termed RNA interference, has developed into a std. method of mol. biol.  This review provides an overview of the mol. processes involved, with a particular focus on the posttranscriptional inhibition of gene expression in mammalian cells, the possible applications in research, and the results of the first clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkLDyjy36ynbVg90H21EOLACvtfcHk0lgs2sCdBiCfnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFOrsLY%253D&md5=20270346c637e5665350c2472a42b4f1</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fanie.200802092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200802092%26sid%3Dliteratum%253Aachs%26aulast%3DKurreck%26aufirst%3DJ.%26atitle%3DRNA%2520interference%253A%2520from%2520basic%2520research%2520to%2520therapeutic%2520applications%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D1378%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Berg, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguso, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMoor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincen, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koropatnick, J.</span><span> </span><span class="NLM_article-title">The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger</span> <span class="citation_source-journal">Curr Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.2174%2F1389450023347605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12102601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFyjtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=297-309&author=R.+W.+Bergauthor=P.+J.+Fergusoauthor=J.+M.+DeMoorauthor=M.+D.+Vincenauthor=J.+Koropatnick&title=The+means+to+an+end+of+tumor+cell+resistance+to+chemotherapeutic+drugs+targeting+thymidylate+synthase%3A+shoot+the+messenger"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger</span></div><div class="casAuthors">Berg, Randal W.; Ferguson, Peter J.; DeMoor, Janice M.; Vincent, Mark D.; Koropatnick, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-309</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review. Thymidylate synthase (TS) is an essential enzyme in the de novo synthesis of thymidylate and is required for DNA synthesis and cell proliferation in the absence of exogenous thymidine.  As a consequence, TS is a target for anticancer chemotherapy by several drugs, including 5-fluorouracil (5-FU) and raltitrexed (Tomudex), in the treatment of colorectal and other tumors.  TS overexpression due to increased gene transcription and mRNA translation can mediate drug resistance.  Decreased cellular uptake and polyglutamylation of TS-targeting drugs (raltitrexed, for example), increased drug efflux, altered metab. of cytotoxic drugs (for example, 5-FU), and other events can decrease the effectiveness of TS-targeting drugs.  Recent preclin. and clin. studies have addressed the resistance problem by using combinations of different drugs that target TS, or by combining TS-targeting and non-TS-targeting drugs.  One approach has been to circumvent and/or prevent TS-overexpression-mediated drug resistance by employing antisense oligodeoxynucleotides (ODNs) to downregulate TS mRNA and protein.  These studies have revealed that targeting the 3'-end of human TS mRNA downregulates TS mRNA and protein, inhibits cell proliferation, and sensitizes HeLa cells to raltitrexed, 5-FU, and 5-fluorodeoxyuridine (5-FUdR) in vitro.  In addn., growth of human HT29 colon carcinoma cell explants in immunocompromised mice is inhibited by antisense downregulation of TS.  TS-overexpressing, 5-FUdR-resistant HeLa cells have been established in order to examine resistance mechanisms and cross-resistance to 5-FU and raltitrexed.  Treatment of 5-FUdR-resistant HeLa cells with TS antisense ODN effectively reduces TS mRNA and protein and decreases the IC50 of 5-FUdR by â¤80%.  These results indicate that antisense ODN treatment improves the efficacy of anti-TS chemotherapeutic drugs in vitro and in vivo and is effective in overcoming tumor cell resistance to these drugs.  However, cellular responses to antisense targeting of different TS mRNA domains are complex.  In fact, targeting the translation start site (but not other TS mRNA regions) stimulates TS gene transcription.  Distinctive cellular responses to targeting of specific TS mRNA regions provide exciting therapeutic opportunities.  Antisense ODN treatment to modulate TS activity, in combination with TS-targeting chemotherapeutic drugs, has the potential to be an effective antitumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvtx_-z0oQFrVg90H21EOLACvtfcHk0li7QuVL9q-NYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFyjtbw%253D&md5=0f1f4718be9dc4777a7e2c3d3563f26e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2174%2F1389450023347605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450023347605%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DR.%2BW.%26aulast%3DFerguso%26aufirst%3DP.%2BJ.%26aulast%3DDeMoor%26aufirst%3DJ.%2BM.%26aulast%3DVincen%26aufirst%3DM.%2BD.%26aulast%3DKoropatnick%26aufirst%3DJ.%26atitle%3DThe%2520means%2520to%2520an%2520end%2520of%2520tumor%2520cell%2520resistance%2520to%2520chemotherapeutic%2520drugs%2520targeting%2520thymidylate%2520synthase%253A%2520shoot%2520the%2520messenger%26jtitle%3DCurr%2520Drug%2520Targets%26date%3D2002%26volume%3D3%26spage%3D297%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Berg, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koropatnick, D. J.</span><span> </span><span class="NLM_article-title">A âcombination oligonucleotideâ antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">â</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2Fsj.cgt.7700566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12679800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1CitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=278-286&author=R.+W.+Bergauthor=P.+J.+Fergusonauthor=M.+D.+Vincentauthor=D.+J.+Koropatnick&title=A+%E2%80%9Ccombination+oligonucleotide%E2%80%9D+antisense+strategy+to+downregulate+thymidylate+synthase+and+decrease+tumor+cell+growth+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance</span></div><div class="casAuthors">Berg, Randal W.; Ferguson, Peter J.; Vincent, Mark D.; Koropatnick, D. James</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) catalyzes de novo prodn. of thymidylate for DNA synthesis and cell proliferation.  As such, TS has been a target of antitumor chemotherapy for many years.  Our lab. has identified several antisense oligodeoxynucleotides (ODNs) that downregulate TS mRNA and protein, inhibit cell proliferation, and sensitize cells to TS-directed chemotherapeutic drugs.  Based on our observation that targeting distinct regions of the TS mRNA with a variety of antisense mols. resulted in differential effects on TS mRNA levels, it was hypothesized that use of multiple ODNs targeting distinct noncontiguous regions would result in synergistic or antagonistic interactions.  In this study, we report that some combinations of TS antisense ODNs were more effective at reducing TS mRNA abundance and inhibiting cell proliferation than the individual ODNs used alone.  However, in contrast to the effects on cell proliferation, the enhanced sensitivity to anti-TS chemotherapeutic drugs (i.e., raltitrexed and 5-fluorodeoxyuridine) that is achieved by treatment with individual ODNs was not further augmented by combined ODN treatment.  This suggests that ODNs targeting TS mRNA inhibit an alternative function of TS mRNA or protein, distinct from thymidylate prodn.  The results are evidence that the novel use of multiple antisense ODNs that target different regions of the same mRNA represents a general strategy to improve antisense effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr466IvcfF2gbVg90H21EOLACvtfcHk0li7QuVL9q-NYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1CitL8%253D&md5=a3cf97b8d5cb12a9297ef3b5fc462968</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700566%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DR.%2BW.%26aulast%3DFerguson%26aufirst%3DP.%2BJ.%26aulast%3DVincent%26aufirst%3DM.%2BD.%26aulast%3DKoropatnick%26aufirst%3DD.%2BJ.%26atitle%3DA%2520%25E2%2580%259Ccombination%2520oligonucleotide%25E2%2580%259D%2520antisense%2520strategy%2520to%2520downregulate%2520thymidylate%2520synthase%2520and%2520decrease%2520tumor%2520cell%2520growth%2520and%2520drug%2520resistance%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D278%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">DeMoor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koropatnick, J.</span><span> </span><span class="NLM_article-title">Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1006%2Fexcr.1998.4059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9716444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Shsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1998&pages=11-21&author=J.+M.+DeMoorauthor=M.+D.+Vincentauthor=O.+M.+Collinsauthor=J.+Koropatnick&title=Antisense+nucleic+acids+targeted+to+the+thymidylate+synthase+%28TS%29+mRNA+translation+start+site+stimulate+TS+gene+transcription"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription</span></div><div class="casAuthors">DeMoor, Janice M.; Vincent, Mark D.; Collins, Olga M.; Koropatnick, James</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is a key enzyme in the synthesis of DNA and a target for cancer chemotherapeutic agents.  Antisense TS nucleic acids may be useful in enhancing anticancer drug effectiveness.  MCF-7 and HeLa cells were transfected with vectors expressing antisense TS RNA or with antisense oligodeoxynucleotides (AS-ODNs) to different TS mRNA regions.  Antisense RNAs were targeted to 30 bases of the TS mRNA including part of the stem loop at the translation start site and to 30 bases spanning the exon1/exon2 boundary.  AS-ODNs were targeted to the translation start site and the translation stop site.  Antisense nucleic acids complementary to the translation start site (and not the exon1/exon2 boundary or translation stop site) significantly enhanced constitutive TS gene transcription.  Therefore, TS mRNA sequences appear to be involved in a novel pathway controlling TS gene transcription.  Induced transcription could hinder antisense-based attempts to inhibit TS and must be considered when designing such strategies.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR4HWJnb0H17Vg90H21EOLACvtfcHk0li7QuVL9q-NYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Shsbo%253D&md5=6e782938382b3ce5d18bab615e66b1a1</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1998.4059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1998.4059%26sid%3Dliteratum%253Aachs%26aulast%3DDeMoor%26aufirst%3DJ.%2BM.%26aulast%3DVincent%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DO.%2BM.%26aulast%3DKoropatnick%26aufirst%3DJ.%26atitle%3DAntisense%2520nucleic%2520acids%2520targeted%2520to%2520the%2520thymidylate%2520synthase%2520%2528TS%2529%2520mRNA%2520translation%2520start%2520site%2520stimulate%2520TS%2520gene%2520transcription%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1998%26volume%3D243%26spage%3D11%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Normanno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selvam, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliulo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span> </span><span class="NLM_article-title">Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">â</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9816209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK28XitVylsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=601-609&author=N.+Normannoauthor=C.+Biancoauthor=V.+Damianoauthor=E.+de+Angelisauthor=M.+P.+Selvamauthor=M.+Grassiauthor=G.+Magliuloauthor=G.+Tortoraauthor=A.+R.+Biancoauthor=J.+Mendelsohnauthor=D.+S.+Salomonauthor=F.+Ciardiello&title=Growth+inhibition+of+human+colon+carcinoma+cells+by+combinations+of+anti-epidermal+growth+factor-related+growth+factor+antisense+oligonucleotides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides</span></div><div class="casAuthors">Normanno, Nicola; Bianco, Caterina; Damiano, Vincenzo; De Angelis, Ernesto; Selvam, Mouna P.; Grassi, Michele; Magliulo, Gabriella; Tortora, Giampaolo; Bianco, Angelo R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-9</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GEO is a well-differentiated colon cancer cell line that coexpresses the epidermal growth factor-like growth factors CRIPTO (CR), amphiregulin (AR), and transforming growth factor Î± (TGF-Î±).  Antisense 20-mer phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against CR, AR, and TGF-Î± mRNAs were equipotent in their ability to inhibit both the anchorage-dependent growth and the anchorage-independent growth (AIG) of GEO cells, with a 50% inhibitory concn. of about 5 Î¼M in the AIG assay.  A supraadditive effect was obsd. when a combination of S-oligos was used.  For example, a combination of two different AS S-oligos (either AR + CR, or TGF-Î± + CR, or TGF-Î± + AR) at a concn. of 1 Î¼M each (total concn., 2 Î¼M) resulted in 50% inhibition of GEO cells AIG, whereas the use of each AS S-Oligo at a 1 or 2 Î¼M concn. resulted resp. in about 10 and 20% growth inhibition.  A combination of the three AS S-oligos was even more effective, resulting in about 60% inhibition of GEO cells AIG at a concn. of 1 Î¼M each (3 Î¼M total concn.).  The AS S-oligos were also able to inhibit specifically the expression of either AR, CR, or TGF-Î± proteins in GEO cells, as assessed using immunocytochem. or Western blot anal.  Finally, a supraadditive growth inhibitory effect of the AS S-oligos and an epidermal growth factor receptor-blocking antibody (monoclonal antibody 528) was obsd.  These data suggest that the use of a combination of AS S-oligos directed against different growth factors and antibodies directed against their receptors might result in an efficient inhibition of colon carcinoma cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO7y5iXyoXs7Vg90H21EOLACvtfcHk0lgjUG7StJK9mA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitVylsro%253D&md5=da42502ca8e2e5c9c31c553f7f8e6807</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNormanno%26aufirst%3DN.%26aulast%3DBianco%26aufirst%3DC.%26aulast%3DDamiano%26aufirst%3DV.%26aulast%3Dde%2BAngelis%26aufirst%3DE.%26aulast%3DSelvam%26aufirst%3DM.%2BP.%26aulast%3DGrassi%26aufirst%3DM.%26aulast%3DMagliulo%26aufirst%3DG.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DBianco%26aufirst%3DA.%2BR.%26aulast%3DMendelsohn%26aufirst%3DJ.%26aulast%3DSalomon%26aufirst%3DD.%2BS.%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DGrowth%2520inhibition%2520of%2520human%2520colon%2520carcinoma%2520cells%2520by%2520combinations%2520of%2520anti-epidermal%2520growth%2520factor-related%2520growth%2520factor%2520antisense%2520oligonucleotides%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1996%26volume%3D2%26spage%3D601%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Dorsett, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuschl, T.</span><span> </span><span class="NLM_article-title">siRNAs: applications in functional genomics and potential as therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=318-329&author=Y.+Dorsettauthor=T.+Tuschl&title=siRNAs%3A+applications+in+functional+genomics+and+potential+as+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDorsett%26aufirst%3DY.%26aulast%3DTuschl%26aufirst%3DT.%26atitle%3DsiRNAs%253A%2520applications%2520in%2520functional%2520genomics%2520and%2520potential%2520as%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D318%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Schmitz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">â</span> <span class="NLM_lpage">1435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1431-1435&author=J.+C.+Schmitzauthor=T.+M.+Chenauthor=E.+Chu&title=Small+interfering+double-stranded+RNAs+as+therapeutic+molecules+to+restore+chemosensitivity+to+thymidylate+synthase+inhibitor+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitz%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DSmall%2520interfering%2520double-stranded%2520RNAs%2520as%2520therapeutic%2520molecules%2520to%2520restore%2520chemosensitivity%2520to%2520thymidylate%2520synthase%2520inhibitor%2520compounds%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1431%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Shirasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakehata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurotaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagihashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinkawa, H.</span><span> </span><span class="NLM_article-title">Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=348&author=T.+Shirasakiauthor=S.+Maruyaauthor=H.+Mizukamiauthor=S.+Kakehataauthor=H.+Kurotakiauthor=S.+Yagihashiauthor=H.+Shinkawa&title=Effects+of+small+interfering+RNA+targeting+thymidylate+synthase+on+survival+of+ACC3+cells+from+salivary+adenoid+cystic+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShirasaki%26aufirst%3DT.%26aulast%3DMaruya%26aufirst%3DS.%26aulast%3DMizukami%26aufirst%3DH.%26aulast%3DKakehata%26aufirst%3DS.%26aulast%3DKurotaki%26aufirst%3DH.%26aulast%3DYagihashi%26aufirst%3DS.%26aulast%3DShinkawa%26aufirst%3DH.%26atitle%3DEffects%2520of%2520small%2520interfering%2520RNA%2520targeting%2520thymidylate%2520synthase%2520on%2520survival%2520of%2520ACC3%2520cells%2520from%2520salivary%2520adenoid%2520cystic%2520carcinoma%26jtitle%3DBMC%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. F.</span><span> </span><span class="NLM_article-title">Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">â</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1038%2Fsj.cgt.7700880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=16052228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsLnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=107-114&author=Z.+Yangauthor=A.+Cloudauthor=D.+Hughesauthor=L.+F.+Johnson&title=Stable+inhibition+of+human+thymidylate+synthase+expression+following+retroviral+introduction+of+an+siRNA+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene</span></div><div class="casAuthors">Yang, Z.; Cloud, A.; Hughes, D.; Johnson, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is an essential enzyme that synthesizes thymidylic acid in the de novo biosynthetic pathway.  Inhibiting TS enzyme activity with substrate or cofactor analogs leads to inhibition of DNA replication and cell death.  For this reason, TS is an important target enzyme for cancer chemotherapeutic drugs.  We describe an alternative approach to reducing cellular TS enzyme activity using short interfering RNA (siRNA) technol. to lower TS mRNA levels.  Plasmids that direct the synthesis of siRNAs that target nucleotides 898-916 and 965-983 (relative to the A of the translational start codon) of human TS mRNA were highly effective at reducing TS enzyme levels in transient transfection assays.  Infection of HeLa cells with retroviruses that contain the effective siRNA genes led to a stable 80-95% redn. of TS enzyme and mRNA.  A similar percent redn. in TS expression was obsd. in a cell line that overproduces TS enzyme 100-fold due to TS gene amplification.  Cells that exhibited the greatest redn. in TS enzyme level grew poorly in medium that lacked thymidine.  These observations suggest that siRNA approaches may provide an alternative therapeutic strategy to reduce TS enzyme levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-7T_sbBVcLVg90H21EOLACvtfcHk0ljkPOJjJiNoVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsLnF&md5=95da1a7d925fde2f3c4baf032c7bcb61</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700880%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DCloud%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DL.%2BF.%26atitle%3DStable%2520inhibition%2520of%2520human%2520thymidylate%2520synthase%2520expression%2520following%2520retroviral%2520introduction%2520of%2520an%2520siRNA%2520gene%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2006%26volume%3D13%26spage%3D107%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takechi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">The effect of reducing reagents on binding of thymidylate synthase protein to thymidylate synthase messenger RNA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">20289</span><span class="NLM_x">â</span> <span class="NLM_lpage">20293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=20289-20293&author=E.+Chuauthor=D.+M.+Voellerauthor=P.+F.+Morrisonauthor=K.+L.+Jonesauthor=T.+Takechiauthor=G.+F.+Maleyauthor=F.+Maleyauthor=C.+J.+Allegra&title=The+effect+of+reducing+reagents+on+binding+of+thymidylate+synthase+protein+to+thymidylate+synthase+messenger+RNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DE.%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DMorrison%26aufirst%3DP.%2BF.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DTakechi%26aufirst%3DT.%26aulast%3DMaley%26aufirst%3DG.%2BF.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520effect%2520of%2520reducing%2520reagents%2520on%2520binding%2520of%2520thymidylate%2520synthase%2520protein%2520to%2520thymidylate%2520synthase%2520messenger%2520RNA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D20289%26epage%3D20293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span> </span><span class="NLM_article-title">Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthase</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">â</span> <span class="NLM_lpage">4887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=4882-4887&author=X.+Linauthor=J.+Liuauthor=F.+Maleyauthor=E.+Chu&title=Role+of+cysteine+amino+acid+residues+on+the+RNA+binding+activity+of+human+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMaley%26aufirst%3DF.%26aulast%3DChu%26aufirst%3DE.%26atitle%3DRole%2520of%2520cysteine%2520amino%2520acid%2520residues%2520on%2520the%2520RNA%2520binding%2520activity%2520of%2520human%2520thymidylate%2520synthase%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D4882%26epage%3D4887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Voeller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac-Kaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegra, C. J.</span><span> </span><span class="NLM_article-title">The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=24-31&author=D.+M.+Voellerauthor=M.+Zajac-Kayeauthor=R.+J.+Fisherauthor=C.+J.+Allegra&title=The+identification+of+thymidylate+synthase+peptide+domains+located+in+the+interface+region+that+bind+thymidylate+synthase+mRNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoeller%26aufirst%3DD.%2BM.%26aulast%3DZajac-Kaye%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520identification%2520of%2520thymidylate%2520synthase%2520peptide%2520domains%2520located%2520in%2520the%2520interface%2520region%2520that%2520bind%2520thymidylate%2520synthase%2520mRNA%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D297%26spage%3D24%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">In vitro selected peptides bind with thymidylate synthase mRNA and inhibit its translation</span> <span class="citation_source-journal">Sci. China, Ser. C: Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">â</span> <span class="NLM_lpage">636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs11427-007-0078-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17879061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGgtbfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=630-636&author=S.+Yanauthor=R.+Niuauthor=Z.+Wangauthor=X.+Lin&title=In+vitro+selected+peptides+bind+with+thymidylate+synthase+mRNA+and+inhibit+its+translation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro selected peptides bind with thymidylate synthase mRNA and inhibit its translation</span></div><div class="casAuthors">Yan, Song; Niu, RongLi; Wang, Zheng; Lin, XiuKun</div><div class="citationInfo"><span class="NLM_cas:title">Science in China, Series C: Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">630-636</span>CODEN:
                <span class="NLM_cas:coden">SCCLFO</span>;
        ISSN:<span class="NLM_cas:issn">1006-9305</span>.
    
            (<span class="NLM_cas:orgname">Science in China Press</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS), an essential enzyme for catalyzing the biosynthesis of thymidylate, is a crit. therapeutic target in cancer therapy.  Recent studies have shown that TS functions as an RNA-binding protein by interacting with two different sequences on its own mRNA, thus, repressing translational efficiency.  In this study, peptides binding TS RNA with high affinity were isolated using mRNA display from a large peptide library (>1013 different sequences).  The randomized library was subjected up to twelve rounds of in vitro selection and amplification.  Comparing the amino acid compn. of the selected peptides (12th round, R12) with those from the initial random library (round zero, R0), the basic and arom. residues in the selected peptides were enriched significantly, suggesting that these peptide regions might be important in the peptide-TS mRNA interaction.  Categorizing the amino acids at each random position based on their physicochem. properties and comparing the distributions with those of the initial random pool, an obvious basic charge characteristic was found at positions 1, 12, 17 and 18, suggesting that basic side chains participate in RNA binding.  Secondary structure prediction showed that the selected peptides of R12 pool represented a helical propensity compared with R0 pool, and the regions were rich in basic residues.  The electrophoretic gel mobility shift and in vitro translation assays showed that the peptides selected using mRNA display could bind TS RNA specifically and inhibit the translation of TS mRNA.  The authors' results suggested that the identified peptides could be used as new TS inhibitors and developed to a novel class of anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1s-yLrntdbVg90H21EOLACvtfcHk0ljkPOJjJiNoVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGgtbfJ&md5=c063b8fb361cc813b9c721691b0bdb70</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2Fs11427-007-0078-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11427-007-0078-1%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DIn%2520vitro%2520selected%2520peptides%2520bind%2520with%2520thymidylate%2520synthase%2520mRNA%2520and%2520inhibit%2520its%2520translation%26jtitle%3DSci.%2520China%252C%2520Ser.%2520C%253A%2520Life%2520Sci.%26date%3D2007%26volume%3D50%26spage%3D630%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Chiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokosuka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imazeki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saisho, H.</span><span> </span><span class="NLM_article-title">Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">â</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=481-491&author=T.+Chibaauthor=O.+Yokosukaauthor=K.+Fukaiauthor=H.+Kojimaauthor=M.+Tadaauthor=M.+Araiauthor=F.+Imazekiauthor=H.+Saisho&title=Cell+growth+inhibition+and+gene+expression+induced+by+the+histone+deacetylase+inhibitor%2C+trichostatin+A%2C+on+human+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DYokosuka%26aufirst%3DO.%26aulast%3DFukai%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DTada%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DM.%26aulast%3DImazeki%26aufirst%3DF.%26aulast%3DSaisho%26aufirst%3DH.%26atitle%3DCell%2520growth%2520inhibition%2520and%2520gene%2520expression%2520induced%2520by%2520the%2520histone%2520deacetylase%2520inhibitor%252C%2520trichostatin%2520A%252C%2520on%2520human%2520hepatoma%2520cells%26jtitle%3DOncology%26date%3D2004%26volume%3D66%26spage%3D481%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Joseph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudduluru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vashistha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajitkumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somasundaram, K.</span><span> </span><span class="NLM_article-title">Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6304</span><span class="NLM_x">â</span> <span class="NLM_lpage">6315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=6304-6315&author=J.+Josephauthor=G.+Mudduluruauthor=S.+Antonyauthor=S.+Vashisthaauthor=P.+Ajitkumarauthor=K.+Somasundaram&title=Expression+profiling+of+sodium+butyrate+%28NaB%29-treated+cells%3A+identification+of+regulation+of+genes+related+to+cytokine+signaling+and+cancer+metastasis+by+NaB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DMudduluru%26aufirst%3DG.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DVashistha%26aufirst%3DS.%26aulast%3DAjitkumar%26aufirst%3DP.%26aulast%3DSomasundaram%26aufirst%3DK.%26atitle%3DExpression%2520profiling%2520of%2520sodium%2520butyrate%2520%2528NaB%2529-treated%2520cells%253A%2520identification%2520of%2520regulation%2520of%2520genes%2520related%2520to%2520cytokine%2520signaling%2520and%2520cancer%2520metastasis%2520by%2520NaB%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D6304%26epage%3D6315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.4161%2Fcbt.2.2.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=12589032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Wktbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=151-163&author=K.+B.+Glaserauthor=M.+J.+Staverauthor=J.+F.+Waringauthor=J.+Stenderauthor=R.+G.+Ulrichauthor=S.+K.+Davidsen&title=Gene+expression+profiling+of+multiple+histone+deacetylase+%28HDAC%29+inhibitors%3A+defining+a+common+gene+set+produced+by+HDAC+inhibition+in+T24+and+MDA+carcinoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Gene Expression Profiling of Multiple Histone Deacetylase (HDAC) Inhibitors: Defining a Common Gene Set Produced by HDAC Inhibition in T24 and MDA Carcinoma Cell Lines</span></div><div class="casAuthors">Glaser, Keith B.; Staver, Michael J.; Waring, Jeffrey F.; Stender, Joshua; Ulrich, Roger G.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-163</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Acetylation of histones in chromatin is one mechanism involved in the regulation of gene transcription and is tightly controlled by the balance of acetyltransferase and deacetylase (HDAC) activities.  In cancer, some genes are repressed by the inappropriate recruitment of HDACs, e.g., tumor suppressor genes.  To understand the genomic effects of HDAC inhibition on gene transcription we studied the gene expression profiles of T24 bladder and MDA breast carcinoma cells treated with three HDAC inhibitors, suberoylanilide hydroxamic acid, trichostatin A, and MS-27-275.  The gene expression profiles of the HDAC inhibitors were generally similar to one another and differed substantially from those produced by structurally related inactive analogs; consequently, the changes in gene expression are mechanism-based.  Hierarchical clustering of expression profiles demonstrated a greater similarity between the two hydroxamate-contg. inhibitors (suberoylanilide hydroxamic acid and trichostatin A) than with MS-27-275.  This difference was also supported by cell phenotypic expts.  As many genes were down-regulated as up-regulated by HDAC inhibitor treatment.  Comparison of the data sets defined a common ("core") set of 13 genes regulated by all of the HDAC inhibitors in three cell lines, 8 up-regulated and 5 down-regulated.  Ten of 13 genes were confirmed in dose response studies in T24 cells by quant.-PCR.  The core regulated genes are involved predominantly in cell cycle/apoptosis and DNA synthesis in response to HDAC inhibitors.  These data will aide in understanding the complex set of events in cells in response to chromatin remodeling induced by HDAC inhibition, which may be responsible for antitumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrObsWYbi10s7Vg90H21EOLACvtfcHk0lgr4M80MtTrpQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Wktbk%253D&md5=233ab984a51fe7e33afe39e23e4d56d4</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.4161%2Fcbt.2.2.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.2.2.349%26sid%3Dliteratum%253Aachs%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DStaver%26aufirst%3DM.%2BJ.%26aulast%3DWaring%26aufirst%3DJ.%2BF.%26aulast%3DStender%26aufirst%3DJ.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DGene%2520expression%2520profiling%2520of%2520multiple%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%253A%2520defining%2520a%2520common%2520gene%2520set%2520produced%2520by%2520HDAC%2520inhibition%2520in%2520T24%2520and%2520MDA%2520carcinoma%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D151%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3085</span><span class="NLM_x">â</span> <span class="NLM_lpage">3095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1158%2F1535-7163.MCT-06-0419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17172411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=3085-3095&author=J.+H.+Leeauthor=J.+H.+Parkauthor=Y.+Jungauthor=J.+H.+Kimauthor=H.+S.+Jongauthor=T.+Y.+Kimauthor=Y.+J.+Bang&title=Histone+deacetylase+inhibitor+enhances+5-fluorouracil+cytotoxicity+by+down-regulating+thymidylate+synthase+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells</span></div><div class="casAuthors">Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3085-3095</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) overexpression is a key determinant of 5-fluorouracil (5-FU) resistance in human cancer cells.  TS is also acutely up-regulated with 5-FU treatment, and, thus, novel strategies targeting TS down-regulation seem to be promising in terms of modulating 5-FU resistance.  Here, we report that histone deacetylase inhibitors can reverse 5-FU resistance by down-regulating TS.  By using cDNA microarrays and validation expts., we found that trichostatin A reduced the expression of both TS mRNA and TS protein.  Cotreatment with trichostatin A and cycloheximide restored TS mRNA expression, suggesting that TS mRNA is repressed through new protein synthesis.  On the other hand, TS protein expression was significantly reduced by lower doses of trichostatin A (50 nmol/L).  Mechanistically, TS protein was found to interact with heat shock protein (Hsp) complex, and trichostatin A treatment induced chaperonic Hsp90 acetylation and subsequently enhanced Hsp70 binding to TS, which led to the proteasomal degrdn. of TS protein.  Of note, combined treatment with low-dose trichostatin A and 5-FU enhanced 5-FU-mediated cytotoxicity in 5-FU-resistant cancer cells in accordance with TS protein down-regulation.  We conclude that a combinatorial approach using histone deacetylase inhibitors may be useful at overcoming 5-FU resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouIBtxuKajMrVg90H21EOLACvtfcHk0lgr4M80MtTrpQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrJ&md5=ded2a1c396bb4c63980caf5c5e560762</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0419%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJong%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520enhances%25205-fluorouracil%2520cytotoxicity%2520by%2520down-regulating%2520thymidylate%2520synthase%2520in%2520human%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D3085%26epage%3D3095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Fazzone, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labonte, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, R. D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">â</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1002%2Fijc.24403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=19384949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1alsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2009&pages=463-473&author=W.+Fazzoneauthor=P.+M.+Wilsonauthor=M.+J.+Labonteauthor=H.+J.+Lenzauthor=R.+D.+Ladner&title=Histone+deacetylase+inhibitors+suppress+thymidylate+synthase+gene+expression+and+synergize+with+the+fluoropyrimidines+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells</span></div><div class="casAuthors">Fazzone, William; Wilson, Peter M.; La Bonte, Melissa J.; Lenz, Heinz-Josef; Ladner, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-473</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Despite recent therapeutic advances, the response rates to chemotherapy for patients with metastatic colon cancer remain at â¼50% with the fluoropyrimidine, 5-fluorouracil (5-FU), continuing to serve as the foundation chemotherapeutic agent for the treatment of this disease.  Previous studies have demonstrated that overexpression of thymidylate synthase (TS) is a key determinant of resistance to 5-FU-based chemotherapy.  Therefore, there is a significant need to develop alternative therapeutic strategies to overcome TS-mediated resistance.  In this study, we demonstrate that the histone deacetylase inhibitors (HDACi) vorinostat and LBH589 significantly downregulate TS gene expression in a panel of colon cancer cell lines.  Downregulation of TS was independent of p53, p21 and HDAC2 expression and was achievable in vivo as demonstrated by mouse xenograft models.  We provide evidence that HDACi treatment leads to a potent transcriptional repression of the TS gene.  Combination of the fluoropyrimidines 5-FU or FUdR with both vorinostat and LBH589 enhanced cell cycle arrest and growth inhibition.  Importantly, the downstream effects of TS inhibition were significantly enhanced by this combination including the inhibition of acute TS induction and the enhanced accumulation of the cytotoxic nucleotide intermediate dUTP.  These data demonstrate that HDACi repress TS expression at the level of transcription and provides the first evidence suggesting a direct mechanistic link between TS downregulation and the synergistic interaction obsd. between HDACi and 5-FU.  This study provides rationale for the continued clin. evaluation of HDACi in combination with 5-FU-based therapies as a strategy to overcome TS-mediated resistance.  Â© 2009 UICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgVTmfMlPeLVg90H21EOLACvtfcHk0lh0PpHVUnNgLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1alsr4%253D&md5=a5ac1aab01cccf6435ce1c125e4d0c17</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fijc.24403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24403%26sid%3Dliteratum%253Aachs%26aulast%3DFazzone%26aufirst%3DW.%26aulast%3DWilson%26aufirst%3DP.%2BM.%26aulast%3DLabonte%26aufirst%3DM.%2BJ.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DLadner%26aufirst%3DR.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520suppress%2520thymidylate%2520synthase%2520gene%2520expression%2520and%2520synergize%2520with%2520the%2520fluoropyrimidines%2520in%2520colon%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2009%26volume%3D125%26spage%3D463%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejligbjerg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, J. W.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">â</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs00280-006-0374-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=17124594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFSktb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=275-283&author=A.+Tumberauthor=L.+S.+Collinsauthor=K.+D.+Petersenauthor=A.+Thougaardauthor=S.+J.+Christiansenauthor=M.+Dejligbjergauthor=P.+B.+Jensenauthor=M.+Sehestedauthor=J.+W.+Ritchie&title=The+histone+deacetylase+inhibitor+PXD101+synergises+with+5-fluorouracil+to+inhibit+colon+cancer+cell+growth+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The histone deacetylase inhibitor PXD101 synergizes with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo</span></div><div class="casAuthors">Tumber, Anthony; Collins, Laura S.; Petersen, Kamille Dumong; Thougaard, Annemette; Christiansen, Sanne J.; Dejligbjerg, Marielle; Jensen, Peter Buhl; Sehested, Maxwell; Ritchie, James W. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-283</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACi) inhibit the growth of cancer cells, and combinations of HDACi with established chemotherapeutics can lead to synergistic effects.  We have investigated effects of PXD101 (HDACi in phase II clin. trials) in combination with 5-fluorouracil, on tumor cell proliferation and apoptosis both in vitro and in vivo.  HCT116 cells were studied using proliferation and clonogenic assays.  Synergistic inhibition of proliferation and clonogenicity was detd. by incubation with PXD101 and 5-fluorouracil, and anal. using CalcuSyn software.  The effect of combining PXD101 and 5-fluorouracil on apoptosis was examd. in vitro using PARP-cleavage and TUNEL.  Finally, the effectiveness of combining PXD101 and 5-fluorouracil in vivo was tested using both HT-29 and HCT116 xenograft models.  Synergistic inhibition of proliferation and clonogenicity was obtained when HCT116 cells were incubated with PXD101 and 5-fluorouracil. 5-fluorouracil combined with PXD101 also increased DNA fragmentation and PARP cleavage in HCT116 cells.  Incubation with PXD101 down regulated thymidylate synthase expression in HCT116 cells.  In vivo studies, using mouse HT29 and HCT116 xenograft models, showed improved redns. in tumor vol. compared to single compd., when PXD101 and 5-fluorouracil were combined.  PXD101 and 5-fluorouracil synergistically combine in their antitumor effects against colon cancer cells in vitro and show enhanced activity when combined in vivo.  Based on the results presented herein, a rationale for the use of PXD101 and 5-fluorouracil in combination in the clinic has been demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprUVcvv3EFHbVg90H21EOLACvtfcHk0lh0PpHVUnNgLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFSktb8%253D&md5=e0be2de4a9657a408a94fff99b85d03f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs00280-006-0374-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-006-0374-7%26sid%3Dliteratum%253Aachs%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DL.%2BS.%26aulast%3DPetersen%26aufirst%3DK.%2BD.%26aulast%3DThougaard%26aufirst%3DA.%26aulast%3DChristiansen%26aufirst%3DS.%2BJ.%26aulast%3DDejligbjerg%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26aulast%3DRitchie%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520PXD101%2520synergises%2520with%25205-fluorouracil%2520to%2520inhibit%2520colon%2520cancer%2520cell%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D60%26spage%3D275%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Phiel, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenther, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span> </span><span class="NLM_article-title">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">36734</span><span class="NLM_x">â</span> <span class="NLM_lpage">36741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1074%2Fjbc.M101287200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11473107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=36734-36741&author=C.+J.+Phielauthor=F.+Zhangauthor=E.+Y.+Huangauthor=M.+G.+Guentherauthor=M.+A.+Lazarauthor=P.+S.+Klein&title=Histone+deacetylase+is+a+direct+target+of+valproic+acid%2C+a+potent+anticonvulsant%2C+mood+stabilizer%2C+and+teratogen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span></div><div class="casAuthors">Phiel, Christopher J.; Zhang, Fang; Huang, Eric Y.; Guenther, Matthew G.; Lazar, Mitchell A.; Klein, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36734-36741</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Valproic acid is widely used to treat epilepsy and bipolar disorder and is also a potent teratogen, but its mechanisms of action in any of these settings are unknown.  We report that valproic acid activates Wnt-dependent gene expression, similar to lithium, the mainstay of therapy for bipolar disorder.  Valproic acid, however, acts through a distinct pathway that involves direct inhibition of histone deacetylase (IC50 for HDAC1=0.4 mM).  At therapeutic levels, valproic acid mimics the histone deacetylase inhibitor trichostatin A, causing hyperacetylation of histones in cultured cells.  Valproic acid, like trichostatin A, also activates transcription from diverse exogenous and endogenous promoters.  Furthermore, valproic acid and trichostatin A have remarkably similar teratogenic effects in vertebrate embryos, while non-teratogenic analogs of valproic acid do not inhibit histone deacetylase and do not activate transcription.  Based on these observations, we propose that inhibition of histone deacetylase provides a mechanism for valproic acid-induced birth defects and could also explain the efficacy of valproic acid in the treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZDcS-2BIhrVg90H21EOLACvtfcHk0lh0PpHVUnNgLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D&md5=6c1daa317cfb4c0cd8c8c2a21d4ed07c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M101287200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M101287200%26sid%3Dliteratum%253Aachs%26aulast%3DPhiel%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DE.%2BY.%26aulast%3DGuenther%26aufirst%3DM.%2BG.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DHistone%2520deacetylase%2520is%2520a%2520direct%2520target%2520of%2520valproic%2520acid%252C%2520a%2520potent%2520anticonvulsant%252C%2520mood%2520stabilizer%252C%2520and%2520teratogen%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D36734%26epage%3D36741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4592</span><span class="NLM_x">â</span> <span class="NLM_lpage">4597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4592-4597&author=A.+Saitoauthor=T.+Yamashitaauthor=Y.+Marikoauthor=Y.+Nosakaauthor=K.+Tsuchiyaauthor=T.+Andoauthor=T.+Suzukiauthor=T.+Tsuruoauthor=O.+Nakanishi&title=A+synthetic+inhibitor+of+histone+deacetylase%2C+MS-27-275%2C+with+marked+in+vivo+antitumor+activity+against+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DMariko%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DY.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DA%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520MS-27-275%252C%2520with%2520marked%2520in%2520vivo%2520antitumor%2520activity%2520against%2520human%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4592%26epage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Prasad, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasquez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J. E.</span><span> </span><span class="NLM_article-title">Histone acetylation resulting in resistance to methotrexate in choroid plexus cells</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">â</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1007%2Fs11060-008-9709-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=18853233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFemuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2009&pages=279-286&author=P.+Prasadauthor=H.+Vasquezauthor=C.+M.+Dasauthor=V.+Gopalakrishnanauthor=J.+E.+Wolff&title=Histone+acetylation+resulting+in+resistance+to+methotrexate+in+choroid+plexus+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Histone acetylation resulting in resistance to methotrexate in choroid plexus cells</span></div><div class="casAuthors">Prasad, Preethi; Vasquez, Hernan; Das, Chandra M.; Gopalakrishnan, Vidya; Wolff, Johannes E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-286</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Choroid plexus carcinomas are rare tumors that typically occur in young children.  Prognosis is poor, and very little information is available to optimize treatment protocols.  We used a cell culture model to evaluate whether combining chemotherapeutic agents such as methotrexate with histone deacetylase inhibitors (HDACI) such as valproic acid and MS-275 could improve efficacy.  Valproic acid increased the cytotoxicity of radiation and of all the chemotherapeutic agents in Z310 and SV11 mouse choroid plexus cell lines, with the exception of methotrexate.  Both HDACIs made choroid plexus cells resistant to this folate antagonist.  Searching for a mol. explanation, we found that thymidylate synthase was up regulated when the cells were incubated with HDACI.  We also confirmed this finding in human choroid plexus carcinoma cells.  Methotrexate should not be combined with HDACI in the treatment of choroid plexus carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrceiWihiATn7Vg90H21EOLACvtfcHk0lhR4Zv189vxKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFemuw%253D%253D&md5=4d3c4ba48a3c0c32047167162ffb5a67</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs11060-008-9709-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-008-9709-z%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DP.%26aulast%3DVasquez%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DC.%2BM.%26aulast%3DGopalakrishnan%26aufirst%3DV.%26aulast%3DWolff%26aufirst%3DJ.%2BE.%26atitle%3DHistone%2520acetylation%2520resulting%2520in%2520resistance%2520to%2520methotrexate%2520in%2520choroid%2520plexus%2520cells%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2009%26volume%3D91%26spage%3D279%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Banerjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnieders, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertino, J. R.</span><span> </span><span class="NLM_article-title">Role of E2F-1 in chemosensitivity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4292</span><span class="NLM_x">â</span> <span class="NLM_lpage">4296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4292-4296&author=D.+Banerjeeauthor=B.+Schniedersauthor=J.+Z.+Fuauthor=D.+Adhikariauthor=S.+C.+Zhaoauthor=J.+R.+Bertino&title=Role+of+E2F-1+in+chemosensitivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DSchnieders%26aufirst%3DB.%26aulast%3DFu%26aufirst%3DJ.%2BZ.%26aulast%3DAdhikari%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DS.%2BC.%26aulast%3DBertino%26aufirst%3DJ.%2BR.%26atitle%3DRole%2520of%2520E2F-1%2520in%2520chemosensitivity%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4292%26epage%3D4296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Kasahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, K.</span><span> </span><span class="NLM_article-title">Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2707</span><span class="NLM_x">â</span> <span class="NLM_lpage">2711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=10914714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslent7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=2707-2711&author=M.+Kasaharaauthor=Y.+Takahashiauthor=T.+Nagataauthor=S.+Asaiauthor=T.+Eguchiauthor=Y.+Ishiiauthor=M.+Fujiiauthor=K.+Ishikawa&title=Thymidylate+synthase+expression+correlates+closely+with+E2F1+expression+in+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer</span></div><div class="casAuthors">Kasahara, Mitsuko; Takahashi, Yasuo; Nagata, Toshihito; Asai, Satoshi; Eguchi, Teruo; Ishii, Yukimoto; Fujii, Masashi; Ishikawa, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2707-2711</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is thought to be one of the target genes that the E2F1 transcription factor binds to and regulates.  However, the relationship between the expressions of TS and E2F1 in primary colon cancer specimens remains unclear.  The aim of this study was to define the relation of TS and E2F1 gene expressions in tumor samples from 23 colon cancer patients.  TS and E2F1 gene expressions were measured by TaqMan reverse transcription-PCR assay using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal std. and expressed as a TS:GAPDH or E2F1:GAPDH mRNA ratio.  A close relationship was found between TS gene expression and E2F1 gene expression (r2 = 0.598, P < 0.001) in 23 tumor samples analyzed.  Surprisingly, a high correlation between TS gene expression and E2F1 gene expression was obsd. even in advanced tumors from stage IV colon cancer patients.  These results suggest that transcription of the TS gene may be regulated by E2F1 in primary colon cancer specimens and that this gene-regulatory pathway from E2F1 to TS may be highly conserved during malignant progression.  Four of the 23 patients showed TS overexpression with increased E2F1 expression.  These results suggest that the ability of a tumor to increase TS expression may possibly be due to an over-expression of E2F1.  Although the no. of patients was relatively small, our study provides new insights into the mol. mechanisms underlying the regulation of TS expression in colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2WUpu1vYDvLVg90H21EOLACvtfcHk0liClOYNxa1M0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslent7k%253D&md5=953be1f26734387a1832df737f0f6914</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasahara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DAsai%26aufirst%3DS.%26aulast%3DEguchi%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DK.%26atitle%3DThymidylate%2520synthase%2520expression%2520correlates%2520closely%2520with%2520E2F1%2520expression%2520in%2520colon%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D2707%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Abe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, M.</span><span> </span><span class="NLM_article-title">UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">â</span> <span class="NLM_lpage">1198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1111%2Fj.1349-7006.2000.tb00904.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=11092986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVGrsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2000&pages=1192-1198&author=S.+Abeauthor=T.+Kubotaauthor=Y.+Otaniauthor=T.+Furukawaauthor=M.+Watanabeauthor=K.+Kumaiauthor=M.+Kitajima&title=UCN-01+%287-hydroxystaurosporine%29+enhances+5-fluorouracil+cytotoxicity+through+down-regulation+of+thymidylate+synthetase+messenger+RNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA</span></div><div class="casAuthors">Abe, Sadanori; Kubota, Tetsuro; Otani, Yoshihide; Furukawa, Toshiharu; Watanabe, Masahiko; Kumai, Koichiro; Kitajima, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1192-1198</span>CODEN:
                <span class="NLM_cas:coden">JJCREP</span>;
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">UCN-01 (7-hydroxystaurosporine) is a newly developed cell cycle inhibitor known to have several modes of action, including inhibition of cyclin-dependent kinase, induction of p21 and suppression of pRb phosphorylation.  In order to test a combination therapy of UCN-01 and 5-fluorouracil (5-FU), growth inhibition of CRL 1420 (MIA PaCa-2; undifferentiated pancreatic carcinoma) by four different treatments was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay.  The treatments used were UCN-01 alone, 5-FU alone, 5-FU followed by UCN-01 (5-FU/UCN-01) and UCN-01 followed by 5-FU (UCN-01/5-FU).  We also assessed changes in thymidylate synthetase (TS) mRNA levels, TS activity, and 5-FU incorporation by RNA (F-RNA) for each treatment.  Although treatment with UCN-01 alone, 5-FU alone, and 5-FU/UCN-01 inhibited CRL 1420 growth in a concn.-dependent manner, treatment with UCN-01/5-FU inhibited the growth of CRL 1420 synergistically at less than 1 Î¼g/mL drug concn.  The down-regulation of TS mRNA by UCN-01 resulted in stable total TS and decreased free TS, and UCN-01/5-FU resulted in enhanced thymidylate synthetase inhibition rate (TSIR) compared to UCN-01 alone and 5-FU/UCN-01.  This increased TSIR due to UCN-01 pretreatment was accompanied by elevated F-RNA concns. in the UCN-01/5-FU treatment.  The suppression of TS mRNA and TS activity by UCN-01 may lead to higher sensitivity of tumor cells to 5-FU and may explain the synergistic antitumor effect of UCN-01/5-FU.  In conclusion, low concns. of UCN-01 (from 0.01 to 1 Î¼g/mL) may be clin. useful, affording low cytotoxicity of UCN-01, while enhancing the antitumor effect of 5-FU.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMMmiqbxphbLVg90H21EOLACvtfcHk0liClOYNxa1M0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVGrsbw%253D&md5=00c49b03b6c95f0f3394ef3b232dc689</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2000.tb00904.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2000.tb00904.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DS.%26aulast%3DKubota%26aufirst%3DT.%26aulast%3DOtani%26aufirst%3DY.%26aulast%3DFurukawa%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DKumai%26aufirst%3DK.%26aulast%3DKitajima%26aufirst%3DM.%26atitle%3DUCN-01%2520%25287-hydroxystaurosporine%2529%2520enhances%25205-fluorouracil%2520cytotoxicity%2520through%2520down-regulation%2520of%2520thymidylate%2520synthetase%2520messenger%2520RNA%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D2000%26volume%3D91%26spage%3D1192%26epage%3D1198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Hsueh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2201</span><span class="NLM_x">â</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=9748140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADyaK1cXmslCjsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2201-2206&author=C.+T.+Hsuehauthor=D.+Kelsenauthor=G.+K.+Schwartz&title=UCN-01+suppresses+thymidylate+synthase+gene+expression+and+enhances+5-fluorouracil-induced+apoptosis+in+a+sequence-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner</span></div><div class="casAuthors">Hsueh, Chung-Tsen; Kelsen, David; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2201-2206</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">UCN-01, a protein kinase C/cyclin-dependent kinase inhibitor, suppressed thymidylate synthase (TS) protein expression in a dose-dependent manner with near complete suppression at 1 Î¼M after a 24-h exposure in human gastric cancer cell line SK-GT5.  Other protein kinase C/cyclin-dependent kinase inhibitors, including flavopiridol and safingol, has a similar effect on TS protein expression, but to a lesser degree.  Moreover, UCN-01 repressed the induction of TS after 5-fluorouracil (FU) exposure by 90-95% and significantly enhanced the induction of apoptosis by FU from 4-8% with either FU or UCN-01 alone to 46Â±1% (P < 0.005 vs. either single drug, reverse sequence, or the combination) when UCN-01 was given after FU.  The effect of UCN-01 on TS was assocd. with a dose-dependent suppression of the E2F-1 protein, a transcriptional activator of TS.  Northern blot anal. revealed that TS mRNA levels decreased gradually as the concn. of UCN-01 increased, but that E2F-1 mRNA levels remained relatively unchanged.  UCN-01 may provide a novel way to enhance cellular sensitivity toward FU by means of suppressing TS expression mediated mainly by down-regulation of E2F-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnPdAGouTdUbVg90H21EOLACvtfcHk0liClOYNxa1M0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslCjsL0%253D&md5=1ac3b728bfa620b9072d98661f6305ae</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DC.%2BT.%26aulast%3DKelsen%26aufirst%3DD.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DUCN-01%2520suppresses%2520thymidylate%2520synthase%2520gene%2520expression%2520and%2520enhances%25205-fluorouracil-induced%2520apoptosis%2520in%2520a%2520sequence-dependent%2520manner%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D2201%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Giacinti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, A.</span><span> </span><span class="NLM_article-title">RB and cell cycle progression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5220</span><span class="NLM_x">â</span> <span class="NLM_lpage">5227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5220-5227&author=C.+Giacintiauthor=A.+Giordano&title=RB+and+cell+cycle+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiacinti%26aufirst%3DC.%26aulast%3DGiordano%26aufirst%3DA.%26atitle%3DRB%2520and%2520cell%2520cycle%2520progression%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5220%26epage%3D5227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Kim, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span> </span><span class="NLM_article-title">Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_elocation-id">e5933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=H.+P.+Kimauthor=Y.+K.+Yoonauthor=J.+W.+Kimauthor=S.+W.+Hanauthor=H.+S.+Hurauthor=J.+Parkauthor=J.+H.+Leeauthor=D.+Y.+Ohauthor=S.+A.+Imauthor=Y.+J.+Bangauthor=T.+Y.+Kim&title=Lapatinib%2C+a+dual+EGFR+and+HER2+tyrosine+kinase+inhibitor%2C+downregulates+thymidylate+synthase+by+inhibiting+the+nuclear+translocation+of+EGFR+and+HER2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BP.%26aulast%3DYoon%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DHur%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DIm%26aufirst%3DS.%2BA.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DT.%2BY.%26atitle%3DLapatinib%252C%2520a%2520dual%2520EGFR%2520and%2520HER2%2520tyrosine%2520kinase%2520inhibitor%252C%2520downregulates%2520thymidylate%2520synthase%2520by%2520inhibiting%2520the%2520nuclear%2520translocation%2520of%2520EGFR%2520and%2520HER2%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Okabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukioka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span> </span><span class="NLM_article-title">Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">â</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm901869w&amp;key=10.1158%2F1535-7163.MCT-07-0567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm901869w&amp;key=18347146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm901869w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWgsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=599-606&author=T.+Okabeauthor=I.+Okamotoauthor=S.+Tsukiokaauthor=J.+Uchidaauthor=T.+Iwasaauthor=T.+Yoshidaauthor=E.+Hatashitaauthor=Y.+Yamadaauthor=T.+Satohauthor=K.+Tamuraauthor=M.+Fukuokaauthor=K.+Nakagawa&title=Synergistic+antitumor+effect+of+S-1+and+the+epidermal+growth+factor+receptor+inhibitor+gefitinib+in+non-small+cell+lung+cancer+cell+lines%3A+role+of+gefitinib-induced+down-regulation+of+thymidylate+synthase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase</span></div><div class="casAuthors">Okabe, Takafumi; Okamoto, Isamu; Tsukioka, Sayaka; Uchida, Junji; Iwasa, Tsutomu; Yoshida, Takeshi; Hatashita, Erina; Yamada, Yuki; Satoh, Taroh; Tamura, Kenji; Fukuoka, Masahiro; Nakagawa, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Somatic mutations in the epidermal growth factor receptor (EGFR) gene are assocd. with the therapeutic response to EGFR tyrosine kinase inhibitors (TKI) in patients with advanced non-small cell lung cancer (NSCLC).  The response rate to these drugs remains low, however, in NSCLC patients with wild-type EGFR alleles.  Combination therapies with EGFR-TKIs and cytotoxic agents are considered a therapeutic option for patients with NSCLC expressing wild-type EGFR.  We investigated the antiproliferative effect of the combination of the oral fluorouracil S-1 and the EGFR-TKI gefitinib in NSCLC cells of differing EGFR status.  The combination of 5-fluorouracil and gefitinib showed a synergistic antiproliferative effect in vitro in all NSCLC cell lines tested.  Combination chemotherapy with S-1 and gefitinib in vivo also had a synergistic antitumor effect on NSCLC xenografts regardless of the absence or presence of EGFR mutations.  Gefitinib inhibited the expression of the transcription factor E2F-1, resulting in the down-regulation of thymidylate synthase at the mRNA and protein levels.  These observations suggest that gefitinib-induced down-regulation of thymidylate synthase is responsible, at least in part, for the synergistic antitumor effect of combined treatment with S-1 and gefitinib and provide a basis for clin. evaluation of combination chemotherapy with S-1 and EGFR-TKIs in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgRKGk_6XgyrVg90H21EOLACvtfcHk0lhheGi5ICSKUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWgsr4%253D&md5=fcc52c6b30f6a8b7a0bb45669bb7dec4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0567%26sid%3Dliteratum%253Aachs%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DI.%26aulast%3DTsukioka%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DJ.%26aulast%3DIwasa%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DHatashita%26aufirst%3DE.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DFukuoka%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DK.%26atitle%3DSynergistic%2520antitumor%2520effect%2520of%2520S-1%2520and%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520gefitinib%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cell%2520lines%253A%2520role%2520of%2520gefitinib-induced%2520down-regulation%2520of%2520thymidylate%2520synthase%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D599%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HVY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HVY','PDB','1HVY'); return false;">PDB: 1HVY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ONB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ONB','PDB','2ONB'); return false;">PDB: 2ONB</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901869w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm901869w%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901869w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677abd2d6ac13ddd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
